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ABSTRACT
The genetic analysis and isolation of cDNA clones for a
constitutively expressed hepatic cytochrome P-450 (P-450), PB-1
(P450-2C), which is involved in chemical detoxification is described
for mice and humans. A rat PB-1 cDNA was used to isolate a full
length human PB-1 cDNA clone from a liver cDNA library. The human
cDNA clone, pHL5,5, has an insert of approximately 2 kilobases.
Sequence analysis proved it to be full length encoding a protein of
490 amino acids 70% of which show identity with rat and rabbit PB-1
forms. The N-terminal sequence derived from pHL5,5 matches a human
P-450 involved in the polymorphic oxidative metabolism of the drug
mephenytoin (an anti-convulsant). Southern blot analysis indicated
there are a minimum of 2 to 3 PB-1 genes in human; these were mapped
to human chromosome 10q24.2 by a combination of somatic cell
genetics and in situ hybridization. This locus was designated
P450C2C.
A companion study was initiated in mice with the rat PB-1 cDNA
clone, pTF-1. Southern blot analysis of rat and mouse genomic DNA
detected 7-8 PB-1 genes in rodents which by a combination of mapping
in recombinant inbred mouse strains, somatic cell hybrids and in
situ hybridization with mouse PB-1 cDNA clones were shown to be
clustered and mapped to the D1/D2 region of mouse chromosome 19.
This locus was termed P450-2C. This region of mouse chromosome 19
contains a number of markers which are also on the long arm of human
chromosome 10, indicating that these chromosomes contain conserved
linkage groups. Three DNA haplotypes, termed P450-2Ca, P450-2C^ and
P450-2Cc, were observed in recombinant inbred mouse strains. P450-
2C showed tight linkage with constitutive aryl hydrocarbon
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hydroxylase (AHH) activity. In vitro evidence suggests that this
activity is also determined by human PB-1 P-450. Thus this locus
could be involved in determining the metabolic fate of polycyclic
aromatic hydrocarbons which are potential carcinogens or mutagens.
The regulation of a number of P-450s, including PB-1, was
investigated in rats and mice and a number of these were found to be
regulated by pituitary factors in both species. A number of species
differences in response to glucocorticoids and pituitary factors
were also noted. The developmental regulation and tissue specific
expression of P-450s and a number of other liver specific genes were
also investigated. In general it was found that the foetal liver
and yolk sac, two tissues of different embryonic lineage, shared a
similar pattern of expression but are independently programmed for
expression of the same set of serum protein genes.
Sequence comparison of rabbit, rat and human PB-1 cDNA clones
was unable to identify orthologous forms between these species. The
data suggests that the members of this family have become
sufficiently diverged between these species that they no longer
share common endogenous function in relation to the metabolism of
steroids. This is discussed in relation to the rodent as a model
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1.1. General background to drug detoxification
We live in a chemically challenging environment. The number of
different products arising in nature and those from human synthetic
capability via the agro-chemical industrial complex is in the order
of hundreds of thousands. The diversity of human exposure can be
illustrated by the content of one cigarette which contains over 1200
different compounds (Steadman, 1968). Western life style can be
characterized by fifty years of good living before the incipient
effects of chronic toxic exposure are felt and seen. Over a
lifetime we absorb, iribibe, ingest and synthesize a wide range of
potential toxins.
The introduction of new compounds into the environment has led
to the establishment of a causal relationship between specific
toxins and their pathological effects. The incidence of these
effects can be estimated by a comparison of epidemiologic and patho¬
logical data from different countries. On this basis 70% of all
cancers have been attributed to environmental factors (Doll and
Peto, 1981). For example Japan has a higher incidence of stomach
cancer and a lower incidence of intestinal cancer than in the United
States (Haenszel and Kurihara, 1968). The cancer pattern of
Japanese immigrants in the United States however reflects the normal
U.S. incidence, which indicates that a non-genetic component is
involved in cancer initiation. Such studies indicate that most of
the major forms of cancer are avoidable. The use of tobacco is
associated with 30% of all cancer deaths in the United States and
Britain (Doll and Peto, 1981; Wynder and Gori, 1977) and probably
responsible for more chronic effects such as emphysema and heart
damage. Diet has been suggested to be another major cause of cancer
(Ames, 1983; Ames et al 1987; Doll and Peto, 1981). These studies
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suggest that a change from excess consumption of fat-rich products
and alcohol to fibre-rich cereals, vegetables and fruits would have
a beneficial effect on cancer incidence. The contribution of diet
indicates that the problem of foreign compounds or xenobiotics in
the environment is not a new one.
The type of compounds that are harmful to living organisms are
those that cannot be incoporated into normal biological processes.
These foreign compounds are termed xenobiotics. The exposure to
xenobiotics during biological development has undoubtedly led to the
evolution of a group of complex mechanisms which provide protection
against chemical challenge. These include a number of anatomical,
physiological and enzymatic systems that provide a means of
resistance to harmful xenobiotics and have, an obvious selective
advantage. Skin/for example/acts as a major barrier to the outside
environment. Most foreign compounds are hydrophobic and as such
they would remain in the lipophilic ■ environment of a multicellular
organism indefinitely unless there was a mechanism for their
excretion. In mammals the major routes for the elimination of waste
products and other redundant molecules involves the atjudous
solutions urine and bile. A number of enzymatic mechanisms have
evolved to convert a plethora of structurally diverse foreign
compounds to more polar derivatives and therefore make them suitable
for rapid elimination (Jakoby, 1980). The liver is the major (but
tkt
not^only) organ of detoxification where enzymes catalysing the
oxidation, reduction, hydrolysis, rearrangement and conjugation of a
broad range of foreign compounds are located.
Understanding the mechanisms of xenobiotic detoxification is a
major goal of research into cancer, heart disease and aging. The
major contribution to cell damage is the formation of chemically
- 3 -
reactive intermediates and oxygen radicals (Miller, 1970;
Heidelberger, 1975) which can form covalent adducts with cell
macromolecules (Miller, 1951). There are many non-enzymatic
substances which act as anti-oxidants in the cell (Ames, 1983;
Temple and Basu, 1987) which include small molecules in the diet
including glut athione which acts as a nucleophil/c acceptor for
harmful electrophiles (Jakoby and Habig, 1980). Paradoxically as a
result of the multip licity and nature of biochemical reactions
involved in foreign compound metabolism^certain compounds are formed
which are pharmacologically and toxicologically more potent than the
parent substrate. Many carcinogens are metabolized to chemically
reactive ultimate carcinogens before they can exert a harmful effect
(Rinkus and Legator, 1979; Singer and Kusmicrek, 1982).
The major enzyme system in the initial conversion of hydro¬
phobic substances to hydrophilic products in mammalian cells is the
cytochrome P-450 (P-450) monooxygenase system. Subsequent reactions
further enhance the polarity of the xenobiotic which leads to its
ultimate excretion. The initial oxidation of a foreign compound can
be mediated by several different P-450s resulting in several
different metabolic pathways. The ultimate balance between these
pathways will determine the fate of a foreign compound. For
example, there are competing pathways in the metabolism of benze
(a)pyrene (B[a]P) (Nebert and Jenson, 1979) which will determine its
potential as a carcinogen. Cytochrome P-450s are characterised by
their broad substrate specificity. As a consequence this leads to
low turnover rates and relatively poor substrate affinities. This
can be compensated by high substrate concentrations, especially in
the liver, the major site of this enzyme system (Astrom and
DePierre, 1986; Waxman, 1986). The multiplicity of the P-450
system and the broad spectrum of enzymatic activities begs the
question what is the function of these enzymes in the absence of
xenobiotic challenge, i.e. do they have a natural substrate?
e
The epidemiological studies indicate that there is a non-genetic
component in susceptibility to environmental cancers. There is
strong evidence that genetically determined differences in drug
metabolizing enzymes will also have a profound effect in determining
a hosts response to xenobiotic challenge (Kalow et al, 1985). For
example adverse drug reactions in humans can be associated with
genetically determined differences in oxidative metabolism (Mahgoub
et al, 1977). A fruitful line of research would be to identify the
genetic factors which regulate the expression of drug metabolizing
enzymes especially the cytochrome P-450 monooxygenase system whose
central role in the initial conversion of xenobiotic compounds is
undisputed.
1.2. Drug metabolism
The study of drug metabolizing enzymes has diverse roots^these
being in pharmacology, cancer, chemical toxicity and mutation
research. These research areas are all related to different aspects
of the metabolism of foreign compounds. The consequence of this
broad research is that the literature on drug metabolizing enzymes
is eclectic to read and cover, with a certain inbuilt redundancy in
many of the published papers. In addition, drug metabolising
enzymes can be involved in many diverse physiological processes
ranging from reproductive physiology (Gustafsson et al, 1983) to
mechanisms of oxygen stress (Gonder et al, 1985). One way to
illustrate the diversification of drug metabolising enzymes is in
relation to chemical carcinogenesis.
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1.2.1. Chemical carcinogenesis and toxins
Historically the area of chemical carcinogenesis can be
divided into five periods. The hypotheses formulated during these
periods formed the basis of current concepts in this area. The
first four periods covering the last 250 years up to about 1950 were
concerned with the nature of chemical toxicity and carcinogenesis,
the last period deals with the characterization of the enzymes
involved in these processes. The last period will be covered in its
own sections.
The first crucial observation was the causal relationship
between chemical exposure and cancer. This showed that environ¬
mental chemicals can be harmful to living organisms. There were
early examples of etiological cancer agents, notably snuff. Hill
(1761) published Cautions against the immoderate use of Snuff
because of the fatal nasal polypusses (cancers) associated with its
excessive use. The irritation associated with the growths led Hill
to speculate as to whether snuff was a causative agent or accent¬
uating an underlying trend (Boutwell, 1974). Apparently, the
practice of tobacco smoking in the seventeenth century was as
subversive as illegal drug use is today (Redmond, 1970). Another
early report was by Percival Potts on the unusually high incidence
of scrotal cancer in London chimney sweeps (Potts, 1775, quoted in
Miller, 1970). This was subsequently attributed to their exposure
to tars and soots. Chimney sweeps from Yorkshire and Europe had a
lower incidence of this type of cancer (when compared to London
chimney sweeps) because of better hygiene and use of protective
clothing (Butlin, 1892, quoted in Miller, 1978). Subsequent to
these studies the observations that industrial exposure to certain
chemicals leads to an increase in specific types of cancer was the
- 6 -
basis for establishing the causal relationship between the two.
This led to the identification of specific groups of workers at risk
from exposure to particular compounds (reviewed by Wynder and Gori,
1977). For example, an increased risk of bladder cancer was found
in workers in the asphalt, coal and pitch, dye stuffs, paint and
leather and shoe industries.
The second period of drug metabolism and cancer (1900- 1930s)
can be associated with research into the nature of this
relationship. Since human neoplasia cannot be experimentally
induced or manipulated^a variety of animal tumour models were
developed with rabbits, dogs, mice and rats. Initially, these model
systems were usually based on topical administration of the
suspected complex chemical mixtures and extracts with subsequent
analysis of the extent of tumour formation. The first reports on
the induction of skin cancer in rabbits and mice by coal tar was
achieved by Yamagiwa and Ichikawa (1915 and 1918). Advancements in
chemical techniques then allowed the fractionation and
identification of the chemical components responsible. It was noted
that tars and oils contained compounds with unusual fluorescence
spectra which suggested the active agents were aromatic hydrocarbons
(Hieger, 1930). The first synthetic carcinogen
dibenz(a,h,)anthracene (DBA) (Fig. 1.1) was identified in 1930
(Kennaway and Hieger, 1930). It was tested because of its
fluorescence spectrum which W(aS similar to those observed in coal
and tar products. B[a]P was first isolated from coal and shown to
be carcinogenic in 1933 (Cook et al, 1933). New carcinogens are
contiguously being discovered from exposure of humans to various
compounds. To date over 500 carcinogens have been identified
(Rinkus and Legator, 1979) unequivocally. In addition the U.S.
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FIGURE 1.1.
Chemical structures of known carcinogens
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National Cancer Institute lists nearly a 1000 suspected carcinogens
(Technical Resources Inc, 1986).
The third period of research in the late 1930s was
characterized by attempts to relate chemical structure to carcino¬
genic potency in order to devise models for chemical carcinogenesis.
It was thought that fluorescence could be used as a general
indicator of carcinogenic activity but this correlat)c^did not hold
(Hieger, 1930; Auerbach, 1976). Such attempts were unsuccessful
as more and more diverse compounds were implicated as carcinogens
and mutagens (Miller, 1978). One of the reasons for the diversity
became apparent with the discovery of the multistage process of
carcinogenesis (Berenblum, 1941). In these studies the development
of mouse skin tumours could be delineated into three events;
initiation, promotion and progression. Initiation could be affected
by a single low dose of carcinogen such as an alkylating agent or
polycyclic aromatic hydrocarbon (PAH) which may cause changes in
cells which/by themselves/will.not cause the development of a
tumour. The second step, promotion, occurs over a period of weeks
and its early stages are reversible by removal of the promoter
(Boutwell, 1974) until commitment to a malignant tumour. The
classic promoting agent is croton oil (Berenblum, 1941) whose active
agent is a phorbol ester (Hecker, 1971). A promoter is an
incomplete carcinogen and can only promote the carcinogenic process
begun by an initiating agent which can be a chemical or a virus
(Balmain and Pagnelll, 1983; Brown et al, 1986).
The fourth period (1940-1950s) was the realization that many
chemical carcinogens and probably mutagens required metabolic
activation before their harmful effects are manifested. For example
it was shown that fluorescent derivatives of B[a]P were covalently
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linked to mouse skin proteins after topical administration to live
animals but this did not occur on dead skin (Miller, 1951). Thus
the search for the reactive products of such a process and whether
their formation had an enzymatic basis was initiated. The
acceptance of the Watson-Crick model for the structure of the
genetic material, DNA (Watson and Crick, 1953) had an obvious
revolutionary effect on this research area because it provided a
target for chemical carcinogens and mutagens. Previous concepts of
the gene included an assortment of protein, protein-DNA complexes
and nuclear versus plasma genes (Miller, 1951; Judson, 1979).
1.2.2. Mechanisms of chemical carcinogenesis and detection
The administration of many carcinogens to laboratory animals
led to the identification of covalent DNA, RNA and protein adducts
(Lawley and Brooks, 1963; Gelboin, 1968; Weinstein et al, 1976;
Heidelberger, 1975; Ashurst et al, 1983; Liehr et al, 1987;
Bradlow et al, 1986). In general, many carcinogens require
metabolic activation to reactive intermediates before adducts are
formed. Once these intermediates have been identified they can be
synthesized in vitro and used as direct carcinogenic and mutagenic
agents (Miller et al, 1961). In this case metabolism of xenobiotics
can be regarded as a black box which identifies the ultimate
carcinogens in vivo. Much of the work on detection of important
intermediates in metabolic activation can be summarized as follows
(Miller, 1970; Miller, 1978; Heidelberger, 1975):
1) Chemical carcinogens that are normally not chemically
reactive must be converted to a chemically reactive form.
2) The activated metabolite is an electrophilic agent.
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3) This activated metabolite reacts with nucleophilic groups
in cellular macromolecules to initiate carcinogenesis.
The requirement for metabolic activation was used in an
innovative step by Ames who incorporated rat liver fractions (which
contain the activating enzymes) in a mutagenesis assay based on
Salmonella Typhimurium (Ames et al, 1973a; Ames et al, 1973b; Ames
et al, 1975). This assay system allowed the identification of
potential carcinogens and the role of metabolic activation. In this
assay revertants in strains of S. Typhimurium were selected that had
defined mutations in the histidine operon. These strains were also
deficient in DNA repair and 1ipopolysaccharide synthesis which
increased the sensitivity of the assay by preventing the repair of
DNA adducts and also by facilitating drug transport into the
bacterium. Reversions of his" to his+ were used to detect mutagens
in the presence of mammalian microsomes. Using this test it was
shown that up to 95% of carcinogens are mutagens (McCann et al,
1975; Rinkus and Legator, 1979). However not all mutagens are
carcinogen (Nagao and Sugimura, 1978) and some carcinogens are not
genotoxic (Warren et al, 1980). These tests can also be used to
measure inactivation of direct acting carcinogens and for studying
genetic and tissue specific differences in carcinogenic activation
by using samples from different sources (Hutton et al, 1979). The
assay can also be used to assess the role of specific activating or
deactivating enzymes. For example the mutagenic potential of B[a]P
is altered when C57BL/6 mice are treated with 3 methylcholanthrene
((3MC) (Fig. 1.1.) prior to microsome preparation. The net number
of revertants per plate increases from 57 to 182 in the presence of
control and 3MC treated C57BL/6 microsomes respectively (Hutton et
al_, 1979).
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The combination of carcinogen and mutagenicity tests allows
some insight into the mechanism of actions of potentially harmful
compounds to be observed. Cancer results from diverse types of
damage to genetic material which can involve recessive and dominant
mutations (Bishop, 1987), large scale rearrangements of DNA (Yunis,
1983) and point mutations (Barbacid, 1986). The idea that direct
mutagenesis of DNA leads to neoplasia derives support from the
effect of carcinogen/ DNA adducts on DNA replication, repair and
transcription in vitro (Waring, 1981) and the activation of
transforming genes in vivo by carcinogenic agents (Barbacid, 1986).
A possible relationship between carcinogens and chromosomal defects
and certain neoplasias involving deletions or trisomy (Mitelman et
al, 1981) has been proposed. In a study of patients with acute non-
lymphocytic leukemia (ANLL) 75% of patients with a history of
exposure to mutagens and carcinogens had chromosomal abnormalities
as compared to 32% of a non-exposed group with ANLL. A specific
range of defects associated with chromosomes 5, 7 and 8 was found in
the exposed group (Mitelman et al, 1981). This group included of
people exposed to solvents (chemical/engineering/print workers),
insecticides (farmers) and petro products (bus/truck
drivers/petroleum workers). It was concluded that the karyotype of
leukemia cells was influenced by the pattern of exposure. This type
of pattern was also seen in patients with secondary ANLL resulting
from therapies involving chemo- and radiation therapy for a previous
malignancy (Rowley et al, 1981). Such changes may provide markers
for ANLL due to chemical exposure.
Before considering direct acting or metabolically activated
carcinogens in more detail it is worth noting a class of compounds
which does not obey the rules for metabolic mutation. The
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administration of clofibrate, an hypolidemic agent caused peroxisome
proliferation in the parenchymal cells of the liver (Hess et al,
1965). The compound was demonstrated to cause hepatocarcinogenesis
(Reddy et al, 1980). However it was negative on Salmonella
mutagenesis assays and did not appear to have genotoxic effects
(Warren et al, 1980). When tested in vivo and in vitro for DNA
adduct formation by labelling and chromatography no DNA adducts
were found on exposure of rat liver to clofibrate. These assays
were extremely sensitive and would detect 1 adduct/10-'-^ nucleotides
(Gupta et al, 1985). By these criteria cloribrate is not a chemical
carcinogen according to the Millers (Miller, 1970; Miller, 1978).
Clofibrate and other classes of compounds are thought to initiate
hepatocarcinogenesis by virtue of their ability to cause peroxisome
proliferation. Several functions are associated with peroxisomes
which include respiration, glycerolipid and fatty acid metabolism,
alcohol oxidation and peroxidation (Tolbert, 1981). Increased
levels of H2O2 generated with peroxisomes are normally metabolised
by catalase and other peroxidases. However, leakage of H2O2 from
peroxisomes would have harmful effects on the rest of the cell.
The subsequent formation of oxygen radicals can give rise to
genotoxic effects and the peroxidation of lipid membranes (Goel et
al, 1986). Clofibric acid is no longer used as a drug, however
other classes of peroxisome proliferators are used extensively in
the plastics industry and may thus pose a potential environmental
risk (Rao and Reddy, 1987). The tissue specificity of the response
has been postulated to be due to lipid receptor mediated mechanisms
which induces a pleiotrophic response in liver (Rao and Reddy,
1987) .
2-Acetylaminofluorene (AAF) is a potent genotoxic hepato-
carcinogen in rats and mice (Miller et al, 1961) which is eventually
converted to a reactive intermediate N acetoxyaminofluorene (N-Aco-
AF) and N-hydroxyacetylaminofluorene (N-OH-AF) (Bartsch et al,
1972). The major effect of these derivates is to mutate DNA. N-
Aco-AF has been shown to bind DNA in vitro in a covalent manner
(Drinkwater et al, 1978). Coliphage JZ&174 DNA modified by acteyl-
aminofluorene derivatives exhibit premature termination by DNA
polymerases at the site of modification (Moore et al, 1981).
Product analysis of modified DNA with N-Aco-AF shows that the
majority of the interactive products are at guanine residues
(Lutgerink et al, 1984). These adducts also affect transcription by
a T7 RNA polymerase on a plasmid containing T7 promoter (Nath et al,
1987), the mechanism of which is postulated to be due to a slowing
in elongation rate by T7 polymerase.
Protooncogenes have been identified as genetic targets that
play a key role in carcinogenesis (Varmus, 1984). Transfection
assays based on immortalized but non-transformed cells can detect
activated protooncogenes, particularly members of the ras family
from a variety of human tumours (Barbacid, 1986). The ras genes are
known to acquire their transforming properties by point mutation at
12th and 61st codons. The ras protooncogenes code for proteins
called p21 of 188 or 189 amino acid residues. Genetic damage
appears to release the biochemical activities of certain proto¬
oncogenes from allosteric controls. The ras protein, p21, binds GDP
and GTP and has GTPase activity. This enzymatic activity is reduced
in mutant p21 proteins coded by activated oncogenes (Colby et al,
1986) which may result in sustained levels of otherwise normal bio¬
chemical activities. Mouse hepatomas induced by N-OH-AF have been
shown to have activated c Ha-ras protooncogenes with mutations at
the 61st codon (Wiseman et al, 1986). Selective oligonucleotide
hybridization demonstrated a CG to AT transition at the first
position of the 61st codon which would cause a glutamine to lysine
amino acid change in the polypeptide. This type of mutation would
agree with the preference of AAF derivatives for deoxyguanosine
(Lutgerink et al, 1984; Singer and Kusmierek, 1982).
Direct mutation of c Ha-ras in rats treated with alkylating
agents can produce mammary tumours, for example N-nitroso-N-methyl-
urea (NMU) mutated the rat c Ha-ras at codon 12 causing CG to AT
transition. Although NMU does not require metabolic activation it
does show a restricted tissue specificity in the site of the tumours
it induces (Heidelberger, 1975) which is indicative that mutagenesis
by NMU is not sufficient for neoplasia to be initiated. Other
factors such as requirement for target cells to be in a
proliferative state, DNA repair and detoxification enzymes are also
postulated to be involved (Barbacid, 1986).
Polycyclic hydrocarbons have also been shown to be directly
involved in animal carcinogenesis models. The binding of B[a]P to
DNA was completely dependant on the presence of liver microsomes
(Gelboin, 1968). B[a]Ps can be metabolized to a variety of products
with different carcinogenic potential (Nebert and Jensen, 1979).
The non-K region dihydrodiols of 7 methylbenz(a)anthracene, 7, 12,
dimethyl benze(a)-anthracene and B[a]P (Fig. 1.2) have been shown to
transform a mouse fibroblast cell line at high efficiency,
approximately 20 foci/10^ surviving cells (Marquardt et al, 1976).
These experiments also showed that the parent compounds had
negligible transforming capabilities, 0.4-2 foci/10^ surviving
cells. Modified derivatives at other positions had insignificant
transforming capabilities indicating that these metabolites are not
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FIGURE 1.2.
Metabolic activation of Benzo[a]pyrenes. The 7,8 oxide is
predominantly formed by cytochrome P-450s following diol formation
by epoxide hydrase, the 7,8 and 9,10-epoxide is also formed by
cytochrome P-450. The diol epoxides are more active, forming
adducts and causing malignant transformation of mouse fibroblasts
(Nebert and Jensen, 1979; Marquardt et al, 1976). Hydroxylation at
1,3,7 and 9 positions leads to non-active metabolites which are
excreted following sulphate conjugation.
Metabolic activation of Benzo[a]pyrenes.
involved in cancer initiation. B[a]P epoxides have also been found
to bind DNA and RNA covalently (Drinkwater et al, 1978; Weinstein
et al, 1976) and cause premature termination by T7 RNA polymerase on
BP-DNA adducts (Nath et al, 1987). For example, B[a]P diolepoxide
DNA adducts have been found in peripheral blood lymphocytes of risk
category coke workers (Harris et al, 1985). In in vitro experiments
with a cloned chicken adult (3-globin gene, B[a]P diolepoxide will
form adducts in a non-random manner to a region 300bp immediately 5'
to the RNA cap site (Boles and Hogan, 1984). This could conceivably
cause a down regulation of RNA transcription. The major adduct
formed with B[a]P diolepoxide is at the N2 position of guanine
(Jeffrey et al, 1977; Ashurst et al, 1983). Mutation studies on
shuttle vectors containing these adducts that are replicated in
human cells show that of 61 base substitutions 45 were GC to TA
transitions in the marker gene (Yang et al, 1987). In contrast,
dimethylbenz(a)anthracene (DMBA) binding to DNA in mouse embryo cell
cultures results in extensive binding to both adenine and guanine
residues (Dipple et al, 1983. This could explain the reduced
potency of B[a]P in comparison to DMBA in the two stage mouse skin
carcinoma model (Bizub et al, 1986; Balmain and Pagnell, 1983).
Mouse skin carcinomas initiated with DMBA, B[a]P and
dibenz(c,h)acridine (DB(c,h)ACR) and promoted by phorbol-12
myristate 13-acetate shown differences in the ability to mutate the
c Ha-ras oncogene and the ability of DNA from the resulting
papillomas to transform NIH3T3 cells (Bizub et al, 1986). Both DMBA
and DB(c,h)ACR induce an A to T transversion at codon 61 of c Ha-ras
in papillomas which efficiently transform NIH3T3 cells. Although
B[a]P induced skin carcinomas, these did not shown any mutation at
codon 61 of c Ha-ras in the tumour nor was the tumour DNA able to
transform NIH3T3 cells. Thus the inability of B[a]P diolexpoide to
mutate deoxyadenosine would decrease its carcinogenic potential in
this experimental system. Similarly, when the alkylating agent N-
agent in the mouse skin tumour model it shows different mutational
specificity to DMBA (Quintilla et al, 1986). MNNG binds deoxy-
guanosine preferentially (Lawley and Brooks, 1963; Auerbach, 1974).
Therefore the genotoxic specificity of a carcinogen can effect the
type of cancer produced in combination with other factors such as
cell proliferation and metabolism. In the majority of cases
DNA/carcinogen adducts can be removed by alkyl-nucleotide
transferases (Sekigucki and Nakabeppa, 1987) and excision repair
enzymes (Walker, 1984). Mutations can be generated during the
repair process or if unrepaired sites serve as templates for DNA
replication (Drinkwater et al, 1978; Eadie et al, 1984; Loechler
et al, 1984).
Carcinogen metabolism will also be a factor in the site of
tumour formation. Cell specificity can be demonstrated in the
activation of foreign compounds. Aflotoxin B^ (AFBj) and B[a]P are
both metabolized by rat liver cells to water soluble products but
only AFB^ is positive on the V79 Chinese hamster cell line mutation
assay (Langenbock et al, 1978). When rat embryo fibroblasts are
treated with these compounds only B[a]P is metabolized to a water
soluble mutagen product on V79 assays. Other metabolic factors will
inhibit skin tumour^enesis in mice by PAH. For example, prior
treatment of mice with 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD)
will reduce the frequency of papilloma formation initiated by DMBA,
B[a]P, 3MC and B[a]P diolepoxide. The mechanism of inhibition by
TCDD is unknown but this compound induces many drug metabolizing
(MNNG) is used as an initiating
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enzymes. For example a 21 fold increase in arylhydrocarbon
hydroxylase (AHH) activity is seen in mouse epidermis on treatment
with TCDD (DiGiovanni et al, 1980). This increases the formation of
mutagenic products from PAHs but the additional biological affects
of TCDD appear to protect the mouse skin from the carcinogenic
potential of these compounds.
The formation of DNA adducts and resulting mutation is not a
property unique to foreign compounds. It has been known for many
years that estrogens have an etiological role in the development of
breast cancer (Wynder and Gori, 1977; Doll and Peto, 1981). It has
been noted by certain workers that a high proportion of women with
breast cancer have an abnormal oxidative metabolism of estrogen
which leads to the formation of high circulating levels of 16a-
hydroxy metabolites (Schneider et al, 1982. This metabolite is
capable of forming adducts with large macromolecules (Yu and
Fishman, 1985; Bradlow et al, 1986). A model system for estrogen
induced renal carcinoma in Syrian hamster identified DNA adducts in
the kidney when natural 17p-estradiol and several synthetic steriod
estrogens were used. Chromatographic analysis showed that these
compounds induced the same modification of DNA (Liehr et al, 1986).
These experiments led to the conclusion that the estrogens induced
the binding of some unknown endogenous compound in target tissue.
The site of the DNA adducts was subsequently localized to the renal
cortex (Liehr et al, 1987). As this is also the site for cytochrome
P-450 enzymes it was postulated that estrogen metabolism by
cytochrome P-450 enzymes would lead to a reactive estrogen
metabolite. Estrogen dependant human breast cancer has been
correlated with the amplification of the HER-2/neu protooncogene
(Slamon et al, 1987). This may be the target for the estrogen
derived metabolites which induces breat cancer. The amplification
is postulated to lead to an increased tyrosine kinase activity
encoded by the HER-2/neu protein (Bishop, 1987). In contrast the
rat homologue to HER-2/neu was isolated from neuro- and
glioblastomas induced in BDIX rats given a single dose of ethyl-
nitrosourea (ENU). HER-2/neu was the transformating gene on NIH3T3
assay and was found to have an T to A transversion in the
transmembrane region of the protein (Bargmann et al, 1986). In this
case mutation rather than overexpression is associated with the
transformed phenotype.
A multitude of natural carcinogens can be found in our diet
including AFBj found in peanut butter, phosphorelins in celery and
hydrazines in mushrooms (Ames, 1983). Derivatives of 4 hydroxy-
methyl phenyl hydrazine produces lung and blood vessel tumour in
mice (Toth et al, 1978). The metabolism of this compound to its
reactive intermediate is thought to be via the mixed function
oxidase system in liver and lung (Lawson and Chanhan, 1985; Lawson,
1987).
In addition to carcinogens, compounds which inhibit
carcinogenesis have also been identified in our diet (Ames, 1983).
Natural anticarcinogens in our diet include diallyl sulphide from
garlic oil (Hayes et al, 1987) and p carotene from carrots (Temple
and Basu, 1987). Diallyl sulphide inhibited the necrotic effects of
an hepatocarcinogen, 1,2,dimethylhydrazine, by reducing its macro-
molecular binding in cultured liver cells. Onion and garlic oil
also have anti-promoter effects in mouse skin exposed to phorbol
esters (Belman, 1985). It is thus becoming recognised that in
addition to harmful compounds in the environment there are many with
beneficial anti-carcinogenic and anti-promoting activities (Ames,
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1983). The basis for the protective effects of diet are now being
investigated with model systems originally developed to detect
harmful compounds in the environment. Prevention is always better
than cure!
1.3. The role of cytochrome P-450s in detoxification
In the fifties it was demonstrated that the liver was a major
organ of detoxification and that there was a multiplicity of enzymes
involved in this process. Rabbits and rats were shown to have a
differential capacity for the liver N-demethylation of narcotics
(Axelrod, 1956). This was measured by the rate of formation of
formaldehyde from the narcotic and the appearance of the amine
derivatives when incubated with liver homogenates. Rabbits were
better at the N-demethylation of L-methadone (heroin substitute) and
mperidine whereas rats had a higher activity towards morphine.
These experiments implied that the enzymes of detoxification were
different between species. Alexrod also noted sex differences in
the enzymatic demethylation of narcotic drugs in rats. Female rat
liver had a decreased metabolizing capacity which could be enhanced
by treatment with testosterone. Support for the idea that the liver
of a single species contained several different enzymes of
detoxication was demonstrated by comparing the metabolizing capacity
of rats before and after treatment with B[a]P (Cooney et al, 1959).
B[a]P administration increased the rate of its own metabolism, as
well as acetanilide, zoxazolamine and 3 methyl-4-methyl aminobenzene
(3MMAB) yet decreased the metabolism of the narcotic, mperidine.
B[a]P administration had no affect on chlorpromazine metabolism. An
important conclusion from this work was that the metabolizing
capacity of an organism could be modulated by exposure to a
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xenobiotic.
1.3.1. Cellular localization of xenobiotic metabolism.
Subcellular fraction studies suggested that the drug
metabolizing enzymatic activities resided in the endoplasmic
reticulum of the liver (Axelrod, 1956; Cooney et al, 1959; Creaven
and Williams, 1963). Studies on the hydroxylation of the corti¬
costeroids also suggested a similar location for this activity in
the bovine adrenal gland (Ryan and Engel, 1957). Of interest here
was the fact that the 21 hydroxylation of corticosteroids could be
inhibited by carbon monoxide but this inhibition was reversible by
light. Subsequently bovine adrenal microsomes were found to have a
carbon monoxide binding pigment. A corresponding liver carbon
monoxide binding pigment was described by Omuro and Sato (1964)
which was demonstrated to be a b type cytochrome. They called this
protein cytochrome P-450 because the peak of the reduced carbon
monoxide difference spectrum was at 450nm. The inhibitory effects
of carbon monoxide on the oxidative demethylation of codeine and
monomethyl-4-aminopyrine and the hydroxylation of acetanilide by rat
liver microsomes was found to be reversed by illumination with light
at 450nm (Cooper et al, 1965). The similarity between the photo¬
chemical action spectrum and the absorption spectrum suggested that
the carbon monoxide binding pigment (P-450) was the terminal oxidase
in drug metabolism in mammals. A similar effect was seen for the
reversible inhibition of 17-hydroxyprogesterone metabolism by
bovine adrenal microsomes (Cooper et al, 1965). When liver micro¬
somes were treated with detergents with the aim of solubilizing
cytochrome P-450s a new peak at 420nm appeared in the reduced carbon
monoxide spectrum. This form was named P-420 to distinguish it from
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the native catalytically active membrane bound form (Omuro and Sato,
1964). Both P-450 and P-420 could be shown to bind substrate by
characteristic spectral changes (Imai and Sato, 1966).
1.3.2. Induction of cytochrome P-450s
The cytochrome P-450 system was found to be inducible by a vast
variety of lipid soluble drugs (Remmer and Merker, 1965; Ernster
and Ornehius, 1965; Sladek and Mannering, 1969). Phenobarbital(PB)
and 3 methylcholanthrene (3MC) (now referred to as the classic P-450
inducers) could be shown to have differential effects on microsomal
N-demethylating activities. PB and 3MC stimulated the N-demethyl-
ation of 3MMAB but only PB stimulated the N-demethylation of ethyl
morphine (Sladek and Mannering, 1969). Both these compounds could
act synergcstically on the stimulation of 3MMAB metabolism.
Previously it had been established that the 3MC induced co-spectrum
w; slightly different to that induced by PB (Alvares et al, 1967)
in that the spectral peak was at 448nm as compared to 450nm for PB.
This again supported the possibility that different forms of P-450
were present in rat liver. Another P-450 inducer was found to be
pregnenolone-16a-carbonitrile (PCN). Following administration of
the compound the spectral characteristics in microsomes were similar
to PB and control but the substrate specificity was changed (Lu et
al, 1972). Marker substrates for PB induction was found to be
benzephetamine, for PCN, ethylmorphine and for 3MC benzo[a]pyrene.
1.3.3. Purification and reconstitution of cytochrome P-450
activity
The solubilization, resolution and reconstruction of a
microsomal hydroxylase system was first achieved in rabbits (Lu and
Coon, 1968; Lu et al, 1969). This consisted of cytochrome P-450,
NADPH cytochrome P-450 reductase and lipid factor (Table 1.1). When
these fractions were recombined many hydroxylase activities could be
regenerated. This was to prove a valuable tool in the analysis of
the biotransformation of steroids (Einarsson et al, 1973) drugs,
carcinogens and a variety of other foreign compounds (Lu and West,
1978). Genetic differences in mouse strains for inducibility of
aryl hydrocarbon hydroxylase (AHH) expression was shown to reside in
the microsomal fraction (Nebert et al, 1973). Additionally NADPH
cytochrome c reductase could be substituted between the rat and
mouse reconstituted systems indicating that differences between
hydroxylation capacities for these two species also resided in the
microsomal fraction.
1.4. Characterization of rat liver cytochrome P-450s
It soom became established that cytochrome P-450s play an
important role in metabolism of endogenous substrates such as fatty
acids and steroids, in the detoxification of many drugs and xeno-
biotics, and in the activation of environmental agents to toxic,
mutagenic and carcinogenic forms. In order to investigate the broad
substrate specificity of the microsomal oxidasesystem many workers
purified the P-450s responsible for specific P-450 mediated
reactions. The ultimate objective of these studies was to determine
the structural features of P-450s in relation to their function. For
example, to identify common structural similarities which may relate
to their monooxygenase function, heme and reductase binding sites.
To establish the factors which determine substrate specificity, to
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Table 1.1 Components of liver microsomal hydroxylation system
and their functions
Cytochrome P-450
Prosthetic group: Iron-Protoporphyrin IX
Function: 1. Oxygen and substrate binding site
2. Monooxygnation of lipophilic substances.
3. Determines substrate specificity of the system:
multiple forms with overlapping substrate
specificities
NADPH - cytochrome c reductase
Prosthetic groups: FMN and FAD
Function: Transfers electrons from NADPH to cytochrome P-450
Phospholipid
Active Component: phosphatidylcholine and possibly other lipids
can be replaced by detergents
Function: Allows the formation of a complex between the reductase
and the P-450 and therefore provides the environment
for electron transfer from the reductase to the P-450.
RH + NADPH + 02
P<*SO
/
(After Lu and West, 1978)
R-OH + NADP+ H20
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evaluate how many P-450s exist and also whether differences in
response to chemical challenge be associated with specific P-450
forms. These are central questions which have resulted in a
multidisiplinary approach to investigate the role and nature of P-
450s in metabolism.
The main areas of investigation that are currently being
followed in this area are (i) the purification of cytochrome P-450
forms and reconstitution in in vitro assays to investigate substrate
specificity; (ii) isolation of P-450 cDNAs to investigate the
number of cytochrome P-450 forms and the extent of their structural
similarities; (iii) the use of genetics to investigate role of P-
450s in susceptibility to the chronic effects of chemical toxins and
carcinogens.
Before considering these areas of research we have to discuss
the complex problem of nomenclature.
1.4.1. Cytochrome P-450 nomenclature
The existence of multiple forms of mammalian cytochrome P-450s
(Lu and West, 1980) has led to a variety of different nomenclatures
(Astrom and De Pierre, 1986) for an increasing number of forms. It
has been estimated that there is a minimum of 12 distinct P-450
forms in untreated rat liver (Waxman, 1986). Previous attempts at a
unified nomenclature have depended on physical, biochemical, immuno¬
logical properties, catalytic specificity and the inducibility of
different forms (Lu and West, 1980). These nomenclatures were (are)
confusing and outdated as the criteria for differentiating between
different P-450 isozymes became well defined. For example the N-
demethylation of ethylmorphine was originally associated with PB-
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inducible P-450 forms but it was then found PCN induced this
activity to a greater extent in female rats (Lu et al, 1972). To
some extent the nomenclatures were adapted according to the activity
of the P-450 form, for exampled those working on steroid hydroxy-
lation would name the forms according to specific steroid hydroxy-
lations e.g. P-450^5p (MacGeoch et al, 1984). On the other hand,
forms isolated in other laboratories were named in order of
isolation e.g. P-450a-k (Ryan et al, 1982; 1984), form i being
equivalent to P-450^5p. The inducibility of these isozymes and
subsequent changes in enzyme activity can vary between species. For
example 3MC which can significantly increase B[a]P activity in rat
or mouse liver microsome preparations has no such effect on adult
rabbit liver preparations (Atlas et al, 1977).
These deficiencies in nomenclature havubeen rectified to some
extent with the accumulation of protein sequences and genetic data.
Therefore, a nomenclature based primarily on sequence data but with
reference to their chromosomal location has been proposed for
different cytochrome P-450 families (Nebert et al, 1987). Each
family is characterized as "P450" followed by an arabic number i.e.
P450-1. Individual numbers can have a subscript number or be
referred by their trivial name. Related subfamilies are designated
by capital letters i.e. P450-2B and P450-2C. Within a given species
any one protein is 40-60% similar to a protein in any of the other
subfamilies. Subfamilies can have different chromosomal locations.
Listed in Table 1.2. is the nomenclature of Nebert et al (1987) for
forms presently isolated and the equivalent rat hepatic P-450s
isolated by Wolf et al (1986). The rat hepatic forms isolated by
different laboratories are also listed (Table 1.3.) and grouped
according on the basis of biochemical and physiological
similarities.
Most of the work in this thesis is concerned with the P450-2C
family of P-450s. In rat liver at least 5 different forms have been
identified (Haniu et al, 1984; Ryan et al, 1982; Waxman, 1986;
Wolf et al, 1986). Collectively these isozymes are related to PB-1
of (Wolf et al, 1986; Waxman and Walsh, 1983). The nomenclature
used here will be that of Wolf (1986) with reference to Nebert et al
(1987). Where no equivalent form exists the trivial and recommended
nomenclature will be used. Certain P-450s have specific functions
involved in steroid biosynthesis (Jefcoate, 1986). These forms are
localized in a variety of steroid ogenic tissues including the
adrenal gland and are not noted for their drug metabolizing
capacity. The nomenclature for these forms are included in Table
1.3.
1.4.2. Purification of cytochrome P-450 proteins
The definitive proof for the existence of multiple cytochrome
P-450s came with their purification. Initial studies in this area
were hampered by the instability and hydrophobic nature of P-450
proteins. This problem was overcome by the use of glycerol to
stabilize the proteins and the use of non-ionic detergents (Imai and
Sato, 1974) followed by hydrophobic chromatography and anion
exchange chromatography (Van der Hoeven et al, 1974; Astrom and De
Pierre, 1986). The use of rodents in toxicology assays has led to
their use in the purification of P-450 isozymes. In initial
purification schemes animals were treated with xenobiotics to
increase hepatic P-450 content and to selectively increase the
metabolism of specific substrates (Guengerich et al, 1982). The
purification of catalytically active P-450 forms could then be
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Table 1.2
Mammalian P450 nomenclature according to Nebert et al (1987)
and equivalent rat hepatic forms isolated by Wolf, 1986. Names in
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(21 hydroxylation of steriods)
(cholesterol side chain cleavage)
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assessed for hydroxylation specificity in reconstitution systems.
In addition to this approach sexual differences in P-450 mediated
steroid hydroxylations were also used to identify and isolate novel
enzymes (Einarsson et al, 1973 ). Female rats have a high 15 (5
hydroxylase activity towards steroid sulphates which is absent in
male rats (Gustafsson and Ingelman-Sandberg, 1974; 1975). Whereas
male rats have prominent 16 a hydroxylation activity towards
testosterone (Einarsson et al, 1973).
The most comprehensive biochemical analysis of cytochrome P-450
structure and function has been determined with rat hepatic P-450
forms. This work provides the best basis with which to compare P-
450 forms between species. A number of criteria have been used to
differentiate between different forms. These are listed below.
a) Mobility on SDS gels: SDS polyacrylamide gel electrophoresis
has proved useful in the determination of the purity of P-450
preparations and distinguishing between related forms. On the
basis of electrophoretic mobility P-450s range in size from
48kd to 56kd (Black and Coon, 1986). Variations can be seen in
the order of migration for purified forms between different
laboratories due to differences in running conditions.
b) Peptide mapping: Peptide maps generated from electrophoretic
separation of peptides obtained by proteolytic digestion have
proved to be a rapid and useful means to examine similarities
and differences of purified forms of P-450. Purified forms are
digested with proteases and run in parallel to compare the
patterns produced. For example, such analysis showed
similarities between PB3a and PB3^ (Waxman and Walsh, 1982),
PBja and PB ^ t> (Wolf et al, 1986) and differences between PB3a
and PB^a (Waxman and Walsh, 1983).
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c) Substrate specificity: Various factors can influence the
activaties of both purified P-450s and those measured in
microsomal samples, so their activities can be influence by the
phospholipid composition and perturbation of the membrane.
Normal catalytic activity requires oxygen and the donation of
two electrons mostly provided by NADPH. A complication is that
one molecule of cytochrome P-450 reductase serves about twenty
P-450 molecules (Peterson and Prough, 1986), thus leading to
potential substrate competition between drugs occupying
different P-450's. The order of affinity for the reductase as
determined by Guengerich (1984) is UT-1 > PB3b > PB2a > M(-3a >
PB3a > PBi > MClb.
The various P-450s can have different but overlapping
specificities. However, by comparing the activity obtained on
substrate specificity in reconstitution systems with microsomes and
inhibiting these activities with specific antibodies, the substrate
specificity may be confirmed. A variety of substrates are currently
being used as markers for specific types of P-450. For example,
benzephetamine which has different turnover rates with purified P-
450 enzymes with PB2a and PB3a having the highest (Table 1.4.) (Wolf
et al, 1986) it is generally used as an indicator for induction of
PB3a by phenobarbital. Similarly the O-dealkylation of ethoxy-
coumarin has significant turnover rates for many P-450s but MC^b has
over a 100-fold higher activity relative to the other forms listed
in Table 1.4. Thus this activity can be used as a marker of 3MC
induction. In control samples MC3b is almost absent and this
activity has been associated with the constitutively expressed PB-1
form (Waxman and Walsh, 1983). Other marker substrates are the
phenoxazone analogues (Burke and Meyer, 1974). These compounds
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Table 1.4
Metabolism of substrates by cytochrome P-450 isozymes*
Enzyme











(P450-2C) PBia 0.31 4. 62 - 0.04 0.41
tl
PBlb 0.33 3.2 0. 25 3.04 0.87
II
PBlc 3.4 - 0.04 0.04 0.31
?B2a 0. 69 15. 9 0.04 0.3 0. 46
(P450-3) PB2b 0.17 3.2 0.02 0.08 0.02
fl PB2c ND ND 0.002 0.01 0.04
(P450-2B) BB3a 2.06 14.84 4.91 9.1 0.05
(P450-1) MClb 56. 7 3.82 0.33 0. 68 28. 0
ND = Not detectable
- = Not determined
* = Wolf et_al, 1986
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Table 1.5
Marker activities for specific cytochrome P-450s
Cytochrome Activity in microsomes
UT1 (P450-2A) Testosterone 7 a hydroxylase
PB^/PB^v, (P450-2B)* Dealkylation of Pentoxyresorufin
Testosterone 16a hydroxylase
MC,a/MC,h (P450-1)* 7 ethoxycoumarin 0 deethylation
B[a]P 3,9 hydroxylase
PB9p (P450-2C) constitutive testosterone 16a-hydroxylase
P4501S(, (P450-2C) 15 (3 hydroxylase
P4502b (P450-3) 6 p hydroxylation of steriods
UT-H (P450-2D) Debrisoquine hydroxylation
* Only measurable following administration of an inducing agent.
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consist of a basic phenoxazone ring structure in which different
alkoxy groupings are substituted at the C 7 position (Figure 1.3.).
The substitution of different R groups alters the rate of metabolism
by different purified P-450 forms. For example, pentoxyresorufin is
fairly specific for PB3a (Table 1.5) and ethoxyresorufin is specific
4
for MCiv.. Benzloxyresorufin has a more broad specificity, in the
L
u
absence of PB3a and MCib it is fairly specific for PB^a. In addtion
to these substrates the metabolism of B[a]P has been used as a
marker for MC]^ (23.4nmol/min per nmol cytochrome P-450) and PB2a
(1.8nm/min per nmole cytochrome P-450) (Ryan et al, 1982; 1984). In
the metabolism of acetylaminoflourene by eight different isozymes of
P-450s, MCia and MC]^ produced much higher levels of N-OH AAF the
metabolite associated with the hepatocarcinogenic effects of this
compound (Astrom and De Pierre, 1985). This metabolite was only
observed with one other isozyme, PB2b/?B2c (P450-3), albeit at 100-
fold reduced levels. Larrey et al (1984) reported the isolation of
a cytochrome P-450 (UT-H, (P450-2D)) which metabolized the anti¬
convulsive drug debrisoquine at 20-fold greater rates when compared
to eight other purified forms.
The catalytic properties of isolated cytochrome P-450 proteins
have also been studied with endogenous substrates such as
testosterone, androstenedione, progesterone, estrogen, chpl esterol
and vitamin D3. Hydroxylations of these substrates in the liver can
be both anabolic and catabolic.
Chloesterol and the C-27 steroids are involved in the bio¬
synthesis of bile acids and vitamin D3. The 25 hydroxylation of C-
27 steroids and vitamin D3 has been shown to be mediated by PB2a
(Anderson et al, 1983). The enzyme is expressed in male but not
female rats (Anderson and Jornvall, 1986) which parallels the sex
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FIGURE 1.3.
Metabolism of phenoxozone analogues by cytochrome P-450s. The R
group determines the specificty of conversion by P-450s.
 
difference in 25-hydroxylation activites.
Hepatic cytochrome P-450s are very active in the hydroxylation
of steriod hormones. UT^ is specific for the 7a-hydroxylation of
testosterone (Ryan et al, 1984; Waxman, 1986). The 16a hydroxy¬
lation of progesterone and estradiol is carried out mainly by PB2a
(Cheng and Schenkman, 1984). This protein also metabolizes
testosterone and androstenodion at this position (Waxman et al,
1983) and accounts for this male specific 16a-hydroxylation activity
measured in adult rat microsomes (Waxman et al, 1985). However,
PB3a also has 16a-hydroxylase activity (Waxman, 1984) which can be
induced in female rat microsomes by phenobarbital administration
(Waxman et al, 1983). An equivalent form to PB2a> which is female
specific has estrogen 15 (3 hydroxylase activity (MacGeoch et al,
1984; Cheng and Scharkman, 1984). The 6(3 hydroxylation of steroids
is associated with PB2C (Waxman et al, 1985). Antibodies to
purified P-450s form can inhibit these activities in liver
microsomes. For example 7a hydroxylase is abolished by anti UT^
antibody (Waxman et al, Guengerich, 1985) and 6(3 oxidation
hydroxylation by anti-PB2c (Gonzalez et al, 1986b). Table 1.5.
lists some marker activities for specific P450s in microsomal
preparations
1.4.3. Induction of cytochrome P-450 isozymes
Numerous compounds have been shown to induce or suppress
microsomal activities and associated cytochrome P-450 proteins.
Classically,inducers of drug metabolism could be divided into three
classes, those which respond to 3MC, PB or PCN. Clearly the 3MC
type is associated with MCja and MC^, the PB type with PB3a and
PB3b and the PCN type with PB2b- It is now apparent that many
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structurally diverse compounds can induce the same form of cyto¬
chrome P-450. Thus phenobarital and Aroclor 1254 (R) induce PB3a,
Aroclor 1254 (R) which is a complex mixture of polychorinates and
biphenyls also induces MC^a and MC^ (Vlasuk et al, 1983). Table
1.6 lists a number P-450 isozymes and their relative level of
expression in control and induced microsomes of male rats. An
important observation is that in the absence of induction there are
many P-450s with a high constitutive level of expression. Notably
PB2a (P450-2C) which in control rat microsomes is expressed at a
level of 1.2nmol/mg of total microsomal protein. Other P-450
isozymes with significant levels of expression are PB?-r(P450-3 ), PB-
1 (P450-2C) and UT-1 (P450-2A). The highly inducible forms of P-
450, PB3a (P450-2B) and MC^a (P450-1) represent only 2.5% of P-450
content in untreated male rat liver. Therefore in the absence of
induction it is the constitutively expressed forms of P-450 which
will be responsible for detoxification of foreign compounds as well
as the metabolism of steroids. A variety of P-450s are suppressed
by the administration of inducing compounds. Phenobarbital
treatment suppresses PB2a, has a marginal effect on the levels of
PB2c, PB-1 and UT-1, while inducing the levels of PB3a and PB3^ 50
and 10 fold respectively. (3-napthaflavone (BNF) induces MC^,
whilst suppressing the levels of PB2a. In general the levels of
PB2a are down regulated by many classical P-450 inducers. One
conjecture is that this P-450 is too specialized in its function in
steroid metabolism to be of use in xenobiotic metabolism.
1.4.4. N-terminal sequence analysis
A variety of methods for distinguishing between P-450 isozymes
are described above, however, the most useful method for
Table 1.6
Microsomal levels of distinct liver P-450 isozymes in control
and induced male rat liver microsomes
P-450 isozyme content (nmol/mg protein)
Isozyme Treatment
Control PB BNF PCN
(P450-2C) PB2a 1. 2 0. 49 0.33 0.,33
(P450-3) PB2b 0.,4 1. 06 0.32 1..32
(P450-2C) PB-1 0.,36 0. 69 0. 26 0.,31
(P450-2A) UT-1 0., 15 0. 10 0. 12 0., 08
(P450-2B) BB3a 0..03 1. 27 0.04 0.. 10
If
BB3b 0..07 0. 92 0.04 0..09
(P450-1) MCib 0..04 0. 04 1.41 0..06
If MCia 0..03 0. 03 0.57 0..03
The data is expressed as nanomole of each protein per milligram
of total microsomal protein. PB = Phenobarbital; BNF - (3
naphtoflavone; PCN = Pregnenolene-5a carbonitrile. Data from
Guengerich et al, 1982.
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constructing identity between P-450 isozyme forms from different
e
laboratories the^fore facilitating the grouping together of
different P-450 forms is N-terminal sequence analysis. This has
formed the basis of the comparison given in Table 1.7 significant
identity can be found between PB-1 and PB2C described by Waxman,
1984; Waxman and Walsh, 1984 RLM5 and RLM3 described by Cheng and
Schenkman, 1983 , f-i (Haniu et al, 1984) and PB^a, PB^, PB2a and
PB2d (Wolf et al, 1986) (Table 1.7). These sequences are distinct
from PB3a and PB3^ (Wolf et al, 1986). A table of identities for
the PB-1 P-450 forms shows that they are all related to each other
(Table 1.8). A notable feature of all rat hepatic P-450s is the
presence of a hydrophobic leader sequence. In a few cases notably
cytochromes MC^a, MC^;-, and PB2d, the N-terminal Met is removed by
proteolysis (Haniu et al, 1984; Wolf et al, 1986). The differences
in homology between P-450h and RLM5 are probably not due to strain
variation as both proteins were isolated from uninduced Sprague-
Dawley rats. P-450h is exactly the same as P450 PB2a from N-
terminal sequence analysis. One difference between the purification
of Schenkman and Levin versus Waxman and Wolf is that the latter two
groups used PB treated rats which marginally increase PB-1 levels
whilst decreasing form PB2a (Adesnik and Aitchison, 1986).
1.5. P-450 forms in other species
Multiple isozymes of P-450 have been purified from liver micro¬
somes of many species notably rabbit, mouse and human (Table 1.9).
In the rabbit at least 8 distinct forms have been identified
(Johnson and Schwab, 1984). Similarly at least 6 distinct forms
have been identified in humans (Wang et al, 1983). In spite of its
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Table 1.9
Comparison of P-450 izsozymes identified in 4 species
Rat Mouse Rabbit Human






MClb P4501 LM6 P4501
PB3a C2 LM2 ?
UT-H ? ? P450db
PB2b ? ? P450NF
j ? LM3a P450j
UTi (Coh) LM2 P4502A
( ) tentative ? = unknown
Mouse forms: Harada and Negishi, 1984b; Negishi and Nebert, 1979; Huang
1976; Kaipainen et al, 1984.
Rabbit forms: Johnson and Schwab, 1984; Leighton et al, 1984, Ozols et al,
Tukey et al, 1985; Black and Coon, 1986.
Human forms: Adams et al, 1985; Disterlath et al, 1985; Gut et al, 1986;
et al, 1986; Shimada et al, 1985; Wang et al, 1983; Watkins
al, 1985; Phillips et al, 1985; Wrighton et al, 1986.
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limited. Nonetheless, at least five distinct forms have been
identified in this species (Table 1.9).
For the P-450s many substrate specificities are maintained
across species. For example, the ethanol inducible forms from rat,
rabbit and human. In contrast the rabbit P-450I is unique in having
progesterone-21-hydroxylase activity. The metabolic pathway is
usually associated with a highly specific P-450 located^the adrenal
gland (Tukey et al, 1985). In addition to mammals P-450s have also
been identified in Saccharomyces cerevisae, Bacillus megatherium,
plants and Drosophilia Melanogaster (Black and Coon, 1986).
Comparative analysis of P-450 isozymes from different species should
provide evidence for conservation of functionally important
activities and domains.
1.6. Molecular analysis of P450s
The number P-450 isozymes identified in rat liver is twelve
(Waxman, 1986). The recombinant DNA approach has been used to
elucidate the nature of this diversity at the genetic and molecular
levels. A number of strategies have been used to clone P-450 cDNA
and genomic clones. Initially as in the biochemical analysis the
favoured animal models were rat, mice and rabbits. At the DNA level
most of the analysis of P-450 isozymes has concentrated on the PB
and MC inducible forms. They serve as useful models for the
regulation of P-450s and their genomic organization.
1.6.1. Cloning strategies for P-450s
The induced forms of P-450 were cloned first because of the
high frequency of recombinants in cDNA libraries synthesized from
hepatic mRNA from induced animals. This class of mRNA was enriched
- 41 -
to use as a source for cDNA cloning by polysome precipitation
(Hardwick et al, 1983; Negishi et al, 1981) or by size
fractionation (Adesnik et al, 1981). Libraries were constructed in
pBR322 and putative P-450 cDNA clones were identified by
differential screening with ^2p labelled control and induced cDNA.
The resulting plasmids were then used to hybrid select mRNA which
could be translated in vitro to see if they correspond to purified
P-450 forms. This strategy for cDNA cloning is now rarely used and
the most commonly used method for isolating P-450 cDNA clones is a
direct screen of expression libraries with affinity purified anti-P-
450 antibodies (Freidberg et al, 1986; Gonzalez et al, 1986a).
1.6.2. Genomic Complexity of P-450s
In rats two distinct forms of 3MC inducible P-450 proteins have
been identified MC^a and MC^i-, (Ryan et al, 1982, 1984). These can
be distinguished by their N-terminal sequence (Haniu et al, 1984)
and their catalytic activity towards B[a]P. has greater
activity than MC^a (Guengerich et al, 1982. Only two 3MC inducible
cDNA clones have been identified in rat liver each of which appears
to correspond to the purified proteins by comparison with N-terminal
sequence of the cDNAs (Kawajiri et al, 1984; Yakasaki et al, 1984).
Orthologous forms have been identified in mouse liver (Negishi and
Nebert, 1979; Gonzalez et al, 1985). Southern analysis indicate
that this is the extent of MC inducible P450 gene family in rats,
mice and humans. The structure of the mouse MC^a and MC^ genes is
very similar, both being 6kb long containing 7 exons (Gonzalez et
al, 1985).
cDNA clones corresponding to phenobarbital inducible PB3a and
PB3b P-450 have also been isolated (Adesnik et al, 1981; Fuji-
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Kuriyama et al, 1982). These two proteins have identical N-terminal
sequences but PB3a has about 5-fold greater metabolising activity
than PB3b (Ryan et al, 1984). Southern blot analysis of genomic DNA
demonstrated that there are many sequences similar to PB3a in rat
DNA (Atchison and Adesnik, 1986). Genomic cloning has identified
eleven PB3a related genes in rats (Mizukami et al, 1983; Atchison
and Adesnik, 1983). These genes have adifferent genomic
organization to MC^ genes in that they are up to 20kb in length and
are split into 9 exons.
The cloning of the PCN inducible P450s has identified two
closely related cDNAs in the rat (Gonzalez et al, 1985b). Southern
blot analysis indicates this is a complex gene family (Hardwick et
al, 1983). However at present there is no data on the genomic
organization of these genes.
Southern analysis and genomic cloning has illustrated that the
potential number of P-450 genes in rats is greater than the proteins
isolated to date. Whether these extra genes are pseudo genes or not
is open to question, they may correspond to extrahepatic on develop-
mentally expressed members of these families.
1.6.3. Functional Domains of P-450s
The number of complete cDNA, and therefore amino acid sequences
of P-450s is rapidly increasing (Adesnik and Atchison, 1986; Nebert
et al, 1987). Black and Conn (1986) list 10 complete primary
structures, 4 of rat liver, 3 of rabbit liver, 2 of mouse liver and
one of bovine adrenal gland. A summary of the molecular data shows
that in rodents hepatic P-450s represent a superfamily composed of
at least 7 distinct gene families, which are distinguishable from
each other by Southern blot and sequence analysis. Direct
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comparison of P-450 sequences provides an insight into the
structural features required for common function. These can best be
illustrated with three distinct inducible P-450 gene families P450-1
(MC), P450-2B (PB) and P450-3 (PCN). At the sequence level they
show less than 35% amino acid identity to each other (Black and
Coon, 1985; Gonzalez et al, 1986b). This indicates that these gene
families diverged 200 million years ago (Gonzalez et al, 1985b).
Comparison of hydrop athy indices, which plots the relative
hydrophobicity or hydrophilicity of the proteins, shows them to be
generally very different^however two regions of similarity can be
noted. All P-450s have a stretch of 15-25 hydrophobic amino acids
after the initiator methionine although the N-terminal sequences of
these P-450s are very different from each other. This stretch has
been demonstrated in vitro to serve as a membrane insertion and stop
signal during translation of the P-450 message (Sakaguchi et al,
1987). This feature has been noted in other mammalian P-450 forms
(Heinemann and Ozols, 1983). A second similarity is a large segment
of hydrophillc amino acids (residus 405-440).This region is present
immediately before a highly conserved region containing the heme
binding system which is present in P-450 proteins.
Overall comparison of P-450s reveals 3 regions which are
conserved between distantly relative enzymes. These regions are
confined to the N- or C-terminal regions of the proteins. The first
conserved region was identified by comparing the sequence of P-
450cam isolated from Pseudomonces putida, and the rabbit
phenobarbital inducible P-450 LM2 (Heinmann and Ozols, 1983). This
region is centered around Cys 152 of PB3a in rats (Table 1.10) and
region Cys 134 in P-450cam. These two forms show 10/18 matches. Two
regions in MC^a and MC^ P450s show some similarity to this region,
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although to a lesser extent. It is interesting that PB2a shows
essentially no similarities to the above proteins over this region.
Indeed the cysteine in this region is missing from PB2a as well as
from P450-2A, P450-2D, P450-2E and P450-4 proteins of rat. A
second cysteine containing region at Cys 436 in PB3a is much more
highly conserved between different P-450 forms (Table 1.10). All P-
450s isolated to date have a cysteine at this region. It has been
shown conclusively in P-450cam that the cysteine containing peptides
provides the heme binding site (Poulos, 1986). A third region of
similarity was described in two forms of rabbit P-450 (Ozols et al,
1981). This tridecapeptide region shows 50% homology between PB3a
and MCia and 45% overall identity between distantly related
mammalian P-450s. The high conservation of these region suggests an
important structural or functional role.
Regions of maximum dissimilarity between P-450s lie in the
region between the N-terminal and C terminal conserved regions
corresponding to regions 200 and 300 of the PB3a protein sequence.
Over this region MC^ and PB3a share 15% identity. MCj^a and MC^
share over 70% amino acid similarity but only 35% idenity over
region 200-300. These two forms have marked differences in their
substrate specificity. Thus this region is thought to be involved
in determining substrate specificity. Indeed, chimeric cytochrome
MC P450s, where the central and carboxy portion of MC]^ is replaced
by that of MC]^a, conferred the substrate specificity of MC^a to this
novel protein (Sakaki et al, 1987). Therefore an idealized
cytochrome P-450 molecule consists of a hydrophobic protein of
around 490 amino acids in length with a hydrophobic leader sequence
for membrane binding, a central region involved with substrate
binding and a carboxy terminal which contains the elements for
- 45 -

































































































































































































































































































































PB3a;Fuji-Kuriyamaetal,1982.MC1 :Y busakaitl,1984. MC1b:Kawjirietl,1984.P-450cam;Haniutl,1982;LM2:Heine an andOzols,1983.
A)N-terminalcysteinefrag entcent r datC 152ofPB3a B)C-terminalcysteinefrag entcent r datC 436ofPB a. C)The'analogoustridecapeptide1regionatMet346-Arq'3.58fPB3a.
reductase and heme binding to allow electron transfer to the
substrate molecule (Fig. 1.4).
The above gives a rough idea of the structural requirements of
the P-450 molecules. However^the factors which determine substrate
specificity are even more subtle for example cDNA clones for the
closely related phenobarbital inducible P-450s PB3a and PB3k have
been identified (Fuji-kuriyama et al, 1982). PB3a has the same
substrate specificity as PB3^ but its specific activity is about 5
times greater than PB3b (Ryan et al, 1984). Sequence comparison of
over 1900bp of these cDNAs indicate them to be 98% homologous
overall but the distribution of homologous and non-homologous
sequences is non-random (Adesnik and Atchison, 1986). The 5' 946bp
are identical (Figure 1.4) whilst there are 36 divergent residues
in the remaining sequence of the two mRNAs with 14 differences
clustered to two divergent segments which flank the conserved
1tridecapetide' region. The gene encoding PB3a has been cloned and
characterized in detail. The gene, which encodes a 2kb mRNA,
is 14kb long and is split into 9 exons. The hypervariable region
has been localized to exon 7 (Atchison and Adesnik, 1983; 1986).
In an elegant study, Atchison and Adesnik sequenced a number of
PB3a/PB3k related genes which showed that at least one of the
divergent segments appeared to result from a gene conversion event
between an ancestral PB3a gene and a related donor gene (gene 3) of
unknown function. A gene conversion event is a non-reciprocal
recombination in which a segment of one gene replaces another. The
sequence data also suggested extensive gene conversion within all
the members of this family including exon 7 and 8 and the intron
inbetween them. Generally, it has been found that the exons of
related genes retain homology while intronic sequences diverge more
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FIGURE 1.4.
Comparison of PB3a and PB3b cDNAs showing common P-450 features, 1-
5, and regions of homology and non-homology within PB3a and PB3b.
The position of the initiation codon is indicated by AUG and the
termination codon by TERM.
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1) Hydrophobic leader sequence
2) Cys 152 containing peptide
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5) Cys 436 containing fragment
rapidly (Li et al, 1985b). Intron 7 of all the cloned PBg^ genes
show 90% homology. Upstream sequences of exon 7 and downstream of
exon 8 also show identity. Genomic blots of germline versus somatic
tissue showed that the hypervariable region does not represent a
somatic rearrangement of the PB3a DNA configeration. Gene
conversion has also been postulated to occur in the PB2b (P450-3)
gene cluster, the rabbit PBcl (P450-2B) gene cluster and the MC^a
(P450-1) gene cluster (Adesnik and Atchison, 1986; Gonzalez et al,
1986b). It can be appreciated that the action of a gene conversion
event can maintain homology between gene family members or introduce
more diversity. New genes encoding proteins with new catalytic
activities could be generated by one gene procuring a new DNA
segment from a related gene or pseudogene. Whether this new gene
becomes fixed could be due to random processes or due to selective
pressure for new catalytic activity. Thus gene conversion could
accelerate the evolution of new P-450 forms.
1.7. Genetics of Cytochrome P-450s in mice
The large number of different P-450 isozymes with overlapping
substrate specificities suggests that genetic variation may not be a
significant factor in our interaction with the chemical environment.
Early demontrations of variation in the response of different mouse
strains to barbituates suggested otherwise (Jay, 1955). The P-450
dependent monoxygenase system reduces the biological effects of
drugs by providing their excretion. The rate at which a drug is
metabolized will differ between individuals due to qualitative and
quantitative differences in these enzymes. Altered rates of drug
metabolism may result from modulation of P-450s by endogenous or
- 48 -
exogenous factors or by genetic polymorphism. In both cases the Km
and Vmax for the substrates can be changed. In addition, if the
xenobiotic is metabolized in a stereospecific manner then a change
in the site of metabolism can have profound effects on drug
disposition, dose, response and toxicity. Genetic factors are known
to play a centrq.1 role in drug response thus it is important to be
able to define the genetic background of an organism's drug
metabolizing system under different chemical exposures. Thus rodent
models for testing the toxicity of foreign compounds will be
affected by the strains used. To understand the P-450 system it is
critical to establish how well the drug metabolizing capacity of a
particular species reflects that of another.
1.7.1.The Ah locus
The first evidence for the existence of polymorphic loci
involved xenobiotic metabolism came from studies on
inbred strains of mice. It was observed that the 3-hydroxylation of
B[a]P [Arylhydrocarbon hydroxylase (AHH)], was strongly inducible in
some mouse strains but not others (Nebert and Gielen, 1972).
C57BL/6 mice were responsive to 3MC induction whereas DBA/2 mice
were non-responsive. Appropriate crosses established that the
inducibility was controlled by a single autosomal dominant gene
(Nebert et al, 1972; Nebert and Gielen, 1972: Thomas et al, 1972).
This locus was termed Ah for AHH responsiveness. Responsive
(C57BL/6) strains carried the Ah^ allele whilst the non-responsive
strain (DBA/2) carried the Ah^ allele. This locus was equivalent to
a locus which also controlled the response to inflammation caused by
skin exposure of DMBA (Taylor, 1971; Thomas et al, 1973). After
topical application of DMBA, C57BL/6 mice show intense ulceration
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and inflammation after a latency period of 10 days whereas DBA/2
mice show no such response. This experiment illustrated again that
carcinogen metabolism was an important feature in a host's response
to chemical challenge and the need to use the appropriate strain for
carcinogen and toxicological testing. Fibrosarcomas initiated by
subcutaneous injection of 3MC are also associated with the Ah^
allele in 14 strains of mice (Nebert and Jensen, 1979).
The Ah locus is thought to be responsible for induction of a
number of different enzymes activities (Eisen et al, 1983) including
aflotoxin hydroxylase (Gurtoo et al, 1978), glut athione
transferase (Czosnek et al, 1984) and UDP glucuronyl transferase
(Jakoby, 1980). Practically all mouse strains exhibit Ah locus
associated responsiveness (Nebert et al, 1982; Taylor, 1984). The
metabolism of many drugs and environmental pollutants by the P-450
o
dependent monojjxygenase system represents an important rate limiting
step in their excretion. Thus the pleiotropic effects of the _Ah
locus implies that it is a regulatory locus which affects the levels
of many structural loci related to xenobiotic metabolism. The
control of inducibility by the All locus thus represents a case where
quantitative changes in the levels of drug metabolizing enzymes can
have profound effects on an organism's drug metabolizing capacity.
Another AHH inducer is 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD).
This compound has about 30,000 times more potency than 3MC as an
inducer (Poland and Glover, 1973). Following interaperitoneal
administration of (^C) labelled TCDD it was found to accumulate at
high levels in the liver of C57BL/6, intermediate levels in
(C567BL/6 X DBA/2)Fl's and to a much lower degree in DBA/2 mice
(Poland et al, 1976). This pattern mirrored the strain sensitivity
to AHH induction by nanomolar amounts of TCDD. It was then
- 50 -
established that TCDD bound to a soluble hepatic cytosolic protein
in C57BL/6 mice but not DBA/2 mice at the concentration tested
(Poland et al, 1976). This was postulated to be due to a receptor
involved in the induction mechanism. It was noteworthy that at
higher doses (10-fold) TCDD is a potent inducer of AHH in Aha
(DBA/2) mice (Poland et al, 1974; Niwa et al, 1975). The
diminished sensitivity of non-responsive mice to AHH induction was
interpreted as being due to a mutation in the TCDD binding protein/
receptor. Further alleles at the Ah locus were suggested by
crossing DBA/2 and C3H/HJe (responsive) mice, an between these
mice showed an additive mode of inheritance for AHH inducibility
(Thomas and Hutton, 1973; Robinson et al, 1974).
A more complex result was obtained by Robinson et al (1974)
using NIH substrains C57BL/6N (responsive) and AKR/N (non-
responsive). At that time these sublines had been separated from
their Jackson laboratory counterparts C57BL/6J and AKR/J for more
than twenty years. In their cross of C57BL/6N with AKR/N they found
non-responsiveness was a dominant trait. This reversal of dominance
appeared to result from the specific interaction of these strains
since both strains showed a normal dominance pattern in crosses to
other strains. In a series of crosses of either C57BL/6J or N or
AKR/N or J un'tU F^s of respectively (AKR/N X AKR/J) X (C57BL/N X
C57BL/6 J) all the resulting progeny showed nearly a 100%
responsiveness which was significantly different from the expected
segregation based on the subline differences. This data was
perplexing and may suggest that additional loci are involved in AHH
induction. For example the TCDD receptor could be a multimeric
protein where specific interactions are required by its subunits for
it to function.
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The structural loci responsive to induction of AHH activity, by
the Ah locus have been associated with a P-450 in the mouse named
cytochrome P^450 (P450-1) (Robinson et al, 1974). Two forms of P-
450 which were part of this family were isolated from induced
C57BL/6 mice. One of which was P^450 associated with AHH activity,
(MClb) and the other, P345O with acetanilide hydroxylase activity
(MCla) (Negishi and Nebert, 1979). Both forms of P-450 were
inducible by TCDD and 3MC in C57BL/6 mice. Recombinant DNA studies
have shown a stoichiometric relationship between translocation of a
TCDD-receptor complex into the nucleus and the accumulation of P^450
mRNA (Tukey et al, 1982). This suggested that the inducer-receptor
complex interacts with chromatin to initiate transcription.
Increases in the mRNAs for P^ and P3 450 are a direct result of
increases in transcription rate as determined by nuclear run off
assays (Gonzalez et al, 1984; Kimura et al, 1986). A cis acting
dioxin responsive element (DRE) has been located upstream of the
Pj^450 gene by splicing 5' Pj450genomic fragments to a reporter gene
(Jones et al, 1986) and by mapping the sites in situ with nuclei
from induced hepatoma cell lines (Durrin and Whitlock, 1987).
The Pj450 and P345O genes have been assigned to chromosome 9 in
mice using a panel of DNAs from Chinese hamster/mouse somatic cell
hybrids (Tukey et al, 1984; Hildebrand et al, 1985a). The regional
localization of the Pj450 gene was assigned by mapping in a set of
recombinant inbred (RI) strains of mice. Briefly, RI lines result
from the systematic inbreeding (>20 generations) of the selected F2
pairs from a cross between two pre-existing progenitor strains.
This essentially fixes within each resulting RI strain a specific
pattern of recombination. The probability of recombination between
any two loci is proportional to the distance between them. Strain
distribution patterns (SDP) can be generated for a set of allelic
chromosomal markers. If differences exist in the progenitor strains
for new markers then a SDP can be generated and compared to the
previously mapped genes and thus determine relative chromosomal
location (Taylor, 1978). By this method the Pj450 (P450-1) gene was
assigned 7cM distal from the Thy-1 locus near Mpi-1 on chromosome 9
(Hildebrand et al, 1985a). The original SDP for the Ah locus did
not allow regional assignment but excluded many parts of the mouse
genome including chromosome 9 (Taylor, 1971; Wood and Taylor, 1979;
Gurtoo et al, 1978) which would support the idea of Ah being a
regulatory locus.
With the accumulation of new markers, the Ah locus has now been
assigned to chromosome 12 in mice in the BxD RI series (Cobb et al,
1987). This places it about 10.5±3.7cM from the ApoB locus (Lusis
et al, 1987).
1.7.2. Coh locus (P450-2B)
The metabolism of coumarin, a constituent of many plants, whose
derivatives are used as anticoagulant drugs, is metabolized by the
P-450 dependent monooxyg lases (Wood and Cooney, 1974). The basal
and phenobarbital (PB) induced levels of this hepatic microsomal
activity are genetically controlled in different strains of mice.
In untreated DBA/2 mice this activity is three- to four-fold higher
than AKR, C57BL/6 and C3H/He strains. After PB treatment this
relative difference has increased to four- to six-fold. PB
treatment induces coumarin hydroxylase activity two- to five-fold.
3MC has no effect on this activity which is therefore distinct from
the Ah_ locus. Analysis of the F^s between DBA/2 and low activity
strains shows that this trait is inherited additively. Comparison
of pH optima, heat stability and Km values for coumarin hydroxylase
activity show no significant differences between the DBA/2 and AKR
strains or the hybrid (Wood, 1979). However, the heme ligands
aniline and metyrapone show differential inhibition of this enzyme
activity in DBA2/J and AKR mouse strains. Metyrapone preferentially
inhibits in AKR microsomes whereas aniline preferentially inhibits
DBA/2 microsomal coumarin hydroxylase activity. The classification
of mice strains has been extended (Lush and Arnold, 1975; Lush and
Andrews, 1978; Wood and Taylor, 1979) and an additional class was
identified as containing medium metabolizers of coumarin or 7
ethoxycoumarin (Lush and Andrews, 1978). However the medium group
was absorbed in to the high metabolism group when 4 methyl
derivatives of coumarin or 7 ethoxycoumarin were used as substrates.
These results were interpreted as evidence that there are two
closely linked genes which determine cytochrome P-450 isozymes with
different substrate specificities.
Additive inheritance of coumarin hydroxylase activity in the F^
generation between DBA/2 and AKR suggested that a structurally
different enzyme rather than an absence of regulatory process may
account for the different levels of enzyme activity (Wood and
Cooney, 1974). Backcross analysis of PB treated AKR, DBA/2 and (AKR
X DBA/2)Fi indicated that coumarin hydroxylase activity is inherited
as a single autosomal trait (Wood and Taylor, 1979). The locus
symbol was designated Coh with subscripts h or 1 for high and low
activity alleles. Backcross analysis between (AKR X DBA/2)F^ and
AKR mice indicated that Coh was 21±6 cM from the albino locus on
chromosome 7. Analysis of the SDP in the BXD RI series indicated
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that Coh is closely linked to -&pi-I on the centromeric side of 7.
The analysis and characterization of PB induced P-450's in the
mouse is very limited, the rat PB3a cDNA clone picks up multiple
sequences in the mouse (Simmons and Kasper, 1983). On Southern
blots of DNA from different inbred strains restriction fragment
length variants can be detected. C57BL/6/DNA gives a different
pattern to DBA/2 on EcoRI, BamHI and PvuII digestion. When these
variants are mapped in the BXD series they show a 100% concordance
with the Coh locus as determined by coumarin hydroxylase activity.
However, in typing 15 mouse strains one discordant was found.
CBA/Ca mice were typed as being Coh-*- but on Southern analysis shows
a DBA/2 (Coh*1) DNA pattern. This discordance tends to support the
idea that there are two closely linked loci involved in the
metabolism of 7-ethoxycoumarin (Lush and Andrews, 1978). This idea
is further supported by semi-purification of PB induced P-450s from
mouse (Huang et al, 1976; Kaipainen et al, 1984). Two PB inducible
proteins termed A2 and C2 were isolated from liver microsomes of
(C57BL/6 X DBA2)Fi mice (Huang et al, 1976). These had molecular
weights of 50 and 56kD respectively. In reconstitution experiments
the fractions containing the A form had ten- to one hundred-fold
greater coumarin hydroxylase activity than the C fractions.
Interestingly, the A fractions also had significantly greater
testosterone 7a-hydroxylase activity. This is a marker substrate
for UT-1 P-450 in rats (Ryan et al, 1984; Waxman, 1984) UT-I
protein from rats also has a molecular weight of 49kD. The C
fractions had significantly greater N-demethylation activity (Huang
et al, 1976) which is suggestive that they are more similar to rat
PB3a (Astrom and De Pierre, 1986). A P-450 Coh has been isolated
from DBA/2 hepatic microsomes (Kaipainen et al, 1984) which has a
Vmax twice as high as, and a Km value tenfold less than a similar
isolate from C57BL/6 in reconstitution systems. This protein also
has a molecular weight of 49kd and antibodies raised to this protein
will not cross react with the higher molecular weight major pheno-
barbital induced E-450. Antibodies to P-450 Coh will block
coumarin 7 hydroxylase activity in DBA/2 and C57BL/6 microsomes.
Thus indirectly the Coh locus appears to be distinct from but
closely linked to the PB inducible P-450 locus on mouse chromosome
7.
1.7.3. PCN locus (P450-3)
There has been virtually no biochemical analysis dorvi
on the steroid inducible P-450s in mice. However, rat derived cDNA
clones have been used to map this locus in mice. Analysis of the
SDP of restriction fragment length variants in the BXD series showed
that this locus was distinct from the Coh, Ah and P450-1 loci. A
panel of DNAs from Chinese hamster/mouse hybrids was used to assign
the locus to mouse chromosome 6 (Simmons et al, 1985).
1.8. Genetic analysis in humans
1.8.1. P-450s induced by Polycyclic Aromatic Hydrocarbons
The human cDNA homologues to the rat and mouse TCDD inducible
P-450s have been isolated (Jaiswal et al, 1985; Quattrochi et al,
1986). This gene family has been assigned to human chromosome 15
(Hildebrand et al, 1985b) and regionally localized to 15q22-q24
(Amsbaugh et al, 1986) by in situ hybridization. This part of
chromosome 15 in man appears syntenic with chromosome 9 in mice as
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Mpi and Pkm2 also map to these regions (Cox and Gedde-Dahl, 1985).
1.8.2. The human Ah locus
The discovery of the Ah locus in mice stimulated the search for
a similar pleiotropic locus in humans. In a study of 353 healthy
subjects inducibility of cultured lymphocytes by 3MC varied widely
from 1.3 to 4.5. times the basal level (Kellerman _et_al, 1973a).
The population could be separated into low, high and intermediate
inducibility. The inheritance of the human Ah locus was therefore
thought to be autosomal co-dominance. High inducibility of AHH has
been associated with susceptibility to bronchogenic carcinoma in one
study (Kellerman et al, 1973b). However these findings were not
confirmed by other laboratories who associated the increased AHH
inducibility with the disease process itself (Paigen et al, 1977).
Lymphocytes from tumour patients had reduced cell growth and reduced
protein synthesis. Thus Paigen and colleagues used a progeny test
because it estimates the AHH inducibility indirectly on healthy
lymphocytes. The progeny test does not depend on the genetic mode
of inheritance. Almost any type of inheritance should produce a
shift in inducibility toward the high end of the range if patients
with lung cancer are shifted towards this range. In this test no
difference in induced AHH activity between lung cancer progeny and
controls was observed (Paigen et al, 1977). Measurement of AHH in
cultured lymphocytes of homozygotic and dizygotic twin pairs showed
that basal and induced AHH activity and AHH inducibility are
heritable traits (Paigen et al, 1978). Using mouse X human somatic
cell hybrids segregating human chromosomes the Ah inducibility locus
was assigned to human chromosome 2 (Weibel et al, 1982). In hybrids
containing large fragments of chromosome 2 the human Ah locus has
been localized to 2q31-2pter (Ocraft et al, 1985). It is difficult
to interpret segregation data from somatic cell hybrids for a
regulatory phenomenon which is the end point. Therefore Ocraft and
colleagues felt they had mapped the structural gene for AHH
activity. The activity assays do not differentiate between the
species origin of the structure gene. There is also a question mark
over whether they are measuring a regulatory or a structural locus.
However there are two compelling reasons for assignment of the Ah
locus to chromosome 2 in humans. Firstly, the AHH gene has been
assigned to chromosome 15. Secondly, human chromosome 2 has regions
of synteny with mouse chromosome 12 (Povey et al, 1985: Lusis et
al, 1987).
1.8.3. Human Pharmacogenetics
It is now well established that genetic variation can play a
significant role in an individual's response to drug treatment.
Genetic differences in the oxidative metabolism of a number of
compounds have been observed (Eichelbaum, 1984; Mahgoub et al,
1977; Kleinbloesen et al, 1984; Kupfer and Preisig, 1984). Now
these drugs serve as probes for variation in xenobiotic metabolism.
The study of the host factors responsible for variations in drug
metabolismf . may give clues to the origins of individual
susceptibility to environmental toxins and carcinogens.
1.8.4. Debrisoquine Hydroxylation
The levels of debrisoquine, an anti-hypersensitive agent, and
its primary metabolite 4-hydroxydebrisoquine have been measured in
the urine of healthy human volunteers after a single oral
administration of debrisoquine (Mahgoub et al, 1977). The ratio
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between excreted debrisoquine and its metabolite showed a bimodal
distribution. Individuals could be characterized as extensive (EM)
or poor metabolizers (PM) of the drug. Family studies demonstrated
that the inability to metabolize debrisoquine was inherited as an
autosomal recessive trait (Eichelbaum, 1984). In a population
study, approximately 5 to 10% of the British Caucasian population
are PM (Price-Evans et al, 1980). The debrisoquine polymorphism has
been associated with susceptability to Parkinsons disease (Barbeau
et al, 1985) and also susceptability to lung (Ayesh et al, 1985) and
liver cancer (Idle and Ritchie, 1983). For example in a study of
245 bronchogenic carcinoma patients and matched smoking controls the
frequency of PMs was reduced in the cancer population compared to
the control population, 1.6% and 9.0% respectively (Ayesh et al,
1985). It was concluded that homozygous dominants have a high risk
of developing lung cancer if they smoke. Similarly there is a low
incidence of PMs in individuals with hepatocelluar carcinomas caused
by exposure to AFB^ (Peanuts) and hepatitis infection in Africans
(Idle and Ritchie, 1985).
Parkinsons disease which is thought to be due to environmental
factors has also been associated with a low incidence of PMs of
debrisoquine (Barbeau et al, 1985). Other drugs which show
variability in oxidative metabolism havfalso been correlated with
debrisoquine metabolism (Idle and Ritchie, 1985).
1.8.5. Mephenytoin and Nifedipine metabolism
The oxidative metabolism of mephenytoin(an anti-convulsant) and
nifedipine (a calcium channel blocker) have also been shown to be
polymorphic in human populations (Kupfer and Preisig, 1984;
Kleisbloesan et al, 1984). Mephenytoin is sold as a racemic
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mixture, the S-enantiomer is quickly hydroxylated and excreted while
the R-form is eliminated at a much slower rate (Kalow, 1986). In
persons with mephenytoin hydroxylase deficiency both the enantiomers
accumulate leading to overdose and toxicity. Mephenytoin
hydroxylase deficiency occurs as a recessive trait (Inaba et al,
1986) in 5% of Caucasian populations (Kupfer and Presig, 1984) and
in 23% of a Japanese population (Jurima et al, 1985). As yet the
mephenytoin polymorphism has not been linked to a marker for altered
susceptability to environmental toxins or carcinogens. There are
currently no studies on this theme.
The metabolism of nifedipine is also bimodal in Dutch
populations (Kleinbloesan et al, 1984). PMs of nifedipine represent
17% of the Dutch population. Again there are no reported
environmental susceptibilities associated with the metabolism of
this drug.
1.8.6. Human P-450s and Drug Metabolism
On the basis of oxidative metabolism of marker substrates the
P-450s responsible for debrisoquine, mephenytoin and nifedipine
metabolism have been isolated. The P-450, P450DB, responsible for
debrisoquine hydroxylation has a molecular weight of 50kD (Gut et
al, 1986) and has a high specific activity towards debrisoquine and
buffuranol (Disterlath et al, 1985). A second related form P-450
DBII with higher Km for bufuranol and no determinable debrisoquine 4
hydroxylation activity (Gut et al, 1986) has also been isolated. In
previous studies it had been shown that female DA rats were poor
metabolizers of debrisoquine (Al-Dabbagh et al, 1985). When human
anti-P-450pg antibodies were used on Western blots a 20 fold lower
amount of P-450DB was found in female relative to male DA rats (Gut
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et al, 1986; Larrey et al, 1984). In humans lack of debrisoquine
activity appears to be due to a structurally altered protein (Gut et
al_, 1985).
Debrisoquine is a P-450 which is constitutively expressed and
can play a role in general xenobiotic metabolism. P-450pg is
distinct from the highly inducible forms on western blot analysis
(Wang et al, 1982; Larrey et al, 1984).
By monitoring the oxidative metabolism of mephenytion two P-
450s have been isolated from human liver which stereoselectively
catalyse the 4-hydroxylation of S-mephenytoin (Shimada et al, 1986).
These were termed P-450mpI and P-450mpII and had molecular weights
of 48kD and 50kD respectively. These P-450s had no debrisoquine
activity and appeared distinct from P-450DB. Western blot analysis
could detect no differences between EM and PM hepatic microsomes.
Neither P-450mpI or P450mpII was correlated with a deficiency in
mephenytoin metabolism. Again this P-450 had high constitutive
levels of expression in adult hepatic microsomes.
In the case of nefedipine it was found that male rats were most
efficient at metabolizing this compound and that this activity could
be induced with PB, PCN and dexamethasone (Guengerich et al, 1986).
This suggested that the P-450 responsible for nifedipine metabolism
was PB2b (P450-3). In reconstitution assays with purified rat forms
the P-450 had high activity towards this compound. The human P-450
responsible for nifedipine oxidation has been isolated and found to
cross react with the rat anti-PB2b antibodies. Monoclonal
antibodies to human P-450^g also reacted with the rat PB2b- This
human P-450 also had high catalytic activity towards steroids
(Guengerich et al, 1986) and erythromycin (Watkins et al, 1985). P-
450nf had 17[3-estradiol activity and at the 2-, 4- and 6(3 position
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of testosterone which makes it similar to the rat form in that it
metabolizes androgens (Astrom and De Pierre, 1986). Again this had
high levels of expression in EM and PM human livers.
1. 9. Aims of this thesis
As described above, the cytochrome P-450s play a central role
in the metabolism of drugs, toxins and steroids. Much of the
biochemical analysis of these proteins has been carried out on
purified forms from rats and the genetic analysis in mice has been
limited and restricted to those forms which are only expressed after
exposure to chemical inducing agents. Pharmacogenetic analysis has
demonstrated that there is considerable genetic variation in P-450
expression in humans. In some cases these polymorphic differences
can be related to suscepttbility to exposure from environmental
toxins and carcinogens. Initial biochemical analysis of the human
P-450s involved in these effects suggest that they correspond to the
constitutively expressed P-450 isozymes in rats and mice.
In the light of our current knowledge important questions need
to be answered. Firstly, what role do these constitutive P-450s
play in a host's response to chemical challenge? As rodents are
used extensively for toxicological models, how well does the rodent
drug metabolizing system reflect the human system. In an attempt to
establish which genetic and regulatory factors govern P-450
expression I decided to use a molecular genetic approach to this
problem. The organisms of choice were human and mice.
Mice were chosen as the animal modeiof choice because of
well characterized genetics, the availability of genetically
homogenous inbred strains and subsequently identified genetic
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mutants and variants. The cumulative data from this system
represents an important contribution to our understanding of
structure/function relationships, evolution and the derivation of
mutant loci. Comparative biology with other systems can indicate
the universality of conclusions reached.
When this investigation was begun I had access to a rat cDNA
clone corresponding to a constitutively expressed P-450 of unknown
function. It was decided to use this clone to characterize the
chromosomal organization of any mouse genes detected by the cDNA and
to identify any variants amongst different inbred strains. These
variants would be analysed genetically with respect to candidate P-
450 functions. A parallel study was begun in humans to isolate the
human counterpart and characterise the human DNA with respect to
known human pharmacogenetic responses. The regulation of this and
other gene families were studied in rodents to establish potentially






2.1.1. Laboratory mice and DNAs
Inbred mice used for these studies were obtained from colonies
maintained at the Western General Hospital Animal Unit (WG) ; The
Jackson Laboratory, Bar Harbor, Maine (JL); AFRC Physiology and
Genetics and Research Station (AFRC); Netherlands Cancer Institute
(NCI); Charles River Laboratories (CR). The following is a list of
different inbred mice used for DNA analysis: C57BL/6 (WG and JL),
CBA/Ca (WG), C3H/HeJ (WG), DBA/2 (JL and CR) 129 (CR), C57/L (JL and
AFRC), AKR (JL), AKR/FuRda (NCI), BALB/c By (WG and NCI), BALB/cHeA
(NCI), STS/A (NCI), 020/A (NCI), C57BL/10 (a gift from P. Jones).
RIII mice were represented by DNA from the C127 breast fibroblast
cell line (Lowy et al, 1978). GRS/A DNA was a gift from Dr. J.
Hilgers (Hilgers et al, 1975).
Spleen DNAs from the (C57BL/6J X DBA/2J), (C57/L X AKRJ) and
(C57BL/6 X C3H/HeJ) RI strains were obtained from the Jackson
Laboratory, Maine, U.S.A. (C57BL/6 X DBA/2) RI strain spleen DNAs
were also a gift from Dr. G. Bui field. Spleen DNAs from the (020/A
X AKR/FuRdA) and (C57BL/6 X BALB/c) RI strains were a gift of Dr. J.
Hilgers.
2.1.2. Wild Mice and DNAs
Mus musculus musculus, Mus musculus domesticus and Mus spretus
mice were a gift from Dr. G. Bui field. Spleen DNAs from a (C57BL/6
X Mus spretus)F; X C57BL/6) backcross were obtained from Dr. Louis
Guenet, Pasteur Institute (Robert et al, 1985).
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2.1.3. Rat Strains
Rats of the Wistar, Spra 'jue-Dawley (SD) and Dark Agouti (DA)
strains were obtained from the Western General Animal Unit.
2.2. Treatment of Animals
2.2.1. Xenobiotic induction
Male Wistar rats (200g) or male CBA/Ca mice (25g) were used.
Animals were treated with either phenobarbital (80mg/Kg i.p. in 0.9%
saline) or 3-methylcholanthrene (20mg/Kg i.p. in sunflower oil)
(Wolf and Oesch, 1983).
2.2.2. Corticosteroid
Male Wistar rats (200g) or male CBA/Ca, BALB/c or C57BL/6 mice
were treated with dexamethasone (200mg/Kg i.p. in corn oil) either
three consecutive days before use (CBA/Ca) or 6 to 24 hours before
use (BALB/c and C57BL/6).
2.2.3. Inflammation
Inflammation was induced in intact male CBA/Ca mice by intra-
per: toneal injection of Escherichia coli 1ipopolysaccharide
(Serotype No. 0127:B8; Sigma). Three doses were administered in
control animals or after administration of phenobarbital, 3 methyl-
cholanthrene and dexamethazone on the three consecutive days prior




Liver RNA from hypophysectomised CBA/Ca, C3H/He and BALB/c mice
were a generous gift from Dr. R. E. Hill (Hill et al, 1985).
Hypophysectomized Wistar rats were purchased from Charles River
Laboratories.
2.3. Origins of Eukaryote DNAs
The origin of rodent DNAs has been specified, Human placental
DNAs were a gift from Mrs. S. Christie, chimpanzee DNA (Pan
troglodytes) was a gift of Mr. R. A. Buckland, sheep (Ovis
orientalis) DNA was a gift of Dr. A. J. Clark and fruitfly
(Drosophila melanogaster) DNA was a gift of Dr. D. Finnegan. Livers
from pig (Sus scrofa domesticus) was a gift of Dr. A. Archibald,
from chicken (Gallus gallus) was a gift of Dr. H. Sange and from the
South African clawed frog (Xenopus laevis) was a gift of Dr. A. P.
Bird. Chinese hamster (Cricetulus griseu) ovary cell pellets were a
gift of Ms A. Hall. Liver from Rainbow Trout (Salmo gairdneri) was
obtained from Dr. C. R. Wolf.
2.4. Somatic cell hybrids
Somatic cell genetics offers a unique method for understanding
gene and chromosome structure in multicellular organisms. Genetic
analysis of somatic cell hybrids bypasses the need for sex and lends
itself to a molecular analysis of DNAs from such somatic cell lines.
It complements mating studies in humans and mice (Puck and Kao,
1982). The fusion of somatic cells from different species can lead
to the subsequent segregation and stabilization of chromosomes of
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one particular species on the background of another e.g. human
chromosomes on a mouse background (Harris, 1965). When rodent
somatic cells are fused to human cells the resulting hybrids usually
lo,;t human chromosomes, so that often only one or a very few human
chromosomes are retained in the hybrids (Nabholz et al, 1969).
These human chromosomes can be identified by both cytogenetic and
isozyme analysis (Kao et al, 1976). A panel of these hybrids can be
used to assign recombinant DNA probes to a chromosomal location
(Ruddle, 1981). Similar ly somatic cell hybrids between Chinese
hamster and mouse somatic cells can lead to the formation of a panel
of hybrids which retain a set of mouse chromosomes (Ruddle, 1981).
These mouse chromosomes are usually identified by isozyme analysis
only (Lalley et al, 1976). In conjunction with other mapping
techniques these Chinese hamster/mouse somatic cell hybrid panels
can be used to assign recombinant DNA probes to their chromosomal
location (Swan et al, 1979; Bennet et al, 1982).
2.4.1. Human/rodent somatic cell hybrids
A panel of human/rodent somatic cell hybrids is maintained at
the M.R.C., C.A.P.C.U. by Mrs. S. Christie. The following somatic
cell hybrid cell lines have been reported in Lund et al (1983), the
numbers in brackets refer to their position on Table 3.1:
SK81.Wg3H.L2.15.3.2. (1), C121 (22), CTP41.7 (14), CTP41.3 (15),
H22.6.9 (16), Horp25.14 (17), ADP3.10.7 (18), PGME25.8 (20),
THYB1.33 (24), THYB1.33.6 (25), SK81-RAG-G5 (12) and ALR.1B5.AG.58A
(11). The following somatic cell hybrids were reported in Meehan et
al (1988): SK81.Wg3H.LI2.15.3 (2), SK8lWg3H:L2.38.2 (9), H22.6.13
(16), Horp25.4 (26), ADP3.10.8 (21), PGME25.9 (27) and X63.BTS4.F9.2
(3). The following hybrids have been described previously and were
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a gift by Dr. N. Spurr: 1WILA4.9 (28) (Nabholz et al, 1969); DUR4.3
(4) and CTP41.A2 (20) (Heisterkamp et al, 1982); 3W4CIS (5), DTI.2R
(6) and CTP34B4 (19) (Hobart et al, 1981); and Horp9.5 (7) (van
Heyningen et al, 1975). The somatic cell hybrids SIF4A31 (13) and
SIF-15 (8) were gifts of Dr. S. Povey.
The karyotype of these hybrids is included in Table 3.1. The
characterization of the hybrids was by established methods (Lund et
al, 1983).
2.4.2. Mouse/hamster somatic cell hybrids
The Chinese hamster/mouse somatic cell hybrids used in this
study were a gift of Dr. J. Hilkens. The fusion procedure and
characterization of the hybrids has been described (Hilkens et al,
1979; 1983). Briefly the presence of mouse chromosomes was
established in each hybrid using variant chromosome markers between
mouse and Chinese hamster. Chromosomal assignment of a recombinant
DNA probe was made on the basis of its concordance with a variant
mouse chromosomal marker (Hilkens et al, 1986).
2.5. Isolation of Eukaryotic DNA
In order to obtain high molecular weight DNA the procedure of
Marshall and Burgoyne (1976) for preparing nuclei was used. To
prepare DNA from spleens or cell lines polyamine stabilised nuclei
were isolated as follows. Freshly excised or thawed material („lg)
was homogenized in 20mls of 0.3M sucrose - 3mM EDTA-'A' buffer,






15mM Tris/HCl pH 7.4
Homogenization was carried out with a motor driver tight
fitting teflon/glass homogenizer (Tri-R Stir-R) on ice. The
resulting homogenate was layered over 15mls of 1.37M sucrose cushion
in 1.5mM EDTA, 1.5mM EGTA-'A' buffer in a 50ml polypropylene tube
and spun at 12k for 15 mins in a HB-4 (Sorvall) swing out rotor.
The nuclear pellet was resuspended in lOmls 1.5mM EDTA-'A' buffer on
ice and an equal volume of 2x pronase buffer (lOOmM Tris, 300mM
NaCl, 200mM EDTA, pHIO) was added.
The nuclei were lysed in 0.1% SDS and lOOpg/ml of DNAse free
RNAaseA (Sigma) was added to remove nuclear RNA. After digestion by
RNAaseA for 1 hr at 37°C, protinase K (Sigma) or pronase
(Calbiochem) at lOOpg/ml in 1% SDS was added to digest protein.
Incubation at 37°C was continued for a further 4hrs to overnight.
Protein was further removed by phenol-chloroform extractions, the
DNA remaining in the aequous phase. The DNA was spooled on a glass
rod by the addition of 2 volumes of ice cold ethanol. Spooled DNA
was washed in 70% ethanol air dried and unspooled in l-4mls of T.E.
(lOmM Tris (pH8.0), 2mM EDTA) The DNA was left at 4°C overnight to
go into solution and the OD determined at 260nm (DNA at an OD26O
1 equals 50pg/ml). Typically one mouse spleen gave a yield of lmg
of DNA.
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2.6. Preparation of prokaryotic DNA
2.6.1. Small scale preparation of plasmids
The LiCl boiling method was used for pUC and pEMBL based
vectors (Wilimzig, 1985). 3ml of LB or 2x YT broth containing
ampicillin (50pg/ml) was inoculated with a single bacterial colony
and grown overnight at 37°C with shaking. The overnight culture was
pelleted sequentially in a 1.5ml Eppendorf tube and the supernatant
discarded. The pellet was resuspended in 400pl of TELT (50mM Tris-
HC1 (pH7.5), 62.5mM EDTA, 2.5M LiCl and 0.4% Triton X100). To this
was added 40pl of lOOmg/ml fresh lysozyme in TELT. The sample was
boiled for 90 sec and cooled on ice for 10 minutes which
precipitates rRNA and protein. The precipitate was pelleted by
centrifugation for 8 mins and the supernatant removed to another
tube containing 0.6 volume of isopropanol. This was spun again for
10 mins at 4°C, the resulting pellet was washed in 70% ethanol and
dried and resuspended in 40pl of T.E. The plasmid was checked by
diagnostic restriction enzyme digestion and electrophoresed on a 14
x 20cm agarose horizontal gel.
It was found that pBR322 and pKT218 plasmids did not respond well
to TELT mini preps method so a scaled down version of the maxi
plasmid preparation was used (Birnboim, 1983). 10ml overnight
cultures of tetracycline resistant colonies were used and processed
in the same way as the maxi-plasmid preparation except they were not
loaded on CsCl gradients.
2.6.2. Large scale preparation of plasmid DNA
This method used a combination of differential precipitation to
remove E.coli genomic DNA and CsCl equilibrium centrifugation
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(Birnboim, 1983). Before CsCl centrifugation the plasmid DNA was
usually clean enough for restriction enzyme digestion, isolation of
inserts, radiolabelling and bacterial transformation. Plasmids were
purified on CsCl gradients when used as cloning vectors and for use
as in situ hybridisation probes to mitotic chromosome spreads.
Single colonies were used to inoculate 5mls of LB (pBR322;
pKT218) 2XYT (pUC or pEMBL) broth in the presence of the antibiotic
tetracycline (20pg/ml) or ampicillin (50pg/ml) respectively. The
resulting overnight cultures were used to inoculate 500mls of LB or
2XYT and grown overnight at 37°C with vigorous agitation.
The next day cells were harvested by centrifugation at 6K for
10 mins. The cell pellet was suspended in 2mls of GTE (50mM
glucose, 2mM Tris-HCl pH8.0, lOmM EDTA) to which was added 8mls of
lysozyme (lOmg/ml) in GTE. This was left on ice for 30 mins. 20mls
of fresh alkaline SDS (0.2M NaOH, 1% SDS) was added 10 mins later.
15ml of high salt solution (3M CH3COOK, 2M CH3COOH, pH5.0) was also
added and mixed in. A white precipitate forms this is removed after
20 min incubation on ice by centrifugation at 8K for 10 mins. The
supernatant was filtered through muslin and the DNA precipitated by
addition of 2 vols of 100% ethanol and incubation at -20°C for 20
mins. The precipitate was collected by centrifugation at 10K for 20
min and redissolved in 6 mis of acetate MOPs (0.1M CI^COONa, 0.05M
MOPs pH8.0). The DNA is precipitated by the addition of 2 vols of
100% ethanol and incubation at -20°C for 20 min. The precipitate
was collected by centrifugation at 10K for 10 min. The DNA is
resuspended in lOmls of T.E. and the E.coli genomic DNA and rRNA is
differentially precipitated by the addition of 0.5 vol. of 7.5M
CH3COONH4 and incubation on ice for 20 min. This solution is then
centrifuged at 12K for 20 min and the pellet is discarded. To the
supernatant 2 vols of 100% ethanol was added and the sample
incubated at -70°C for 45 min (or -20°C overnight). The precipitate
is collected by centrifugation and consists mainly of plasmid DNA,
RNA and lipopoly saccharide. This was resuspended in 2mls of T.E.
containing 50mM NaCl and SDS (0.1%). RNAaseA (DNAase free) was
added at lOOmg/pl and the solution incubated at 37°C for 15 min.
The SDS concentration was increased to 1% and pronase or proteinase
K added to lOOpg/ml and incubated at 37°C for a further hour. An
equal volume of phenol/chloroform (1:1) is added and the solution
well shaken. The phases were separated by centrifugation at 400g
for lOmins and the aqueous phase extracted sequentially with equal
vols of chloroform and ether respectively. DNA was precipitated by
addition of 1/10 vol of 2M CHgCOONa (pH5.5) to the aqueous phase and
2.5 vols of 100% ethanol and incubated at -70°C for „1 hour. The
DNA pellet is redissolved in 1ml of T.E. if purification is to be
stopped here, it can be checked by restriction enzyme digestion for
purity and concentration. For banding on CsCl density gradients the
volume is increased to 3.21ml with T.E. and 3.55gm of CsCl is added
(lgm/ml) and 340pl of lOmg/ml EtBr. The dark red solution is loaded
into a 5ml polyallomer (Sorvall) tube and put in a TV865 vertical
rotor (which allows the CsCl to reach equilibrium rapidly).
Centrifugation was at 40K for a minimum of 18 hrs at 20°C. The
plasmid band was visualised by exposure to U.V. (300nM) and
collected with a syringe. The EtBr is removed by extraction with 2-
butanol saturated with isoamyl alcohol. The DNA was precipitated
with 2 vols of 70% ethanol following incubation at -70°C for 30
mins, the DNA was collected by centrifugation at 10K for 15 min and
resuspended in 400pl of T.E. and reprecipitated with 0.2M CI^COONa
(pH5.5) and 2 vols of 100% ethanol. The DNA was checked by running
on agarose gels and by reading the O.D. at 260nm (1 OD26O = 50pg/ml
DNA) .
2.6.3. Preparation of bacteriophage lambda DNA
The method of Helms was used (1985). 1ml of overnight Q358 or
LE 392 were infected at a high titre (lO^pfu) and plated out on
large 20 x 20cm plates. After lysis the phage were collected by
washing with 40mls of SM (50mM Tris-HCl (pH7.5), 0.01% gelatin, lOmM
MgSO^., lOOmM NaCl). To this was added a few drops of chloroform and
the phage suspension was spun at 3K for 10 min to remove debris.
The phage were collected by centrifugation for 90 minutes in a 8x
50ml MSE fixed angle rotor at 35K using an MSE Prespin 65. The
phage are resuspended in 3mls of phage lysate buffer (lOmM Tris-HCl
pH8.0) and the lysate is applied to a 1ml DEAE-cellulose (DE.52)
column, the column run through is discarded. 5ml of chase buffer
(lOmM Tris-HCl [pH8.0]], lOmM [CH3COO]2Mg, 60mM CH3COONa) is added
and the run through discarded. Then 1ml of elution buffer (lOmM
Tris-HCl (pH8.0), 50mM [Ch3COO]2Mg) is added and the run through
discarded. The next 0.6ml of elution buffer are collected and the
phage lysed by the addition of lOpl of lOOpg/ml proteinase K and
24pl of 10% SDS. After 5min lOOpl of 3M CH3C00K are added and the
sample heated to 88°C for 20 min and then cooled on ice (a white
precipitate forms). The white precipitate was removed by
centrifugation (12K for 10 min) and to the transferred supernatant
is added 20pl of lmg/ml mussel glycogen to act as carrier. The DNA
was precipitated by the addition of 700pl of isopropanol, collected
by centrifugation, the pellet was washed with 70% ethanol, air
dried and resuspended in lOOpl of T.E. The DNA was checked for
purity on agarose gels.
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2.7. Analysis of DNA
2.7.1 Restriction endonuclease digestion
Restriction enzymes were purchased from Amersham International
pic, BRL, Boehringer-Mannheim GmbH or New England Biolabs.
Restriction endonuclease digestions were carried out according to
the manufacturers' recommendations in either high, medium or low
salt buffer (Maniatis et al, 1982). A 4-5 fold of excess of enzyme
was used over a 5-12 hr incubation period. The reaction was stopped
by the addition of 0.1 vol of lOx stop buffer (20% Ficoll, lOOmM
EDTA).
High salt buffer: lOOmM NaCl, lOmM MgCl2
500M Tris-HCl (pH7.5),
lOmM (3-mercaptoethanol
Medium salt buffer: 50mM NaCl, lOmM MgCl2
lOmM Tris-HCl (pH7.5)
lOmM (3-mercaptoethanol
Low salt buffer: lOmM MgCl2
lOmM Tris-HCl (pH7.5)
lOmM (3-mercaptoethanol
Smal/Kpnl buffer: 20mM KCL, lOmM MgCl2
lOmM Tris-HCl (pH8)
lOmM (3-mercaptoethanol
Usually 5-10pg of genomic DNA and 0.5pg to lpg of plasmid DNA
were digested for subsequent analyses.
2.7.2. Gel electrophoresis of DNA
DNA was analysed on horizontal agarose gels (Sigma Type II) of
0.8 to 1.5% in TAE buffer (0.04M Tris acetate, 0.002M EDTA (pH8.0).
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Gels were run at a voltage of 0.3 to 5v/cm. After each run gels
were stained by addition of a drop of EtBr (lOmg/ml) in buffer for
10 min and destained in buffer for 20 min before visualization of
DNA under UV illumination. Gels were photographed with Kodak Plus-X
professional film and developed through a Fugi film X-ray auto
processor.
2.7.3. Southern Blotting
Gels were transferred to nitrocellulose or Hybond-N nylon
sheets (Amersham) according to Southern (1975). Gels were
irradiated with U.V. for 5 min to break up large DNA fragments (this
improves their transfer) and then soaked in denaturing solution
(1.5M NaCl, 0.5M NaOH) for 45 min with shaking. Gels were then
transferred to neutralizing solution (3M NaCl, 0.5M Tris-HCl, pH7.5)
and left for 45 min to 3 hrs. After neutralization DNA was
transferred from the gels to nitrocellulose or Hybond in 20x SSC (3M
NaCl/0.3M sodium citrate) through a wick of 3mm paper. DNA was
immobilized on nitrocellulose by baking at 80°C in vacuo or on
Hybond by exposure to a U.V. light box for 5 minutes.
2.7.4. Probe Stripping of filters
Filters were stripped of radiolabelled probes by immersion in
500mls of 1% SDS at 95°C and allowed to cool to room temperature.
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2.8. Isolation of insert DNA
The cDNA inserts were isolated from their parental plasmid DNA
by preparative agarose gel electrophoresis according to Dretzen et
al (1982). Plasmid DNA („50pg) was digested to completion with the
appropriate enzyme and electrophoresed on 1.2% low melting point
agarose (FMC). The relevant band was localized by EtBr staining and
UV visualization and a slit inserted in front of it with a fine
point scalpel. A piece of DEAE nitrocellulose (Schlier and Schull)
which had been equilibrated in running buffer was inserted into the
slit and electrophoresis continued until the DNA fragment was run
"in" to the DEAE paper. The paper containing bound DNA was washed
in DEPC treated water and the DNA was eluted off in 400pl of 2M NaCl
in T.E. at 68°C for 20 mins. After elution the paper was removed
and the DNA precipitated with two vols of 100% ethanol. After
recovery of DNA by centrifugation it was resuspended in 50pl of T.E.
and 1/10 vol. run on gel to determine the DNA concentration.
- 77 -
2.9. DNA Size markers
Three sets of DNA size markers were used. Hindlll digested cT 8S? Sa«
lambda phage DNA, EcoRI digested lambda phage DNA and Haelll cut
0X174 coliphage DNA. Generally 0.5-1.0pg of marker DNA was run per
track.
Sizes of fragments in kb
0X174 lambda lambda
(Haelll) (Hindlll) (EcoRI)
1353 23130 (sticky) 21226 (sticky)
1078 9416 7421
872 6682 5804
603 4361 (sticky) 5643
310 2322 4878







Radioactive ^2p_iabelled nucleic acids hybridized to nitro¬
cellulose or Hybond filters were visualized by exposure to Kodak X-
AR5 film. Filters were placed in X-ray cassettes with an
intensifying screen and preflashed film laid on them. Cassettes
were then stored at -70°C for the relevant exposure time.
(Typically 3 days to 2 weeks).
2.11. Bacterial culture
2.11.1. Media used for culture of E. Coli
L Broth: lOg tryptone (Difco)
5g yeast "
lOg NaCl /litre pH7.2
For the growth of plasmids glucose (BDH Chemicals) was added to
2g/l.
For growth of bacteriophage lambda maltose (Sigma) was added to
2g/l and MgSO^. to 0.5g/l (2mM) was added before autoclaving.
L-Agar contains in addition 15g agar/1 and 6.5g/l of agarose
(Sigma, Type II) for Top agarose.




lOg Agar /litre pH7.2




H agarose contained only 8g of agarose instead of agar.
2xYT: 16g Tryptone
lOg Yeast extract
5g NaCl /litre pH7.0
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Ampicillin (Sigma) was made up as a lOOOx stock in sterile
ddH20 at 50mg/ml.
Chloramphenicol (Sigma) stock solution was made up at 36mg/ml
in 50% ethanol and used on plates at a concentration of 20pg/ml.
Tetracycline (Sigma) was made up as 500x stock at 12.5mg/ml in
50% methanol.
2.12. Bacterial strains
2.12.1. pBR322 vector strain
E. coli K-12 HB101 (hrs-, hrrrf, recA-, gol-, str-, Bl~). This
strain is commonly used as a recipient in transformation of pBR322
based vectors and is a good host for large scale growth and
purification of plasmids (Bolivar et al, 1977).
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2.12.2. pUC and pEMBL vector strains
E.coli K12 JM83 (ara, Lacpro, strA, thi, o80d, lac ZW 15)
(Veira and Messing, 1982). This strain can be a host for the high
copy pUC (Veira and Messing, 1982; Norrander et al, 1983) and pEMBL
(Dente et al, 1983) vectors. Both these plasmids contain the p-
galactosidase genes. In the presence of XGal and ampicillin the
JM83 strain carrying these vectors appear blue, if the p-galacto-
sidase gene has been disrupted by insertion of DNA into the cloning
sites of these vectors the colonies will appear white but will still
be ampicillin resistant.
2.12.3. M13 coliphage strain
E.coli K12 JM101 (W lac pro, thi, supE, F'traD36, pro AB, lac
q2 M15). This strain is used for the propagation of M13 coliphage.
The mutation lac^2 mutation leads to overproduction of the lac
repressor. To compete out the repressor IPTG is added so that XGal
can be metabolized to its blue substrate by the p-galalactosidase
carried on the M13 mp8/9 coliphages. Again when this gene is
disrupted by the insertion of DNA the M13 plaques will appear clear.
2.12.4. Bacteriophage lambda strains
LE392 (hsdR-, SupE, SupF) (Kaiser and Murray, 1985). This
strain was used for the propagation of the lambda gt 11 human liver
cDNA library, it is deficient in restricton (hsdR-) to protect
introduced DNA.
E.coli Q358 (hsdR-, SupE)
E.coli Q359 (hsdR-, SupE, p2).
This strain carries a P2 lysogen so that spi- recombinants of
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phage will more readily grow on this host (Karn et al, 1983;
Frischauf et al, 1983).
2.13. Recombinant libraries
2.13.1. Liver cDNA libraries
a) Humans: A human liver cDNA library of 230,000 members
(Woods et al, 1982) was used to screen for human PB-1 P450 cDNAs.
This library was made from RNA from a single white male individual
and was constructed in the pBR322 deletion derivative vector pKT218
(Talmadge et al, 1980). This plasmid is deleted with respect to
most of the p-pencillinase gene and so is only tetracycline
resistant. A second human cDNA library in lambda gtll of 300,000
members was obtained from Clontech (California).
b) Mouse: A DBA/2 male liver cDNA library was obtained from
Clontech, California, USA. This library of 100,000 members was
constructed in the pBR322. vector.
2.13.2. DBA/2 mouse genomic library
This library was a gift of Dr. R. E. Hill and was constructed
in the bacteriophage EMBL3 vector (Frischauf et al, 1983; Karn et
al, 1983) by size selecting a Sau3A partial digest of DBA/2 mouse
spleen DNA and cloning into the BamHI sites of this vector.
2.14. Ligation of DNA fragments
Ligations were performed by the following procedure: 200ng of
linearized vector DNA was incubated with a 3-5 fold molar excess of
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insert DNA in ligation buffer (50mM Tris-HCl pH7.5, lOmM MgCl2) plus
lmM DTT, ImM rATP and 10 units of T4 DNA ligase in as small a volume
as possible. Incubations were carried out at 12-16°C overnight and
then stored at -20°C before use.
2.15. Vectors
2.15.1. pBR3 22
This plasmid (Fig.2.1) has proved a popular cloning vector for
cDNA libraries, because it is small (4.3kb), carries five unique
restriction sites for insertion of DNA (Bolivar et al, 1977). It
contains two selective markers which confer resistance to the
antibiotics tetracycline and ampicillin. Insertion into the PstI
site inactivates the [5-pencill vnase gene which codes for ampicillin
resistance. This site has been utilized for cloning by the oligo
(dG) oligo (dC) trailing method (e.g. Barth et al, 1982).
2.15.2. pKT218
This plasmid is a deletion derivative of pBR322 (Talmadge et
al, 1980). It has been deleted for most of the |3-pencill'.nase gene
from the PstI site toward the pencillinase signal sequence at
position 218 from the EcoRI site (Fig. 2.1). The PstI was recreated
by ligation of PstI linkers. It was hoped that cDNA libraries
constructed in this vector would more readily secrete recombinant
products.
2.15.3. pUC 8/9
These are a series of highly popular high copy number plasmids
with multiple cloning sites for insertion of DNA fragments (Vieira
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and Messing, 1982). These plasmids carry the ampicillin resistance
Of
gene and the (3-glactosidase gene (Fig. 2.1) The multiple cloning
sites are positioned in the amino terminus of the p-galactosidase
gene. Insertion of DNA fragments into these sites disrupts gene
function which can be tested by a histochemical reaction on agar
plates. The functional |5-galactosidase gene can convert X-Gal to a
blue indolyl derivative, in recombinant pUCs the colonies whilst
still ampicillin resistant remain colourless in the presence of X-
Gal.
2.15.4. pEMBL 8/9
These plasmids (Fig.2.1) are derivatives of pUC 8/9 which
contain the region of the F1 genome carrying all the elements
required for DNA replication and morphogenesis (Dente et al, 1983).
Thus upon super infection with F1 phage, virus capsids contain F1 ss
DNA or pEMBL ss DNA at about the same frequency. In the same manner
as pUC plasmids the pEMBL variety contain multiple cloning sites in
the amino terminal of the p-galactosidase gene and the ampicillin
resistance gene. The ss DNA from pEMBL recombinants can be used as
templates for sequencing using the universal primer. However, it
was found that large fragments inserted into pEMBL tended to
rearrange when going through the F1 replication step (R. E. Hill and
R. Meehan, unpublished observations). Therefore these vectors were
only used to maintain recombinant DNA fragments and not as sources
of sequencing templates.
2.15.5. M13 mp8/9
The bacteriophage vector M13 mp8/9, M13 18/19 were developed as
cloning vectors for DNA sequencing (Messing, 1983; Norrander et al,
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FIGURE 2.1.
Restriction maps of vectors used in this study. pBR322 was first
described by Bolivar et al, 1977. pKT218 is a deletion derivative
of this (Talmadge et al, 1980). pEMBL is from Dente et al, 1983,
pUC from Veira and Messing, 1982 and the bacteriophage vector M13
mp8/9 from Messing, 1983. Also shown is the polylinker region for
pUC8/9, pEMBL 8/9 and ml3 mp8/9. The insertion of the polylinker
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1983). During the life cycle of the M13 bacteriophage its genome
can exist in two forms: as double stranded DNA during the
replicative phase inside the host bacterium or as a single stranded
DNA filamentous phage which is secreted by the host into the growth
medium. As in the pUC plasmids foreign DNA is cloned into the poly
linker region of the aminoterminal of the lac Z gene in the M13
replicative form (RF) (Fig. 2.1). Recombinant M13 phage can be
identified as clear "plaques" when plated on JM101 host E.coli in
the presence of IPTG and X-Gal. Annealing of the universal oligo¬
nucleotide primer next to the multiple cloning site of the ss form
allows inserts to be used as templates for copying by the Klenow
fragment of E■coli DNA polymerase I. Thus inserts can be copied
from the multiple cloning site and used as templates for the dideoxy
sequencing reaction (Sanger et al, 1977).
2.15.6. EMBL 3 bacteriophage lambda
This is a replacement vector for cloning fragments of 9-20kb
(Karn et al, 1983; Frischauf et al, 1983). The selection scheme
for recombinants depends on plating these phage on P2 lysogen
containing strains which will select against phage carrying a
functional gam gene. This recombinant phage (Spi~) in which the gam
gene has been replaced will only grow on such a host e.g. Q359.
2.15.7. cDNA clones
A large number of liver cDNA clones were used in this study and
these are listed in Table 2.1. A clone for muscle actin, pAM (Minty
et al, 1981) was also used.
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TABLE 2.1
Liver cDNA probes used in this study
Plasmid Species Product References
plv54 mouse contrapsin Barth et al, 1982
plv5 6 II MUP It
plvi806 II apolipoprotein A1 II
plvl706 If albumin II
plvl796 II 0>! ~'Ant itryps in If
LVA329 mouse transferrin Clissold and Bishop, 1981
pRl 7 rat cytochrome P450-2B Adesnik et al, 1981
p5 ' 2 n cytochrome P450-2B Adesnik et al, unpublished
pTF-1 it cytochrome P450-2C(f) Freidberg et al, 1986
pTF-2 it cytochrome P450-2C(PB-1) II
pCL46 mouse cytochrome P450-1 Negishi et al, 1981
pPB3-15 mouse cytochrome P450-2C This study
pM8-l ti It II
pPB5-21 ii It ii
pPB4-i7 ii II ii
pm^EH4 mouse metallothionein Durnam et al, 1980
pHL5,5 human cytochrome P450C2C This study
pHLl,5 human It ii
pPB2-29 human unknown Wolf et al, unpublished
pRl7-13 ti cytochrome P450C2B Miles et al, unpublished
pPCN it cytochrome P450C3 Stevenson et al, unpublished
pMClb ii cytochrome P450C1 Stevenson et al, unpublished
piivS-5 mouse prealbumin Derman et al, 1981
plivS-7 it unknown ii
piivS-8 it II ii
piivS-9 it II ii
piivS-10 II II ii
piivS-11 it ii if
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2.16. Bacterial transformation by plasmid DNA
2.16.1. pBR322, pUC, pEMBL and pKT218
Competent E.coli cells were prepared by the CaCl2 method
according to Maniatis et al (1982). The strain of choice was grown
from an overnight culture to an OD550 of 0.6. The culture was
chilled on ice and spun down (3K for 5 min) and resuspended in 0.5
volume of 50mM CaCl2 and kept on ice for a further 20 mins then the
cells were spun down again and resuspended in 1/10 of the original
volume of 50mM CaCl2. The cells were then stored at 4°C and used
for up to 5 days after their preparation for transformation by DNA.
For transformation DNA was added to 200pl of cells and stored
on ice for 20 min and then heat shocked at 42°C for 90 sec. The
cells were returned to the ice for a further 20 min and then 1ml of
appropriate broth was added and the mix incubated at 37°C to allow
for expression of the selectable marker. 20pl of the incubation mix
were plated directly on the plates of choice and incubated at 37°C
overnight.
2.16.2. M13
The procedure of Messing (1983) was used here. The E.coli
strain JM101 was used for M13 transformations which requires the
production of a pilus by the host cell to be infective. The pilus
is encoded by an F plasmid. A colony of JM101 is picked from
minimal (+glucose) plates and grown up in 20ml of 2XYT to an OD55Q
of 0.3 and competent cell prepared as in the previous section. The
cells are aliquoted into 200pl portions, the ligation mix added and
the mix kept on ice for 40 min In the meantime a fresh culture of
JM101 is prepared for the lawn by adding 2ml of 2XYT to the dregs of
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the culture left over from making the competent cells. After
incubation on ice the 1igation/competent cells mix is heat shocked
at 42°C for 90 sec while cells are being heat shocked, 30pl of BC1G
(20mg/ml in DMF); 20pl of IPTG (24mg/ml in water) and 0.2ml of
exponential JM101 are added to 4ml of molten top H-agarose. The
agarose is added to the transformed cells and plated out on minimal
(glucose) plates or H plates and incubated at 37°C overnight.
2.17. RNA extraction
2.17.1. Guanidinium hydrochloride method
For the vast majority of RNA extractions the method of Cox
(1968) was used. lg of fresh tissue was placed in 20mls of 8M
guanidinum hydrochloride (GHCL) solution (8M GHCL, 0.01M EDTA, 0.05M
A.
Tris, pH7.5) and homogenized in an omnimix MSE at maximum speed for
45 sees. Cellular debris is removed by a clearing spin at 8K for 10
mins. The supernatant is removed to a fresh tube and the nucleic
acids precipitated by the addition of 0.5 vol of 100% ethanol and
incubation at -20°C for 45 mins (maximum incubation time). The RNA
is collected by centrifugation at 10K for 10 mins in fixed angle or
swing out rotor. Depending on the pellet size, it is resuspended in
5-10mls of 6M GHCL with the help of a tight fitting glass to glass
dounce homogenizer. The RNA is again precipitated by addition of
0.5 vol of absolute alcohol and incubation at -20°C for greater than
45 min. The RNA is collected by centrifugation and resuspended in 6M
GHCL as before, precipitated again and resuspended in DEPC treated
H2O (0.1% diethylpyrocarbonate in dd^O which has been autoclaved to
inactivate this methylating agent). One tenth vol of 2M NaOAc pH5.5
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is added and 2 vols of absolute alcohol and the mix incubated over
night at -20°C. The RNA is again collected by centrifugation and
the precipitation step repeated so as to remove traces of GHCL.
Then the RNA is resupended in l-2mls of DEPC H2O and the RNA
concentration measured by measuring its OD26O (for RNA 1 OD260 =
40pg/ml) and stored at -70°C.
2.17.2. Lithium chloride/urea method
This method was used when RNA was to be extracted from frozen
tissues and follows the procedure described by Jackson et al (1985).
RNA was prepared by homogenizing lg of frozen tissue in 20mls of 3M
C
LiCl/6M urea. The RNA was allowed to precipitate overnight at 4°
and collected by centrifugation at 10K for 30 mins at 0°C. The
pellet is resuspended in 8ml of 3M LiCl/6M Urea and spun again at
10K for 30 mins at 0°C. At this point the RNA is resuspended in 6
e
mis of T.E. plus 0.5% SDS to which is added prot|inase K to 50pg/ml
and incubated at 37°C for 30 mins. The RNA solution was extracted
sequentially with phenol, chloroform and ether. Ribonucleic acid is
precipitated by the addition of 1/10 vol of 2M CI^OONa and 2.5 vols
of absolute ethanol and incubation at -20°C for greater than three
hours. The RNA is collected by centrifugation at 10K for 10 mins
and resuspended in l-3mls of DEPC H2O and its concentration
determined spectrophotomfr(/Oc«(l^ at 260nm and then stored at -70°C.
2.17.3 Isolation of poly(A)_ RNA.
The method of Aviv and Leder (1972) was followed. Before
loading, the RNA was denatured at 80°C for 10 mins and then an equal
volume of 2x loading buffer (20mM Tris pH7.6, 0.5M NaCl; ImM EDTA,
0.1% SDS) was added. This was loaded to a 1ml oligo (dT)-cellulose
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column which had been equilibriated with loading buffer. The flow
through was collected and reapplied to the column. The column was
then washed in loading buffer minus SDS and then eluted with 3
volumes of elution buffer (lOmM Tris pH7.5, ImM EDTA), 0.5ml
to
fractions were collected and assayed spectrophc^netrically for RNA.
The most concentrated fractions were pooled and the RNA precipitated
by the addition of C^COONa and ethanol as before.
2.17.4. Gel electrophoresis and analysis of RNA
RNA was size fractionated through formaldehyde denaturing gels
by a modification of Derman et al (1981) according to Meehan et al
(1984). RNA was suspended in 50% formamide, 6% formaldehyde and
lOmM sodium phosphate, pH6.5. Samples were heated to 50°C for 15-30
min prior to loading and then bromophenol blue/orange G dye added in
the presence of Ficoll (10%). The electrophoresis buffer was lOmM
sodium phosphate pH6.5 and samples were run at 30V for 10-16 hours.
The gels were soaked in lOx SSC prior to transfer to nitrocellulose
or Hybond-N (Amersham) in lOx SSC according to Southern (1975).
Filters were then baked in vacuo at 80°C if nitrocellulose or if
Hybond exposed to UV for 5 minutes to bind the RNA to the filter
prior to hybridization.
2.18. Radiolabelling of DNA
2.18.1. Nick translation
Double stranded DNA (dsDNA) was labelled by the nick
translation (Rigby et al, 1977) reaction. E.coli DNA polymerase
repairs nicks in dsDNA by adding a residue to the 3'-OH terminus of
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the nick. It also has 5' exonuclease activity with a net result
that nucleotides are removed in a 51 direction and replaced by
addition at the 3' end. Typical reactions contained 0.1-0.2pg of
DNA in 20pl. The reaction contained 2pl of lOx nick translation
buffer (500mM Tris pH7.5, 50mM MgSo4, 0.1M (3-mercaptoethanol,
lOmg/ml BSA and 60mM each of dATP, dCTP and dGTP), 30-40pCi of a-^P
dTTP (>800Ci/mmol [Amersham]), lpl of DNAase 1 (BRL) (O.lpg/ml
freshly diluted from a lmg/ml stock) and 1-5 units of E.coli DNA
polymerase I. This reaction was incubated at 16°C for 1-2 hours and
the percentage incorporation of the labelled mix determined by
trichloroacetic acid precipitation (TCA), (Furlong, 1967). GF/4B
filters (Whatman) were spotted with the radioactive mix and counted
in a Packard Tri-carb scintillation counter. The filter is then
washed extensively with 5% TCA and counted again. The percentage of
counts remaining on the filter gives an estimate of incorporation.
Normally specific activities were greater than 10®dpm/pg of DNA.
The reaction was terminated by the addition of EDTA to 20mM.
Labelled DNA was isolated by SP-50 chromatography. Briefly, the mix
is applied to a 5ml SP-50 column in lx column buffer (0.3mM NaCl,
lOmM NaOAc pH5.0). Large molecules are excluded from the column and
pass through more rapidly than small unincorporated nucleotides.
Separation is monitored by a Geiger counter and the labelled
fraction collected in 0.3ml. Before use as probes the labelled DNA
is denatured in a boiling water bath for 10 mins in a 4ml loose
capped Sarstedt tube. The DNA is then quenched on ice for
10 mins before addition to the hybridization mix.
2.18.2. Random priming
This method was a modification of that reported by Feinberg and
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Vogelstein (1983; 1984) using Klenow fragment to extend random
hexamers (Pharmacia) with the DNA of interest as template. Double
stranded linear DNA is denatured by boiling for 2 minutes in the
presence of 0.2pg of hexamers, cooled on ice made up to 20pl by the
addition of 2|il of lOx nick translation buffer (previous section)
30-40pCi a-32p TTP, DEPC H2O and 1-3 units of Klenow. Klenow
retains only the 5'-3' polymerase activity and the 3'-5' exonuclease
activity but lacks the 5'—3' exonuclease activity. Because of this
the labelling reaction can be carried out overnight at 37°C without
degradation of the product. Percentage incorporation was measured
by TCA precipitation and the reaction terminated by diluting it in
400pl of T.E. The mix is not cleaned up any further but heat
denatured before use as a hybridization probe.
2.18.3. End-labelling reaction
This labelling reaction is mediated by T4 polynucleotide kinase
which catalyses the transfer of the a-phosphate of ATP to a 5'-OH
terminus in DNA or RNA (Richardson, 1971). Typically 5-10 pmoles of
5' ends are labelled in a reaction. The reaction mix consists of
lpl of lOx kinase buffer (0.5M Tris, pH7.6, 0.1M MgCl2, 50mM DTT,
ImM spermidine, ImM EDTA), 5-10pM of 5' ends, 80mCi -3 2p ATp
(3000Ci/mmol) and 10-20 units of T4 polynucleotide kinase (Biolabs).
The reaction mix is incubated at 37°C for no more than 30 mins and
stopped by addition of 2pl of 0.2M EDTA. The reaction can be
checked by running the sample (typically 20 mers on a denaturing
acrylamide gel or by hybridizing to a reference plasmid. The
reaction is used without further manipulation as a probe.
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2.19. Hybridization conditions of radiolabelled DNA to DNA or RNA
immobilized on membranes
2.19.1. Random primed or nick translated DNA.
Filters were prehybridized in sealed plastic bags in a 68°C





150-200pg/ml denatured salmon sperm DNA
10% Dextran sulphate.
20x Denhardts is : 0.2% BSA 'Sigma'
0.2% PVP 360 (Sigma)
0.2% Ficoll 400 (Sigma)
After prehybridization the radiolabelled DNA probe is added and
hybridized overnight at 68°C. Standard wash conditions were a total
of 2 litres of 2x SSC, 0.1% SDS and 0.1% PPi at 68°C per filter over
a period of 1 hour or more. Stringent wash conditions were 0.1-
0.05x SSC, 0.1% SDS, 0.1% PPi at 68°C . Low stringency
hybridization and wash conditions were done at 55°C in the absence
of dextran sulphate.
2.19.2. End labelled oligonucleotides
These hybridizations used the same hybridization mix as for
random primed or nick translated conditions except that dextran
sulphate was omitted. The temperature used varied from 37°C to 50°C
and hybridization was carried out overnight at the required
temperature. Filters were washed in a large volume of 4x SSC, 0.1%
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SDS, 0.1% PPi at two or three degrees higher than the hybridization
temperature.
2.20. Screening of recombinant libraries
2.20.1. Liver cDNA libraries
A method derived from that of Grunstein and Hogness (1975) was
used to bind DNA from plasmid containing colonies onto nitro¬
cellulose. Bacterial colonies were plated out on sterile nitro¬
cellulose sheets (Schleicher and Schuell) on top of agar plates.
Replica filters were made by placing a fresh sheet of "damp" nitro¬
cellulose on top of the colonies and pressing them together to
transfer colonies; filters were then marked for orientation. The
filters were peeled apart and if necessary placed on fresh agar
plates. One replica was retained on a master plate and stored at
4°C. Filters to be probed were placed colony side up on a sheet of
Whatman 3MM chromatography paper saturated with 10% SDS for 2 min.
Filters were then denatured on paper soaked in denaturing solution
(0.5M NaCl, 1.5M NaCl) for 5 minutes. Filters were then neutralized
on paper saturated in neutralizing solution (0.5M Tris, pH7.5, 1.5M
NaCl) for a further 5 mins before rinsing in 2x SSC for 5 mins. The
filters were then air dried at room temperature and baked at 80°C
under vacuum for a minimum of 2 hours to bind DNA to the filters.
Subsequently filters were hybridized with radiolabelled probes of
interest and colonies identified to be of interest picked from the
master plate and rescreened until plasmid pure and suitable for DNA
minipreparation.
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2.20.2. Lambdaphage genomic and cDNA libraries
The method of Benton and Davis (1977) was used. For screening
bacteriophage lawns agarose was used in place of agar in the top
layer of the plates and the plates incubated for at least 3 hours at
4°C before "lifts" were taken. This prevents a peeling away of the
top layer. Nitrocellulose filters fresh from the box were carefully
lowered onto a lawn of plaques for a minimum of 1 minute. For
subsequent lifts absorption times were doubled, i.e. 2, 4 min etc.
The nitrocellulose filters were orientated on the plate by marking
both filter and plate with india ink. Then, as in the Grunstein
Hogness procedure, the filters were peeled off and floated on
denaturing solution (30 sec), neutralizing solution (5 mins) and 2x
SSC (5 mins). Filters were then dried and baked. These filters
were then screened with radiolabelled probes and as necessary
rescreened until plaque pure.
2.21. Sequencing in M13
As mentioned in the text most of the sequencing of the human
PB-1 P450 insert cDNA clone pHL515 was done by Janice Sweeney.
However it was my responsibility to subclone all the relevant PstI
fragments of pHL5,5 into M13 mp9, grow up the recombinants and get a
partial sequence on each template in order to identify what part of
the PB-1 mRNA transcript that pHL5.5 cDNA corresponded to. After
this was done Janice continued the sequence with an Amersham ^5g
sequencing kit according to their protocol. After a sequence of
250-300 nucleotides had been determined sequencing proceeded using a
synthetic 18mer primer which was made on an Applied Biosystems DNA
synthesizer by the I.C.R.F. Synthesis service or by John Inglis.
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Overlapping and complementary sequences were read for verification
and tested by restriction mapping of pHL5,5. Each sequence was
determined a minimum of 5 times.
2.21.1. Subcloning of PstI fragments of pHL5,5 into M13 and DNA
preparation
The three PstI insert fragments from pHL5,5 were first
subcloned into pEMBL9 and re-isolated to prevent contamination and
resubcloned into double stranded M13 for preparation of the single
stranded template for sequencing by the dideoxy method (Sanger et
al, 1977). JM101 were transformed with the relevant ligation mix
and recombinant phage identified by the blue/white colour test on X-
gal/IPTG plates. Recombinant phage were picked with a tooth pick
into 1ml of a log culture of JM101 in 2XTY medium and grown for a
further 5 hrs at 37°C. The culture was transferred to Eppendorf
tubes and the supernatant cleared of cells by centrifugation for 5
min. The supernatant (containing single stranded phage) was
transferred to a fresh Eppendorf tube and 200pl of PEG/NaCl (20% PEG
6000/2.5M NaCl). The tube was shaken and allowed to stand for 15
min at room temperature. The phage were precipitated by
centrifugation for 5 min and the supernatant discarded. The tubes
were inverted on tissues for 5 min and then lOOpl of T.E. was added
to the pellet. After resuspension the solution was extracted 1 to 3
times with an equal volume of ultra-pure phenol (BRL). The DNA in
the aqueous phase was precipitated by the addition of 1/10 volume of
2M CH3C00Na (pH5.5) and 2.5 volumes of ethanol. This was incubated
overnight at -20°C. After 10 min centrifugation the resulting
pellet was washed in 70% ethanol and resuspended in 50pl T.E. In
some cases 5pl of the miniprep was run on agarose gels to check for
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the presence of DNA.
2.21.2. Sequencing reaction and polyacrylamide gel
electrophoresis
5 to 8pl of single stranded template was added to 2.5ng of
universal primer DNA (BRL) and lpl of annealing/sequencing buffer
(lOx is lOOmM Tris pH8.0; 50mM MgCl2) and made up to 10 with
sterile ddl^O. The annealing reaction mix was placed in a 60°C oven
for 1-2 hours after which it was quenched on ice for 2 mins.
Four different sequencing reactions are performed, each
supplied with all four dNTPs but each reaction containing a
different ddNTP. Incorporation of a ddNTP terminates the primer
extension reaction carried out by the Klenow fragment of E.coli DNA
polymerase. This is because there is no 3'-OH group available to
form the next phosphodiester bond. The ratio of dNTP:ddNTP
determines the frequency and size of DNA fragments generated by the
Klenow fragment but all fragments originate at the primer and
terminate at the site of ddNTP incorporation. By the use of
labelled NTP (^S or 32p) these fragments can be visualized by
autoradiography on high resolution acrylamide gels. The smallest
fragment is the first band on the gel and represents the first base
of the sequence. The next band up is the next smallest etc., etc.
Gels are read upwards towards the comb and in a 5' to 3' direction
from the primer.
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The following solutions of dNTPS and ddNTPs were made up:
A° C° G° rpO
0. 5mM dATP 1 20 20 20pl
0. 5mM dCTP 20 1 20 20pl
0. 5mM dGTP 20 20 1 20pl
T.E. 20 20 20 20
A' mix: equals vols A° plus 0. ImM ddATP
C' mix: equals vols C° plus 0. ImM ddCTP
G' mix: equals vols G° plus 0. ImM ddGTP
T' mix: equals vols rjiQ plus 0. ImM ddTTP
After quenching on ice, 2 units of Klenow („0.5pl) and lOpCi of
a-32p dTTP (>800Ci/mmol) were added to the annealing mix and 2.5pl
of this aliquoted to four tubes marked A, T, G and C. Then 2pl of
the relevant dNTP/ddNTP mix were added and the reaction allowed to
proceed for 15 min when 2pl of chase solution (0.5mM TTP) were added
and the reaction continued for a further 15 min. The reaction was
terminated by the addition of 4pl formamide dye mix (100ml
formamide, O.lg xylene cyanol FF, O.lg brophenol blue, 4ml of 0.5M
EDTA). The samples were placed in a boiling water bath for 3
minutes directly before loading 3-5pl aliquots onto a sequencing
gel.
Sequencing gels were prepared as follows: two glass 20cm x
40cm plates were cleaned with ethanol. One plate, with notched
rabbit ears, was coated with siliconizing solution (2% dimethyl-
dichlorosilane in 1,1,1-trichloroethane [BDH]) whilst the other
unnotched plate was treated with -methacryloxypropyl-
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trimethoxysilane (Sigma). Buffer gradients were used to get more
even spacing of bands over the length of the gel which was made up
in TBE (10.8g Tris base, 5.5g boric acid, 0.93g EDTA, pH8.4/1itre).
A 40% stock of acrylamide (19:1) acrylamide:NN'-methylenebis
acrylamide) was made up and de-ionized by mixing with amberlite MB1
resin for 30 mins and subsequently filtered. 80ml of light solution
(36.8g urea, 8ml lOx TBE, 12ml 40% acrylamide) and 20ml of heavy
solution (9.2g urea, 5ml lOx TBE, 3ml 40% acrylamide, lg sucrose,
lmg bromophenol blue) were prepared. Before pouring 150pl and 40pl
of 10% ammonium persulphate (fresh) and 80pl and 40pl of TEMED was
added to the light and heavy solutions respectively. 12.5ml of
light solution followed by 12.5ml of heavy solution was drawn up
into a 25ml pipette and poured at a steady flow rate between the two
glass plates and topped up with light solution. Then the comb was
added and gels allowed to set for 45 min. After setting the gels
were clamped to a Bio-Rad sequencing apparatus. The buffer tanks
were filled with TBE buffer and the comb removed. 3-5)il of
denatured DNA were loaded per slot and the gel connected to an LKB
2197 power supply and run at approximately 1500v at 0.46mA until the
bromophenol blue marked dye had run off the bottom. The gels were
then removed from the gel tank and prized apart with the gel
sticking to the non-notched plate. Gels were fixed in 10% acetic
acid, 10% methanol for 10 minutes and washed extensively under tap
water for 5-10 min. The gel was dried to the glass plate by baking
at 80°C for greater than 1 hour. The gels were placed in direct
contact with X-AR film and exposed at room temperature overnight.
Sequences were read directly into the computer for data storage and
mani -pulation.
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2.22. Oligonucleotides used in this study
A variety of oligonucleotide probes were used in this study to
identify selected cDNA clones as cytochrome P-450s and to
distinguish between members of the same cytochrome P-450 family.
These probes were synthesized on the basis of sequence comparisons
between rabbit PB-1 cDNA clones (Leighton et al, 1984) and rat PB-3
cDNA clones (Fuji-Kuriyama et al, 1982). Oligonucleotides were
synthesized by ICI (a personal gift of Dr. M. Rose), I.C.R.F. and by
J. Inglis (a personal gift). All oligonucleotides, except for
sequencing oligonucleotides, were made anti-sense so they could be
used in northern blot analysis.
b and e oligomer^, . Rat cytochromes P-450b and P-450e are
extremely homologous forms of the rat P-450 family P450-2B. They
are over 97% homologous over their primary cDNA structure (Fuji-
kuriyama et al, 1982; Adesnik and Atchison, 1986; Atchison and
Adesnik, 1986) but there is a region of hypervariability centered
around amino acids Ser 334 to Thr 339 for P-450b and Ser 334 to Ser
339 for P-450e. Over this region 4 out of 18 nucleotides are
mismatched and thus oligonucleotides directed to this region can be
used to distinguish these forms at the RNA (Omiecinski et al, 1985)
and DNA level. Interestingly a sequence for mouse P-450b has been
published which differs from the rat in this region (Stupans et al,
1984) so an oligo was made from this sequence as well.
A/s 5 1
Rat P450b (PB3a)
GGT TGG TAG CCG GTG TG
Rat P-450e (Pb3b)
GGA TGG TGG CCT GTG AG
_ 99 _
Mouse P-450b (PB3a)
GGT GGG TAG CCT GTG AG




This oligonucleotide was made to a conserved region between a
rabbit P-450, P-450 PBc2 (P450-2C) (Leighton et al, 1984) and a rat
P-450, P-450b (P450-2B) (Fuji-Kuriyama et al, 1982). At the time it
was thought these forms were orthologous but
subsequently (through this work and others) this was found not to be
the case. However, this oligo turned out to be a very useful probe
for identifying P-450 cDNA probes as discussed in the text. The




3 ' 5 '
Amino Acid Arg Leu Glu Glu Val Leu
The Leu corresponds to residue 153 in P-450b (P450-2B) (Fuji-
kuriyama et al, 1982).
oligonucleotide: C129
mer CI29
This oligonucleotide was derived from rat P-450b (P450-2B)
I
(Fuji-kuriyama et al, 1982) from a conserved region around cyste^ie
thought to be part of the heme binding region of P-450's (Black and
Coon, 1986). This turned out to be fairly rat specific.
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A/S 5' 3'
GGC AAT GCC TTC GCC AAG ACA
CCG TTA CGG AAG CGG TTC TGT
Amino Acid: Alu lie Gly Glu Gly Leu Cys
oligonucleotides: RWE296 and RWE297
It was soon realised how oligonucleotides directed to amino
acids around region 150 of the Phenobarbital inducible P-450s would
be a useful method for identifying potential P-450 cDNA clones so a
set of mixed antisense oligos were made to Glu^gg to Arg^gg. These
were made in two sets.
RWE296
5 '










Both of these are 17 mers of a 144 mix.
CG T A A TTC TTC
T C G C C
CG AAA TTC TTC
T G G C C
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2.23. In situ hybridization to metaphase chromosomes
This method of mapping is a useful addition of the genetic
approach where genes can be localized physically on a chromosome or
chromosomes and compared to the genetic map. This method was a
collaboration with J.R. Gosden, D. Rout and R.M. Speed. I
identified and prepared probes deemed useful as in situ
hybridization probes.
2.23.1. Human metaphase spreads
Chromosomes were prepared from peripheral blood lymphocytes
stimulated with PHA and cultured in RPM1 1640 with 15% fetal calf
serum in the usual way. After 72h the cells were synchronised by
the addition of 200pg/ml BrdU, cultured overnight, and released the
following morning by replacing the BrdU with 2 x 10_^M thymidine.
Culture was continued for 5h 15 min, colcemid added for 40 min,
harvesting and fixation was carried out in the usual way.
Chromosome preparations were air-dried on acid alcohol cleaned
siides.
0.5pg of pHL5,5 was labelled with ^H-dATP, dCTP and dTTP
(Amersham) by random oligonucleotide primed-synthesis (Feinberg and
Vogelstein, 1983; 1984) to a specific activity of ^.lO'' dpm/pg. In
order to eliminate hybridisation of the repeat sequence, the
labelled probe denatured and was annealed with 200pg of total human
DNA in 5x SSC in a volume of 80pl, for 30 min at 70°C. The
remainder of the hybridisation mix (tRNA, formamide, dextran
sulphate) was added as described previously (Gosden et al, 1986) to
make final concentrations of 50% formamide; 10% dextran sulphate 2x
SSC; 400pg/ml tRNA. The chromosomes were treated with RNAse A and
the chromosome DNA was denatured in 70% formamide; 0.6 x SSC at
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70°C, while the probe was denatured at 70°C for 5 min and applied to
the slides as described previously (Gosden et al, 1986). The slides
were incubated at 37°C overnight and washed in 50% formamide, lx SSC
at 40°C (4x5 min) and lx SSC at 40°C (4x4 min) before
dehydrating through an alcohol series and dipping in Ilford L4
liquid nuclear emulsion. Slides were exposed at 4°C for 7 days,
developed and fixed as described previously and thoroughly dried.
They were then stained in Hoescht 33258 (50pg/ml in 2 x SSC) for 20
min, the slides were flooded with 2x SSC in a Petri dish and exposed
to UV for 17 min, before rinsing thoroughly in 2x SSC and staining
in Wright's stain for 8 min. This produced clear G-bands, enabling
simultaneous analysis of karyotype and grain distribution to be
performed.
2.23.2. Mouse metaphase spreads
Chromosomes were prepared from CD female bone marrow cells by
standard methods (Ford and Hamerton, 1956) and the chromosomes
karyotype identified on a subset by trypsin banding. Hybridization
conditions were the same as for human except that slides were not
post-banded just developed and fixed as in Gosden et al (1986). The
probes used were pHL5,5, pPB3-15 and lambda 35.1. G-banded
karyotypes were constructed following the trypsin banding method of
Gallimore and Richardson (1973).
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CHAPTER 3
ISOLATION, CHARACTERIZATION AND MAPPING
A HUMAN PB-1 P-450 cDNA CLONE
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3.1. Detection of sequences homologous to rodent P-450s in human
genomic DNA
In order to initiate a study into human P-450 genes it is
important to determine whether cDNA probes corresponding to rodent
P-450s could detect human homologues. Three distinct classes of
cDNA probes were available. Firstly, two rat cDNA probes pR17 and
p5'2 which correspond to the highly PB inducible P-450, PB3a (P450-
2B). These probes together include over 85% of the coding region
for this P-450 (Kumar et al, 1983). Secondly, a mouse cDNA probe
pCL46, corresponding to the 3MC inducible P-450, P^450 (P450-1).
This clone contains a 1.lkb insert which corresponds primarily to
the 3' untranslated region of P^450 mRNA (Negishi et al, 1981;
Adesnik and Atchison, 1986). Thirdly, two clones pTF-1 and pTF-2
which were isolated from a rat cDNA library with antibodies raised
to a constitutive form of P-450, PB-1 (P450-2C). These clones
contained inserts of 1200 and 400 base pairs respectively (Freidberg
et al, 1986) and were subsequently shown to correspond to forms f
and PB-1 respectively by comparing their sequence with almost full
length clones for these P-450s (Freidberg et al, 1986; Gonzalez et
al, 1986a).
Southern blots of rat, mouse, CHO, chimp and human DNA digested
to completion with restriction enzymes Mspl and EcoRI were
hybridized overnight under low stringency conditions with the
respective probes. Low stringency conditions in this instance are
hybridization at 55°C with standard hybridization mix but without
the addition of dextran sulphate. Blots were washed in 2 x SSC at
55°C. As shown in Fig. 3.1a, pR17/p5'2 detects multiple bands in
rodent (CHO, mouse, rat) and to a lesser extent in human DNA
samples. The same observation can be made for Southern blots
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FIGURE 3.1.
A) Hybridization of pR17 (P450-2B) to various DNAs at 55°C. 10pg
DNA from various species was digested with EcoRI (R) and Mspl (M).
Electrophoresed on agarose gels, Southern blotted and hybridized
with pR17 plasmid under 'low' stringency conditions. DNAs are as
follows: 129, male mouse DNA; BWJ, mouse hepatoma cell line DNA;
Wistar, male rat DNA; FAZA rat hepatoma cell line DNA; CHO,
Chinese hamster ovary cell line DNA; F2, female human DNA; Mo,
male human DNA. Hybridisation was at 55°C in the absence of dextran
sulphate and washes were 2 x SSC at 55°C.
B) Hybridization of pTF-1 (E450-2C) to various DNAs at 55°C. DNA
digestion, samples and hybridization conditions as in Fig. 3.1.A.
A
Hybridization of pR1 7 to various DNAs at 5 5° c.
6
BWJ WISTAR FAZA CHO Fz Mo
r m rmrmrmrmrm
Hybridization of pTF— 1 to various DNAs at 5 5° C.
analysed with the pTF-1 probe (Fig. 3.IB), however the pattern
appears to be distinct between the two sets of probes. The probes
are comparable in that each encodes about 85% of the coding region
of their respective cDNAs. Thus both probes detect multiple
homologous sequences in human DNA digests. In contrast under these
conditions pCL46 gave only a background smear in both rodent and
primate DNA digests (data not shown). To obtain a distinguishable
pattern of hybridization with this probe, higher stringency
conditions had to be used. Southerns were hybridized with pCL46 at
68°C under standard hybridizations including dextran sulphate and
washed in 2 x SSC at 68°C. In this case two distinct bands could be
detected in digest of rodent DNA and a faint single band at 4.4kb
for EcoRI digests human and chimp DNA (data not shown).
3.2. Detection of homologous sequences to rodent P-450s in human
hepatic mRNA.
Identical Northern blots with control and induced rat hepatic
mRNA preparations and mouse and human hepatic RNAs were probed under
low stringency conditions with pR17/p5'2, pTF-1 and pCL46. pCL46
only detected a 2.3kb mRNA in the 3MC induced rat liver preparation
and none in untreated rat, mouse and human hepatic RNA samples even
after long exposure (data not shown). However, both pTF-1 and
pR17/p5'2 detect transcripts in human polyA+ RNA preparations and to
a lesser extent in total human preparations (Fig.3.2). The human
2.1kb mRNA detected by pTF-1 appeared to be slightly larger than the
rodent equivalents but it also has a high constitutive level of
expression. The 3kb mRNA detected in human samples by pR17/p5'2 was
also larger than its rodent counterpart and as in untreated rodents
had a low level of expression. For pTF-1 rats and mice appear to
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FIGURE 3.2.
Northern blot analysis of hepatic RNA from rodent and human. 2ug of
polyA+ and 15ug of total RNA were fractionated on denaturing agarose
gels. Northern blotted and hybridized with the indicated probes at
55°C. Wistar rat male liver RNA were (c) control; (3MC) 3 methyl-
cholanthrene induced; (PB) phenobarbital induced; Mouse RNAs were
from untreated BALB/c and 129 males; Human RNAs were from adult
males Hu and M67 respectively and from a human hepatoma cell line
HepG" 2 (Knowles et al, 1980); Rat ost is RNA from a rat osteo¬
sarcoma cell line which is negative for P-450 expression. Size
markers were the 18S and 28S ribosomal bands.


















Northerns hybridized at 55° C.
have comparable levels of expression in adult liver and this is
marginally induced by PB administration of rats. However the highly
PB inducible P-450 mRNA has a higher basal level of expression in
rats when compared to untreated mice. Other controls on these blots
were RNA from HepG2 a human hepatoma cell which expresses many liver
specific functions (Knowles et al, 1980) and RNA from a rat
osteosarcoma cell line which is negative for P-450 expression. The
HepG2 RNA sample appeared slightly degraded but even still no
significant transcripts were observed. The two bands seen in the
rat osteosarcoma RNA correspond to the non-specific binding of the
probes to ribosomal RNA. These experiments deomonstrated that the
rodent probes identify human P-450 counterparts and that these
probes can be used to isolate the homologous human genes.
3.3. Isolation of a human P-450 cDNA
To isolate a human P-450 cDNA clone I screened a human liver
cDNA library constructed in a pBR322 derived vector (Woods et al,
1982). The only probes which offered any chance of success were
pTF-1 and pR17/p5'2. Inserts were derived from these probes and
used to screen 10-20,000 colonies by the method of Grunstein and
Hogness (1975) (Fig.3.3). Most of the hybridization on these
filters appeared non-specific as both pR17/p5'2 and pTF-1 gave
similar background (data not shown). Two colonies were identified
which gave strong signals with pTF-1 insert on filters (Fig.3.3).
These were picked along with colonies which gave slightly increased
hybridization with pTF-1 or pR17/p5'2 for secondary screening. Only
the two strongly hybridizing colonies came through the screen with
pTF-1 (Fig.14). No colonies were identified with pR17/p5'2. The
failure to identify human homologues for pR17/p5'2 may be due to
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FIGURE 3.3.
Primary screen of a human cDNA library with pTF-1 insert. Colonies
(2000 per filter) were screened in situ by the method of Grunstein
and Hogness (1975) under low stringency conditions . The arrows
indicate the resulting positive colonies.
 
FIGURE 3.4.
Secondary screen of human liver cDNA library with pTF-1 insert.
Approximately 50 picks were streaked onto nitrocellulose filters and
screened as before under low stringency conditions. The indicated
colonies were picked and grown up in bulk for plasmid DNA
preparation.
Secondary screen of hman liver cDNA library
with pTF— 1 insert (hybridized at 55°C).
failure to identify human homologues for pR17/p5'2 may be due to
their low representation in human liver mRNA and subsequently
constructed cDNA libraries. This library was originally amplified
on plates which might further reduce the chance of identifying a low
abundance message.
3.4. Characterization of human cDNA clones
The colonies identified with the pTF-1 insert were grown up in
bulk and their plasmids isolated on CsCl gradients. Digestion with
Pst-I releases their inserts from the parental pKT218 plasmid.
Analysis by agarose gel electrophoresis revealed that pHLl,5 and
pHL5,5 had inserts of 700 and 2,000 base pairs (bp) respectively.
The large plasmid contained two internal PstI sites (Fig.3.5). This
gel was transferred to nitrocellulose and then probed with the pTF-1
insert under high stringency conditions 68°C (+ dextran) and washed
in 2 x SSC at 68°C (Fig.35B). Only the two larger inserts of pHL5,5
and the 700bp pHLl,5 insert hybridised to the pTF-1 insert.
Negative controls on these blots were the drosophilia homeo box
containing probes Ant and Ftz (kindly provided by B. McGinnis) which
failed to light up. If the experiment was repeated substituting
the pTF-2 insert as a probe only the larger 900bp PstI fragment from
pHL5,5 lit up and the 700bp fragment from pHLl,5 (data not shown).
The insert from pTF-2 corresponds to amino acid residues 132-268 of
the PB-1 protein (Freidberg et al, 1986; Gonzalez et al, 1986)
whereas pTF-1 corresponds to amino acid residues 87 to 490 of the f
protein (Freidberg et al, 1986; Gonzalez et al, 1986). One of the
assumptions that could be made is that the insert in pHLl,5
represents a truncated form of a human cDNA. Additionally it seemed
that the 900 and 700bp PstI fragments of pHL5,5 contained the main
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FIGURE 3.5.
A) Size estimation of inserts from putative human P450 containing
plasmids. Plasmids were run digested and undigested. pHLl,5
(1,5), pHL5,5 (5,5) and pHL7,5 were digested with PstI. pHL7,5
represents the parental plasmid vector without an insert. The
plasmids ANT and FT2 contain Drosophilia homeo box fragments and
were digested with BamHI/PvuII and PvuII respectively. The size
marker is Haelll digested 0X174.
B) Detection of human containing P-450 plasmids. The gel in (A)
was Southern blotted and probed with pTF-1 insert under normal
stringency conditions, i.e. 68°C. The autoradiographic bands in
































coding region corresponding to the rat PB-1 P-450. The small 400bp
Pst-I fragment of pHL5,5 represents either an extreme 5' or 31 part
of human cDNA with no significant homology to the rodent PB-1 cDNA
probes.
3.5. Oligonucleotide probing of P-450 cDNAs
The plasmid pHL5,5 was further characterized by probing with
oligomers which corresponded to two conserved cysteine containing
regions of cytochrome P-450. C128 is an antisense 19mer to the
Cysl52 region of rat PB3a which was designed on the basis of
homology between rat PB3a (Fuji-kuriyama et al, 1982) and a rabbit
P-450 (Leighton et al, 1984). Overall these P-450s share 50%
homology at the DNA level. Over the Cys 152 region they have an 8
amino acid region of identity and a 16/19 nucleotide identity (Fig.
3.6). A second oligomer, C129, was made to the Cys435 region of the
rat PB3a cDNA sequence. Over this region the two P-450 forms shared
only 50% identity. It was reasoned that if divergent P-450s
maintain nucleotide sequence similarity over conserved regions then
oligomers to these regions would identify potential P-450 cDNA
clones. That this was the case was proved by using the C128 oligo
which hybridized to plasmid p5'2 and pTF-2 (Fig. 3.7 A and B) which
share only 50% sequence homology overall (Freidberg et al, 1986).
This oligonucleotide also hybridized to the 900bp and 700bp fragment
of pHL5,5 and pHLl,5 respectively. The pTF-2 clone has a 16/19
match-up with CL28 with a maximum stretch of 12 nucleotide homology.
pTF-1 has 15/19 match but only a 5 nucleotide run of maximum
homology which does not allow for stable hybrid formation. Although
the hybridization to the human clones is much reduced compared to
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FIGURE 3.6.
Oligomers derived from conserved cytochrome P-450 regions. Two
peptides are shown for 4 P-450s together with the nucleotide
sequence. Rabbit Pbc2 (P450-2C) (Leighton et_al, 1984); rat P-450
PB3a (P450-2B) (Fuji-kuriyama et al, 1982); PB-1 and f (P450-2C)
(Freidberg et al, 1986). denotes the template for the antisense
oligomer. 1 - ' denotes mismatches between the oligomer and P-450
cDNA sequence for the respective forms.
Cys 15 2 (C128) , Cys436 (C129)
Amino Acid Amino Acid
Rab PBc2 CLVEELRK CLGE A_L
Rat PB2a CLVEELRK CLGEGI
Rat pTF-2(PB-l) CLVEELRK ___

















A) Gel photograph of PstI digested P-450 containing plasmids.
0X174, size marker; pR17 and p5'2, rat PB3a cDNAs (P450-2B); pTF-1,
pTF-2, rat PB-1 cDNAs (P450-2C); pC146, mouse P-450 (P450-1),
pHL5,5 human PB-1 P450 (P450C2C); p/M2, p/T, p/M and p/B are
subclones of the PstI inserts from pHL5,5; Woods - PstI digested
cDNA library; pl706 mouse albumin.
B) The above plasmids probed with oligomers direct against
conserved regions of rat PB^a cDNA. C129 is towards
Cys 436 of PB3a and C128 is towards Cys 152 of PB3a cDNA.
 
the rodent clones it is significantly above background. This was
further evidence these were P-450 containing plasmids are almost
full length. As suspected from the sequence comparison C129 only
lit up pR17 in this panel of plasmids. Subsequently a mixed series
of oligonucleotides to region Cys 152 was made which hybridizes to
all P-450 containing plasmids which encoded the conserved sequence -
Glu Glu Leu Arg Lys -. This oligomer mix gave a pattern of
hybridization similar to C128 but the relative signal intensity was
similar for each plasmid (see Chapter 4).
3.6. Northern Blot analysis
The human clone pHL5,5 was further characterised by using
Northern blots of treated and untreated rodent liver and human liver
RNA samples. Phenobarbital treated rats show a marginal increase in
PB-1 related hepatic mRNA on hybridization with pTF-1. This was
also the case when pHL5,5 was used, i.e. the major transcript at
approximately 18S (Fig. 3.8) was increased two-fold by phenobarbital
treatment (Fig. 5B). In human liver an RNA transcript was observed
with a high level of expression which was larger than its rodent
equivalent (Fig. 8 D and E). The pattern of hybridisation with the
human clone was the same as when the rat pTF-1 is used as a probe to
rodent and human liver RNA samples (Fig. 3.2). Interestingly minor
transcripts could also be seen in the rodent and human RNA samples
which are larger than the major forms. These may correspond to
processing intermediates or to alternative RNA species.
The level of expression of PB-1 related mRNAs is around 0.25%.
This calculation is based on the number of PB-1 containing plasmids
found on antibody screening of an 8,000 member pBR322 cDNA library
(Freidberg et al, 1986). Three clones were identified, if we accept
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FIGURE 3.8.
Northern blot analysis of human and rodent liver RNA samples with
the PB-1 cDNA clone pHL5,5. Lane A, rat liver control polyA+, RNA,
(lpg); Lane B, PB induced rat liver polyA+ RNA (1 pig); Lane C, , A.
Lout J I\6rt»^a.\ V\<aua.O(^ l|J«rKW "y
C57BL/6 mouse liver control total RNA (10pg);^ Lane E, normal human
male liver polyA+ RNA (2.5pg); Lane F, indicates multiple
transcripts in human tracks. Size markers were denatured Hindlll
fragments and 28S and 18S ribosomal RNA markers. All these samples










that a cDNA clone has a 1/6 chance of being in the right orientation
for expression then this corresponds to 18 PB-1 clones/8000 or
approximately 0.25% of the total mRNA content. This corresponds to
1000 mRNA copies/hepatocyte (Hastie and Bishop, 1976). A comparable
level of expression is seen with pHL5,5 in human adult male liver.
3.7. Southern blots to genomic DNA
pHL5,5 was used as a probe against Southern blots of human and
rodent DNA to determine the genomic complexity detected by this
cDNA. This experiment was hampered by the presence of a low level
repeat which was subsequently localized to the 400bp PstI fragment
of pHL5,5 (see below). However washing at high stringency (0.01 x
SSC at 68°C) removed this background and revealed a unique pattern
of hybridization of some complexity (Fig. 3.9). In humans the
amount of hybridizable DNA detected by pHL5,5 ranged from 70-150
kilobases (kb) depending on the restriction enzyme used, whereas in
rodents the pattern was more complex (even at this high stringency
wash). This implies that pHL5,5 is a member of a conserved small
multigene family or corresponds to a very large gene.
3.8. Crude restriction map of pHL5,5
A restriction map of pHL5,5 was determined by standard methods
and later confirmed by sequence analysis (Fig. 3.10). The three
PstI fragments were subcloned into the multicloning site vector
pEMBL9 (Dente et al, 1983). Hereafter these clones are referred to




Southern blot analysis of primate and rodent DNAs with pHL5.5 This
blot was washed at high stringency (0.01 x SSC at 68°C). The
restriction enzymes used were BamHI (Lanes A and B) and EcoRI (Lanes
C-H). Lane A and C human liver DNA; lane B and D, AKLO a human
cell line DNA; Lane E, male chimp DNA; Lane F, Chinese hamster
WG8H cell line DNA; lane G, Wistar male rat DNA; Lane H, C57L
mouse male DNA.





Restriction map of the cDNA insert of pHL5.5. The restriction map
was derived as described in the text. Also indicated is the
sequencing strategy; the PstI fragments were subcloned into M13 mp8
and sequenced by the dideoxy chain termination method. The arrows
indicate the segments and direction of sequences (underlined) read
from synthetic oligonucleotide primers (see Materials and Methods).
The orientation of the cDNA in the parental pKT218 plasmid is such
that the EcoRI site in the vector is 3' to the second indicated PstI
site.
Sacl BamHI Smal Hindlll Pstl Sail Sphl Sail Pvull Pstl
_1 ^ I ^ L_L_
t 200bp
3.9. Sequence of pHL5,5
The pEMBL vector also contains sequences of the F^ coliphage
required for DNA replication and morphogenesis (Dente et al, 1983).
On superinfection with F^ phage pEMBL containing bacteria also
C
produce pEMBL ss DNA in vir^n capsids. This can be isolated and
used as a template for DNA sequencing by the dideoxy chain
termination method (Sanger et al, 1977). However it was found that
large fragments cloned in pEMBL tended to rearrange when going
through the F]^ replication step (R. Hill and R. Meehan, unpublished
observations). Therefore the three PstI fragments were reisolated
from pHL5,5 and subcloned into double stranded M13 mp8 at the PstI
site for the single stranded DNA template. The initial sequencing
was carried out by myself which identified polyGC tails in p/T and
p/B subfragments. This is in accordance with the method of library
cDNA construction and identified these fragments as representing the
5' end and 3' ends of the cDNA. Sequencing of the p/M subfragment
identified a sequence with significant homology to the pTF-1 cDNA
sequence. This confirmed that pHL5,5 was a human homologue, of the
rat PB-1 P-450. At this point the sequence of pHL5,5 became a
collaborative effort with Ms Janice Sweeney. After a sequence of
250-300 nucleotides had been determined, sequencing continued using
a synthetic 18 mer primer which was made by an Applied Biosystems
DNA synthesiser (synthesis carried out by J. Inglis and the I.C.R.F.
synthesis laboratory). Overlapping and complementary sequences were
read for verification. Each sequence was determined a minimum of 5
times. The sequence strategy is also illustrated in Fig. 3.10.
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3.10. pHL5,5 encodes a P-450 which is a member of the P450C2C
family of proteins and is related to a human P-450 which
metabolizes mephenytoin.
The complete sequence of pHL5,5 is presented in Fig. 3.11. the
accurate size of the PstI fragments was determined to be 894, 640
and 430bp respectively. The sequence surrounding the first ATG is
included in the consensus sequence (A/G) NNATG (A/G) characteristic
of an active start codon (Kozak, 1984). An open reading frame of
1470 nucleotides was found which terminates 37 nucleotides before
the second internal PstI site. There is a 31 untranslated region of
nearly 400 nucleotides mostly encoded by the small PstI fragment.
The most obvious polyA+ addition site is AATTAAAA which is in the
expected position 25-30bp from the polyA+ tail. It is possible that
there is a longer 51 leader sequence which would account for the
larger size of the mRNA transcript alternatively the size difference
could be due to polyA+ tail length which is normally 200-300
nucleotides long (Hastie and Bishop, 1976).
The primary coding sequence of pHL5,5 predicts a protein of 490
amino acids long with a calculated molecular weight of 55.6 kd. The
first 29 amino acids from the putative N-terminal sequence is
identical to that reported for a human P-450 which metabolizes
mephenytoin (Shimada et al, 1986). The molecular weight of the
mephenytoin P-450 is 50kd on SDS gels. This size difference between
predicted and estimated molecular masses has been noted for many P-
450s (Black and Coon, 1986). The primary coding sequence of pHL5,5
can be aligned with rat P-450 forms, PB-1, f and M (Freidberg et al,
1986; Gonzalez et al, 1986a; Yoshioka et al, 1984) without the
need for insertions or deletions. At the amino acid level these P-
450s show greater than 70% homology (Table 3.1). Thus this human
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FIGURE 3.11.
The nucleotide sequence of pHL5,5. This corresponds to the human
PB-1 cDNA (P450C2C) sequence and its predicted amino acid sequence.
The amino acid sequence underlined corresponds to the N-terminal
sequence determined for P450mp (Shimada et al, 1986). The boxed
sequence corresponds to the putative heme binding site around cys435


























































































Percent similarity of amino acid sequences among the P450C2C gene
family in three species. (A) overall similarity (B) over region 200-300
of the protein.
(A)
Hu Rat f m RabI Pbcl Pbc2 Pbc3 PBoa
PB-1 PB-1
1 2345 67 89
1. Hu PB-1 -
2. Rat PB-1 74. 8 -
3. Rat f 72.2 75.8 -
4. Rat M((h) 75.5 72.6 69.8 -
5. Rabbit I 76.8 74.5 69. 2 74.3 -
6. Rabbit PBcl 71.8 67.6 64.3 31.0 72.8 -
7. Rabbit PBcl 73.9 70. 2 65.8 71.6 74. 2 84.0 -
8. Rabbit PBc3 68. 7 65.3 62.3 66. 7 66.0 64.5 65.5
9. PB3a 49.6 50. 1 48.9 53.3 51.3 50. 7 51.4 49.
(B)
1 2345 6 7 89
1. Hu PB-1
2. Rat PB-1 59 -
3. Rat f 54 64 -
4. Rat M((h) 67 64 54 -
5. Rabbit I 66 65 55 72.7 -
6. Rabbit PBcl 67 61 55 67.0 65.9 -
7. Rabbit PBc2 67 65 56 69 65. 9 78 -
8. Rabbit PBc3 53. 6 47 43 43.4 51. 1 58 54. 5
9. RB3a 40 40 36 43 43.3 41 41 39.4






Gonzalez et al, 1986
Yoshioka et al, 1987
Tukey et al 1985
Leigton et al, 1984
Fuji-kuriyama et al, 1982
This study
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P-450 is now referred to as human PB-1 and is a member of the
P450C2C family of P-450s (Nebert et al, 1987). Human PB-1 also has
50% homology with the highly phenobarbital inducible rat form PB3a
(P450-2B) (Fuji-Kuriyama et al, 1983) and other members of the P450-
2-_ subfamily of P-450s in rats (Nebert et al, 1987). This family
includes 5 distinct members showing 50% amino acid similarity to
each other and includes P450-2A, P450-2B, P450-2C, P450-2D and P450-
2E. With the other members of the superfamily of P-450s human PB-1
shows less than 35% homology.
Human PB-1 also has 45% amino acid identity with the partial
sequence of human UT^ (P450C2A) (Phillips et al, 1985) but only 35%
homology with members of the P450C1 and P450C3 gene families in
humans (Quattrochi et al, 1986; Beaune et al, 1986). The nomen¬
clature of P-450 gene families inserts a C into the human forms.
Thus P450C2C in humans is the same as P450-2C in rats, mice and
rabbits. The C corresponds to cDNA as proteins corresponding to all
the human P-450 cDNAs have not yet been identified (Nebert et al,
1987).
Human PB-1 also contains the conserved regions found in all
cytochrome P-450s (Table 3.2.). It is interesting that the N-
terminal conserved fragment has a cysteine at amino acid 144 whereas
the equivalent rat forms have an arginine at this position, over
this region pHL5,5 is most similar to PB-la of rat. This cysteine
at 144 has not been described in any other P-450 forms. In the
conserved C-terminal fragment there is a glycine at position 444
which has not been found in other P-450 forms. Whether these
changes are functionally significant is unknown.
The DNA sequence detected by the C128 oligomer shows 6/19
mismatch with a continuous stretch of 8 nucleotides showing maximum
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TABLE 3 . 2.
Comparison of three conserved amino acid regions form diverse cytochrome
P-450s with human PBl P-450.
A) N-terminal cysteine fragment centred at Cys 152 of PB3a
B) C-terminal cysteine fragment centred at Cys 436 of PB3a
C) The 'analogous tridecapeptide' region at Met346-Arg358 of PB3a
P-450 sequence
aa
PB-1 hu I E D C V Q E E A R c - L V E E L R K 158
PB3a rat V E E R I Q E E A Q c - L V E E L R K 159
PBla II I E D R V Q E E A R c - L V E E L R K 158
f II I E D R V Q E E A Q c - L V E E L R Q 158
PB2A(M) rat I E D R I G E E A Q c - L V E E L R K 158
UT-1 rat V E E R I I E E A G Y - L J K M L Q G 161
Db-1 it T L R T F G M G K K S - L E E W V T K 158
Db-1 it T L R D F G V G K K S - L E Q W V T K 158
j ii N E A R I Q R E A Q F - L V E E L K K 170
CLO ti L D K Y E Q L A G Q D - S S I E J F Q 186
PB2b it M F P I I E Q Y G D T - L V K Y L K Q 163
MCla H L E E H V S K E A N H - L J S K F Q K 177
MClb ii L E E H V S K E A E Y - L V S K F Q K 179
MCla ii J A S D P T S V S S C Y L E E H V s K 166
MClb ii I A S D P T L A S s C Y L E E H V s K 168
P-450 cam L E N R I Q E L A - c S L J E S L R P 142
aa
PB-1 hu F S A G K R I C V G E A L A G M E L F L F 448
PB3a rat F S T G K R I C L G E G I A R N E L F L F 449
PBla II F s A G K R M C A G E G L A R M E L F L F 448
f It F s T A K R I C V G E G J A R Q E L F L F 448
PB2A(M) rat F s A G K R I C A G E A L A R T E L F L F 446
UT-1 rat F s T G K R F C L G D E L A K M E L F L L 450
Db-1 H F s A G R R A C L G E P L A R M E L F L F 459
Db-2 H F s A G R R A C L G E P L A R M E L F L F 459
J
n F s A G K R V C A G E G L A R M E L F L L 450
CLO II F s G G A R N C I G K Q F A M S E M K V I 468
PB2b H F G N G P R N C I G M R F A L M N M K L A 456
MCla ■I F G L G K R K C J G F J P A K W E V F L F 469
MClb H F G L K G R K C I G E Y I G R L E V F L F 473
P-450 cam F G H G S H L C L G Q S L A R R F J J V J 368
aa
PB-1 hu M P Y T D A V V H E V Q R 357
PB3a rat M P Y T D A V J H F I Q R 358
PB-1 M P Y T D A H D H E V Q R 357
f M P Y T D A V I H E J G R 357
PB2a (M) rat M P Y T D A V V H E I Q R 357
UT-1 rat M P Y T Q A V I N E L Q R 369
Db-2 11 M P L T N A V J H E V Q R 356
j II M P Y M D A V V H E I Q R 359
CLO II J P Y T T M C J K E A L R 379
PB2b II R L Y P I G N R L F R V C 390
MCTa 11 L P Y L E A P I L E I Y R 375
MClb It L P Y L E A P I L E I P R 380
LM2 .rabbit M P Y T D A V I H E J Q R 350
- life-
alignment. This could explain the slight hybridization observed
with this oligomer. The sequence is:
C128 TTGGTGGAGGAACTGCGGA
PB-1 C T_T G T G G A G G A G T T G_A G_A A
3.11. Genomic complexity of human P450C2C
The high stringency Southern blots of pHL5,5 to human and
rodent DNAs (Fig. 3.9) revealed an unique pattern of hybridization
of some complexity. The result implied that human PB-1 is a member
of a small multigene family or corresponds to a very large gene.
The former interpretation seems reasonable because of the multiple
PB-1 forms identified in many species including humans (Adams et al,
1985; Shimada et al, 1986). In order to investigate this
hypothesis, the DNA of one individual was digested with EcoRI and
BamHI and probed with the separate PstI fragments from pHL5,5. The
894bp fragment represents the 5' coding half of the PB-1 transcript,
the 640bp fragment represents the 31 coding half of the PB-1
transcript and the 430bp represents the 3' end of the transcript.
In order to obtain a minimum gene count for the P450C2C locus
identical Southern blots were probed with these PstI fragments. Any
DNA fragments which hybridize to both 5' and 3' probes must
represent separate and distinct genes or pseudogenes. Therefore the
fragments in common give a value for the minimum number of genes.
As can be seen for Fig. 3.12, there are a number of DNA fragments in
common with the 894bp fragment and 640bp fragment PstI fragments.
The 430bp fragment gives a persistent smear at this stringency wash
(2 x SSC wash) and at lower stringency (0.1 x SSC). However 2
major fragments do appear to be in common to all three probes. The
use of the 430bp untranslated region probe may provide an
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FIGURE 3.12.
Complexity analysis of the P450C2C DNA pattern. Three identical
Southern transfer of BamHI (A) and EcoRI (B) digested human DNA were
probed with the three individual PstI fragments from p/T, p/M and
p/B respectively. The p/T fragment corresponds to 5' half of the
cDNA. (Lanes A° and B°). The p/M fragment corresponds 3' coding
half of the cDNA (Lanes A' and B'). The p/B fragment corresponds to
the 3' untranslated region of the cDNA (Lanes A" and B").
indicates fragments in common.
_• -f ' -ff








underestimate of the gene number because this region can show great
diversity between members of the same multigene family (Li et al,
1985a). If we consider the coding region probes then a minimum
count would be 3 genes for PB-1 in human. Also apparent in the
original Southern blot with pHL5,5 plasmid was the greater
complexity of rodent PB-1 sequences relative to primate. Gene
counts for rodent were obtained from Southern blots of EcoRI, BamHI
and Kpnl digests of rat and mouse DNA with the two coding region
probes (Fig. 3.13 A and B). In mouse the minimum estimate for the
number of PB-1 genes was 5-7 and for rat 4-6 genes. In the case of
rat this is in rough agreement with the number of different PB-1
forms purified to date, which presently stands at 6.
3.12. Chromosomal location of human PB-1 P-450.
It was of interest to know the relationship of the different
members of the PB-1 gene family to each other i.e. whether they
mapped to a similar or distinct chromosomal location. Somatic cell
hybrid DNAs which contained selected human chromosomes on a Chinese
hamster ovary (CHO) or mouse cell background were used.
To establish that human PB-1 genes could be distinguished on
these backgrounds a Southern blot were carried out in which CHO DNA,
DBA/2 mouse DNA and human male DNA (MO) were digested with a number
of restriction enzymes and probed with a mixture of p/M and p/T
inserts. Although the resulting pattern was complex BamHI digests
of human and rodent DNA suggested that a triplet of human fragments
at 4kb could be distinguished on a rodent background (data not
shown). Additionally Southern blots of BamHI digests of human
placental DNAs probed with p/T and p/M did not detect any
restriction fragment length polymorphism (RFLP) (data not shown).
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FIGURE 3.13.
Gene counts in rat and mouse
A) Male wistar rat DNA was digested with EcoRI (A), BamHI (B) and
Kpnl (C). Identical blots were run and probed with p/T (A1, B' and
C') and p/M (A", B" and C").
B) Male C57L DNA was digested with EcoRI (A), BamHI (B) and Kpnl
(C). Identical blots were run and probed with p/T (A1, B' and C')
and plan (A", B" and C").
'0' fragments in common.
















— &>- H 5,804** r 5,643
*T. • I .<• - 4,878
- 3,330
Therefore the different sources of the hybrids would not be
compromised by RFLPs.
Initially a small panel of mouse/human somatic cell hybrid DNAs
was analysed. Most of the hybrids used contained single human
chromosomes (Fig. 3.14). As controls human male and female DNA was
run as well as the parental rodent DNAs. This would indicate
whether PB-1 mapped to either the X or Y chromosomes. In this
initial analysis none of the hybrids appeared to contain human
sequences homologous to the p/T and p/M inserts used as probes. The
human chromosomal content of these hybrids had previously been
characterized in our laboratory and thus human chromosomes 2, 4, 7,
11, 13, 15, 21, 22, X and Y could be excluded for the location of
human PB-1 genes. A screen of a larger representative panel of
rodent/human somatic cell hybrids identified one hybrid which
contained human DNA fragments which hybridized with p/T and p/M. A
major triplet of human PB-1 fragments can be observed at around 4kb
and a minor fragment at „2.3kb (Fig. 15 A and I). Analysis of these
hybrids showed human chromosome 10 was concordant with this signal.
In order to confirm this assignment a range of other chromosome 10
containing hybrids from rat, mouse and Chinese hamster fusions were
studied. These hybrids gave 100% concordance between the human
signal and chromosome 10 (Table 3.3). Three hybrids deserve special
mention; numbers 2 and 9 (Table 33) are sister subclones with an
almost identical human chromosome content except that hybrid 2
contains a chromosome 10 and hybrid 9 contains a chromosome 9. In
this case only hybrid 2 was positive for human fragments (Fig. 3.16,
1 and 2). The third hybrid (mouse) of note is hybrid 3 which has a
diploid number of human chromosome 10 and gave an increased signal
intensity relative to the mouse background when probed for human
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FIGURE 3.14.
Southern blot analysis of human/rodent somatic cell hybrids probed
with p/T and p/M. 10pg of DNA were digested with BamHI,
fractionated on agarose gels, and blotted. The human chromosome
content of the hybrids is indicated on Table 3.1. L cell and DBA/2
represent the parental rodent cell line DNA. F4 is human female
















Hybridization of P/T and P/M to
human/mouse somatic cell hybrids.
FIGURE 3.15.
Southern blot analysis of a representative panel of human/rodent
somatic cell hybrid DNA with p/T and p/M. Lane A, hybrid 1, Lane B,
hybrid 24; lane F, hybrid 21; Lane G, hybrid 17; Lane H, hybrid
10; Lane I, hybrid 1; Lane J, hybrid 27; Lane K, hybrid 20; Lane
L, hybrid 14; Lane M, hybrid 12; Lane N, WG3H (control hamster
DNA); lane 0, C57L (mouse control DNA; Lane P, human female
placental DNA only 1/4 of the amount loaded compared to the hybrid
DNA). ' 1 on the right hand side indicates fragments there mapped
to chromosome 10. Only one hybrid (Lanes A and I) were positive for
human bands. See Table 3.1 for karyotype of hybrids and Materials










Segregation of PB-1 P-450 with Human Chromosomes in Cell Hybrids
Human Chromosomes £
cell
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y
"1 - + - (+) (+) - - + - + - + - - - - - - - - + - - -
"2 - + + - + - - + - + - + - + - - - + - - + - - -
*3 + + + - - + + + - + - + - + - + + + - - + + + -
~ 4 - - + - + - - - - + + + + + + - + + - + + + + -
"5 - - - - - - + - - + + - - + + - + - - - + - + -
"6 - - + - - - - - - + + - + - + - + + - + + + - -
"7 + + + - + + + -
"8 - + - - - + + - - + - - - + + - - - - - - - + -
9 - + + - + - - + + - - + - + - - - + - - + - - -
10 + + + - + + + - + - -
*11 + - + - + + - - + - + + - + - + - - - - + - - -
*12 - - - + - - + - - - - - - - - + - - - - - - - -
13 - - + + + + + -
14 - - - - - + - + - - - - - + + + + -
15 + + + + + + - - + - - - -
*16 + + + - + + + + + + - + - -
*17 - + - + - - + - - - + - - - + - - - - - + - + -
*18 + - + - - + - - - - + - + - - - - - + - + + - +
19 + + + - + + + + - - - + - + - + + + - - - - + -
20 - + + - - + + + -




Concordant 53 71 64 64 64 57 61 67 89 100 71 71 69 69 69 46 75 71 61 71 71 69 64 64
* These hybrids also contain unidentified human marker chromosomes and some identified
translocations, see Lund et al (1983), but these abnormal human chromosomes did not give rise
to any aberrant segregation patterns for the PB-1 P- 450 cDNA clone.
$ "+" indicates the presence of the human chromosomes >20% of the metaphases analysed, (+)
indicates the presence in 10% of metaphases analysed. indicates the absence of the human
chromosome in the metaphases analysed.
Hybrids 1 to 8 are chromosome 10 containing hybrids.
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FIGURE 3.16.
Southern blot analysis of a mini panel of human/rodent somatic cell
hybrid DNA probed with p/T and p/M. CHO, Chinese hamster; Lane 1,
hybrid 1; lane 2, hybrid 2; lane 3, hybrid 9; F2, human female
DNA, 1/4 loaded in comparison to hybrid DNAs.
CHO
PB-1 sequences (data not shown). To reduce the complexity of
hybridization and to map more of the human fragments duplicate blots
of hybrid DNAs were probed with p/T and p/M respectively. Nearly
all the PB-1 fragments appeared to be located on chromosome 10 (data
not shown).
In order to sublocalise the PB-1 P-450 genes and to ascertain
whether they were clustered on human chromosome 10 pHL5,5 was used
by Dr. J. R. Gosden as a probe to metaphase spreads from human blood
lymphocytes. The cDNA probe was annealed with total human DNA to
eliminate hybridization of the repeat sequence (Sealey et al, 1985;
Porteous et al, 1986). Twenty three cells were analysed with a
total of 111 grains. Of these 21 grains (23%) were localized on
chromosome 10 and of these 13 (62%) were in the region 10q24.1-
10q24.3 with a peak at 10q24.2 (Fig. 3.17). From this it was
concluded that the PB-1 genes do appear to be clustered on human
chromosome 10. In accordance with the nomenclature this locus was
designated P450C2C.
3.13. RFLP search for P450C2C
It is important to note that all adverse drug side effects so
far identified with P-450s have been associated with constitutively
expressed forms and not the highly inducible forms beloning to the
P450C1 and P450C2B gene families (Wolf, 1986). RFLPs for P450C2C
would be useful for doing linkage analysis in relation to oxidative
metabolism in phenotyped families.
A panel of nine individual placental DNAs was digested with
eight restriction enzymes, fractionated on agarose gels, Southern
blotted and probed with inserts derived from p/T and p/M subclones
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FIGURE 3.17
Autoradiographic grain distribution following hybridization in situ
of pHL5.5 to human chromosomes. The horizontal axis shows the
chromosomes, with the centromeres indicated by a vertical bar. The
vertical axis shows the total grains found at each site in the 23
cells analysed. Note the peak of grains in the long arm of

































of pHL5,5. No variant patterns of hybridization were seen with
EcoRI, BamHI, Hindlll, PstI or KpnII digests of human DNA. On PvuII
digestion two individuals (Table 3.3) showed an apparent shift in
hybridization of a lOkb fragment. The same two individuals showed a
loss of a 3kb band on Mspl digestion (Table 3 . <+) . This was
rechecked by taking a representative from each different group M4
and F2 and digesting again with EcoRI, Mspl, PstI, Kpnl and PvuII
(Fig. 3.18). Again on PvuII digestion F2 showed a change on the
migration of a lOkb band, F2 also showed the loss of a 3kb Mspl
fragment. Due to the complexity of hybridization in all these
experiments it is difficult to see the appearance of new bands of
hybridization, concomitant with the loss of the Mspl fragment and
shift in the PvuII fragment. However M4 digested with PvuII does
look like it contains two fragments, one slightly larger than the
other at lOkb (Fig. 3.18). However the proximity of the two bands
at lOkb does not make it useful for distinguishing between the
different variants for this particular enzyme. The Mspl variants
did not look useful either as again the pattern was too complicated
to determine between homo- or heterozygotes. TaqI digestion
initially looked very promising as 5/9 individuals had a variant
fragment at approximately lkb (Figure 3.19) which could be observed
even after digestion overnight with TaqI at 65°C. Again no
concomitant change could be seen in the individuals without this
extra Ikb band. This fragment could only be detected with the p/T
subfragment which corresponds to 5' coding region of pHL5,5. Even
with this reduced complexity of hybridization no additional variants
could be identified either with p/T or p/M subclones. Partial
digestion of the DNA could be ruled out because when duplicate blots
of TaqI digested DNA were probed separately with p/T or p/M no
- 122 -
FIGURE 3.18.
Concordance of Mspl and PvuII RFLP. Male (M^) and Female (F2) DNA
were cut with the indicated restriction enzymes and analysed as in
Fig. 3.15. Arrows indicate PvuII polymorphism in F2 and possible
doublet in M.
EcoR I Msp I Pst I Kpn I Pvu II
Hybridization of P/T and P/M to human
DNA digests.
FIGURE 3.19
TaqI polymorphism detected by p/T and p/M. DNA from 17 individual
lymphoblastoid cell lines DNAs was digested with TaqI and analysed
as in Fig. 3.18. Size markers ^ Hindlll and the arrow indicates
the polymorphic band.
Hybridization of Human DNAs with P/T and P/M subclones.
TABLE 3 . <+









BamHI 0/9 - - 0/9
EcoRI 0/9 - - 0/9
Hindlll 0/9 - - 0/9
4 PvuII 2/9 - - 2/9
4 Mspl 2/9 - - 2/9
Kpnl 0/9 - - 0/9
PstI 0/9 - - 0/9
TaqI 5/9 6/17 6/14 17/40
1 Panel of 9 random DNA samples
3 17 random samples provided by Dr. P. Middleton
3 UTAH family DNA, generation II provided by Dr. N. Spurr.
^ Same two individuals gave a variant pattern of hybridization
on digestion with PvuII and Mspl and probed with p/T and
p/M.
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partials were seen with the individuals who had the lkb band when
probed with the p/M subclone (data not shown). In a UTAH family
pedigree the lkb Taq fragment showed a consistent inheritance
through three generations (Fig. 3.20). This pedigree was originally
chosen as GM6990 showed an intensely hybridizing TaqI lkb band. It
was hoped this might have been a homozygote but only one parent had
this band on TaqI digestion and 2 out of 9 progeny which suggests it
was heterozygous for this fragment. Single allele polymorphisms are
of no use in trying to look for segregation of genotype and linked
phenotype in families. This has been remedied for P450C2C by Dr. N.
Spurr who has identified a simple 2 allele polymorphism with XmnI
digestion of human DNA and probing with the p/T subclone (Dr. N.
Spurr, pers. comm.). This can now be used in family studies to see
whether there is tight linkage between P450C2C and mephenytoin
metabolism.
3.14. Discussion
One of the aims of this study was to isolate and characterize a
human cytochrome P-450 cDNA, preferentially a constitutive form as
these had been implicated as being polymorphic with respect to the
oxidative metabolism of many marker substrates (Kalow et al, 1986).
By a number of criteria one of the two clones isolated was shown to
correspond to the rat P-450s PB-1, f and M. This included a
characteristic induction pattern on northern blots of hepatic mRNA,
Southern blot analysis and sequence comparison. Additionally the
human PB-1 appeared to correspond to a human P-450 involved in the
metabolism of mephenytoin, P-450mp, which is polymorphic in humans.
Recently antibodies to P-450mp were used to screen a human liver
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FIGURE 3.20.
Pedigree analysis of TaqI polymorphism. Filled circles represent
members of this pedigree which have the lkb TaqI band. Each
individual DNA was digested with TaqI and analysed as in Fig. 3.29.
"
= male. "0" = female.
UTAH PEDIGREE K-1331
























bacteriophage /\gtll library (Umbenhauer et al, 1987). The amino
acid sequence of this cDNA shows 5/485 amino acid differences with
that encoded by pHL5,5 which shows these two clones are closely
related if not the same. When the overall amino acid composition
was compared between P-450mp and that derived from the mp cDNA and
pHL5,5 there was a large difference in the determination of several
amino acids (Table 3.5). This was particularly the case for the
alanine, aspartic acid/asparagine and glycine. These differences
could reflect the limits of accuracy in the determinations of amino
acid composition. Alternatively the mp cDNA and pHL5,5 code for a
protein related to but not one identical with that of P-450mp.
3.14.1. How many forms of human PB-1 are there?
A number of criteria suggest there is more than one form of
human PB-1 P-450 that are not allelic variants of each other.
Firstly, more than two forms of P-450mp are detected in a single
liver sample (Shimada et al, 1986) of 48kd and 50kd respectively.
Western blot analysis of human liver microsomes with anti-rat PB-1
detects two bands (Adams et al, 1985; L. Forrester, pers. comm.) of
50kd and 54kd respectively. This difference in size estimates could
be due to differences in gel electrophoresis conditions. The larger
size detected by the rat antibodies, 54kd, is in closer agreement
with the predictr.-.'i molecular weight of human PB-1 P-450 of 55.6kd.
Northern blot analysis of human liver mRNA samples detected
multiple bands which may correspond to different PB-1 transcripts.
In the initial screen of the Woods cDNA library two cDNA clones were
isolated which hybridized with rat pTF-1 insert. This same probe
was used to screen another human liver cDNA library constructed in
/\gtll. Four positive plaques were isolated each of these had the
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TABLE 3.5
Amino Acid compositions of purified P-450mp protein, derived from mp cDNA
and pHL5,5 cDNA sequences.
*P-450mp *mpcDNA pHL5.5. cDNA
Ala 31 ± 7 18 18
AR3 22 ± 5 21 20
Asx 33+5 47 47
Glx 41 ± 6 46 46
Gly 39 ± 1 27 28
His 12 ± 2 12 12
He 26 ± 4 34 34
Leu 51 ± 5 57 59
Lys 46 ± 12 35 35
Met 12 ± 1 13 14
Phe 26 ± 4 32 31
Pro 31 ± 2 31 31
Ser 31 ± 4 31 32
Thr 23 ± 4 24 24
Trp 3 ± 1 3 3
Tyr 14+3 11 13
Val 30 ± 3 29 30
* Data from Umbenhauer et al, 1987
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same restriction map as pHL5,5 on PstI and EcoRI digestion (data not
shown). This suggested that this is the major form of PB-1 which is
expressed and corresponds to the pHL5,5 cDNA. In addition the Woods
and gtll liver libraries were grown up and DNA prepared from them.
These were digested with restriction enzymes to release their
inserts and Southern blotted. When pTF-1 was used as a probe most
of the bands detected appear to correspond in size to those seen
with pHL5,5 (data not shown).
The complex pattern of hybridization seen on Southern blots of
human DNA also suggest the presence of multiple genes. A minimum
gene count would suggest 2-3 genes. In human breast tissue a human
PB-1 protein is detected on western blots with anti-rat PB-1
antibodies which is intermediate in size between the 2 liver forms
(L. Forrester, pers. comm.) which would support this estimate. An
extensive tissue search has not been made for expression of PB-1
forms but PB-1 proteins have also been detected in human kidney
(Beaune et al, 1987) which might suggest the presence of additional
members of this gene family.
3.14.2. Function of cytochrome P-450 PB-1 and oxidative
polymorphism
In view of the structural homology between human PB-1 and the
human enzymes involved in mephenytoin metabolism it would appear
that the human PB-1 cDNA is part of this gene family, P450C2C. In
the case of mephenytoin, 2 phenotypes have been identified,
trivially named extensive (EM) and poor metabolizers (PM)
(Eichelbaum, 1984; Kupfer and Preisig, 1984). Population and
family studies have established that these differences are genetic
in character and that the PM phenotype is inherited as an autosomal
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recessive (Inaba et al, 1986; Jurima et al, 1985). Comparative
intersubjective studies have shown discordance between the
mephenytoin and a polymorphism in the oxidation of the drug
debrisoquine (Jurima et al, 1985). Poor metabolizers of mephenytoin
exist at a frequency of 5% in Caucasian populations which suggests
that carriers of the recessive allele should exist at frequency of
q-pj \,i-in the population. There is no correlation
between the amount of immunoreactive P-450mp in human livers and
mephenytoin metabolism (Shimada et al, 1986). This suggests that
the difference in the metabolism is due to a structurally altered
form.
Some drugs have been found to induce immunoallergic hepatitis
in humans with the appearance of circulating antibodies in human
sera directed against cell organelles (Homberg et al, 1985;
Mackay, 1985). The major epitope of these antibodies was found to
be kidney and liver endoplasmic reticulum in rat (Homberg et al,
1984). Subsequently it was found that 12 out of 20 sera recognised
a human P-450 which was identified as that which metabolizes
mephenytoin (Beaune et al, 1986b). A great number of these sera
were from patients who were given the anaesthetic, tienilic acid.
This P-450 (P-450mp) was specific for the metabolism of tienilic
acid at the 5 position and can lead to the formation of reactive
intermediates which form adducts to microsomal proteins. However
administration of tienilic acid did not itself induce the immuno
allergic hepatitis response which is only observed in 1/10,000
patients. Some sort of secondary event must be required. It is
suggested that this cytochrome could be alkylated by a reactive
intermediate and migrate to the hepatocyte membrane surface which
would then be recognised by the immune system leading to the auto-
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immune hepatitis response (Beaune et al, 1986b). This observation
is seen with several types of hepatitis induced by drugs with
concomitant production of liver and kidney auto-antibodies which are
distinct from each other and are thought to be directed against many
hepatic cytochrome P-450 forms (Mackay, 1985).
In vitro studies have demonstrated that steroids such as
cortisone, 21-deoxy — cortisone and progesterone are potent
inhibitors of S-mephenytoin hydroxylase in human liver (Inaba,
1986). None of the purified forms of P450mp have been reported to
have significant steroid hydroxylation activity towards the 21
position of progesterone or the 2 position of 17 [3-estradiol
(Umbenhauer et al, 1987). 2- and 4-hydroxylation of 17 (3-estradiol
have been attributed to P-450 NF (P450-3) in human liver (Beaune et
al, 1986a) which is not structurally related to P-450mp. Other
steroid hydroxylation reactions have yet to be reported for P-450mp.
Purified forms of P-450mp also had significant AHH activity but this
activity could not be inhibited with anti-P-450mp antibodies
(Shimada et al, 1986).
3.14.3. Comparison of human P450C2C cDNA with rabbit and rat
P450-2C cDNAs: identification of possible orthologous
genes?
The identity of functional and historical counterparts between
related gene families is complicated because it is difficult to know
whether the comparison has been made between orthologous or para-
logous forms. Orthologous forms are those genes which are identical
by descent and have been separated by speciation events. Paralogous
forms share their origin by gene duplication. This distinction is
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best illustrated with the P450C1 gene family. In rat, rabbits,
mouse and human this gene family consists of two closely related
members which share 70% homology (Nebert et al, 1987). The
duplication event which created this family appears to have happened
prior to the split that led to the human rodent and rabbit lineages.
Pl450(MC^k) in human shows significantly higher homology to P^450 in
mouse, rat and rabbit than to P3450(MC^a) forms in these species
(Table 3.£). Indeed the orthologous form of this gene family appear
to share greater functional properties between species than do the
paralogous forms in relation to substrate specificity and induction
characteristics (Jaiswal et al, 1985; Negishi et al, 1979).
In Table 3.1 is listed the overall amino acid percent
similarity of members of the P450-2C gene family in three different
species. This comparison indicates that rat forms are as similar to
each other as they are to the human form. The same observation can
be made when comparing human and rabbit forms. Only differences of
greater than 5% are significant in these comparisons (Nebert et al,
1987). Thus rabbit forms Pbcl and Pbc2 are clearly more similar to
each other than to the other forms listed. Rabbit form Pbc3 is
border line but appears to be distinct from all the other forms
listed. However this sequence represents only two thirds of a
putative P-450 form (Leighton et al, 1984).
The substrate specificity of P-450s appears to lie within the
200-300 amino acid region of the protein. This region of P450C2C
protein was compared to identify any similarities for forms between
different species. In all comparisons the percentage similarity for
this region was significantly less than that seen for the overall
comparisons. Over this region human PB-1 showed less homology to
rat forms f and PB-1 in comparison to rat M and rabbit forms I, Pbcl
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TABLE 3.(o.
Percent similarity of amino acid sequence among members of
P450C1 gene family in four species (adapted from Nebert
et al, 1987).
123456789
1. Human P345O -
2. Human Pj^450 72 -
3. Mouse P345O 73 68 -
4. Mouse P]^450 69 80 73 -
5. Rat MClb(d) 75 67 93 71 -
6. Rat MCla(c) 68 79 69 93 70 -
7. Rabbit form 4 77 68 73 67 73 67 -
8. Rabbit form 6 65 71 60 72 59 72 68
9. Rat PB3b(c) 36 35 35 36 35 35 36 34
JL
Included as a control, member of P450-2B gene family.
Human P^450 = mouse P]^450, rat MCla(c) and rabbit form 6.
Human P345O = mouse P345O, rat MClb(d) and rabbit form 4.
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and Pbc2. This suggested that human PB-1 is functionally more
related to these forms. Rat M is associated with the male specific
16a hydroxylation of testosterone and 2 hydroxylation of estradiol
(Yoshioka et al, 1987). Rabbit form I also metabolizes estradiol at
the 2 position and the 21 hydroxylation of progesterone (Tukey et
al, 1987). No function has been assigned to rabbit forms Pbcl or
Pbc2.
Another method for comparing rates of change is to use
nucleotide sequence comparisons which distinguish between those
nucleotide changes which cause amino acid replacements (non-
synonymous changes) and those that do not (synonymous changes) in
coding regions.
Because synonomous changes are subject to fewer functional
constraints it is a more reliable estimate of the rate of change
between two genes. To estimate the number of substitutions of both
types of sites in the P450-2C family of proteins I have used the
method of Li et al (1985a). This method gives a (number of
substitutions per asynonomous site) and Kg (number of substitutions
per synonomous site) value for the genes compared. The values
for all functional genes that have been analysed are lower than the
Kg values, but show a range of values depending on the functional
constraints placed on the protein (Li et al, 1985b). In this
comparison the program identified rabbit form Pbc3 as being already
too divergent to meanifully estimate substitution rates.
In Table 3.7 the and Kg values for all the comparisons of
rabbit, rat and human forms is presented. In all the pairwise
combinations of human PB-1 with rat and rabbit forms the K^'s are
very similar and significantly less than the Kg values. The Kg
comparison discriminates between the various forms. Rat M is more
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TABLE 3.7.
Number of substitutions per synonomous (Kg) and non-synonomous (K^)
sites between P-450 genes.
*Synonomous rates (Kg)
Hu Rat
p"d_ i p"R— 1 f M Rab I PBc 1 PBc2
1 2 3 4 5 6 7
1. Hu PB-1 -
2. Rat PB-1 .66±•08 -
3. Rat f .62±.06 .56±.06 -
4. Rat M .69+.07 1.0±.1 .91±.09 -
5. Rabbit I .54+.06 .81+.08 .78±.08 .74±.02
6. Rab PBc1 .49±.05 .80±.08 .77±.08 .83+.09 .59±.06 -
7. Rab PBc2 .46±.05 .80±888 .73+.07 .77±.08 .55±.06 .3+.04




PB-1 f M Rab I PBcl PBc2
1 2 3 4 5 6 7
1. Hu PB-1 -
2. Rat PB-1 . 14± -
3. Rat f .17±.02 .16±.02 -
4. Rat m .13+.02 .17±.02 .19+.02 -
5. Rabbit I .16±.02 .19±.02 .21+.02 .19±.02
6. Rab Pbcl .16±.02 .19±.02 .22±.02 .17±.02 .02+.02 -
7. Rab Pbc2 .14±.02 .18±.02 .20±.0 2 . 16±.02 .18+.02 .085±.009 -
* = calculated with program of Li et al, 1985b
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similar to human PB-1 than to the other rat forms whereas rabbit
form I is as similar to human PB-1 as it is to rabbit forms Pbcl and
Pbc2. The comparison also distinguishes two groups of P-450s
within the P450-2C family in rat and rabbit. This is paradoxical as
the two groups are similarly close to human PB-1. It would suggest
that the two groups duplicated at or before the rat, rabbit and
human radiation which is thought to have occurred 80 million years
ago (mya). A prediction from this analysis is that a second
unidentified member of this gene family exists in humans which may
show greater identity with the PB-l/f or Pbc21/Pbc2 group than M or
form I in rats and rabbits respectively. The existence of two
members in the second group which show greater identity with each
other also suggests that a second duplication event occurred in the
rabbit and rat lineages. These may have been independent events.
Another observation is that in general the rabbit forms show a
lower rate of divergence in relation to human PB-1 than the rat
forms. The average human/rabbit Kg is 0.5 whereas the average
human/rat Kg is 0.66. The Kg between rats and rabbits is
significantly higher than that between humans and rats or humans and
rabbits. However these calculations are based on a number of
assumptions. Firstly, the rate of nucleotide substitution is the
same in each species, secondly, no gene conversion has taken place
and thirdly, that the comparison is between equivalent forms.
Wu and Li (1985) have estimated the rate of synonomous
substitution has been on average about two times higher in the
rodent lineages than in the human and artiodactyl lineages. This
increase is attributed in part to the generation effect, that is
rodents have shorter generation times and thus higher mutation
rates. As yet there is no comprehensive data on human/rabbit
comparisons but the lower Kg seen for rabbits and humans could be
due to a reduced nucleotide substitution rate in rabbits when
compared to rats. Gene conversion events between PB-1 genes in rats
and rabbits also could lead to higher rates of change between
related forms. There are probably greater than 9 genes for the
P450-2C family in rats and rabbits which would be ample material
for gene conversion to occur. The environmental niche of rabbits
and rats is distinct from humans thus the selective pressures of the
chemical environment will be different. After gene duplication in
rabbits and rats had occurred a comparable functional equivalent to
the human PB-1 form might be no longer maintained. In such cases
there are no strictly orthologous forms between rabbits, rats and
humans for members of the P450C2C family. The difference in
substitution rates (Kg rat > Kg rabbit > Kg human) would give a
false picture of orthology between rabbit and human forms.












At some point in time the rate of nucleotide substitution would
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begin to differ between the three species when this occured would
have a bearing on the timing of the gene duplication events. The
above scheme is based on a divergence time of 3.3 x 10^ my for a 1%
difference in amino acid change to be observed for rabbits and
approximately half that time for rats. One prediction of this
scheme is that orthologous forms to M, PB-1 and f could exist in
mice as the duplication event for PB-1 and f is prior to the
mouse/rat divergence time estimated to be 25 mya (Sarich, 1985).
3.14.4. Map location of human P-450s
Each cytochrome P-450 involved in xenobiotic metabolism appears
to map to a distinct chromosomal position. The majority map to
different chromosomes (Table 3.8). The exception are the P450C2B
and P450C2A which both map to chromosome 19. P450C2A has been
localized to 19ql3.1-qter with P450C2B mapping to the same
chromosome. Members of these two P-450 families share 50% sequence
homology (J. Miles, pers. comm.). The P-450 families with the
prefix P450C2 all share 50% sequence homology to each other (Nebert
et al, 1987). The localization of P450C2E is to chromosome 10 (F.J.
Gonzalez, per. comm.). The assignment of P450C2C and P450C2E to
human chromosome 10 provides much needed molecular markers for this
chromosome. HMG8 (Grzeschik and Kazazian, 1985) shows only 28
mapped loci for chromosome 10 (including fragile sites) and of these
only 8 were molecular probes.
3.15. Summa ry
In this chapter the isolation of a cDNA corresponding to a
constitutively expressed cytochrome P-450 is described.
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TABLE 3.8
Chromosomal locations of hepatic P-450s in humans









Nebert et al, 1987
Nebert et al, 1987
Dr. C. R. Wolf, pers. comm.
This study
Nebert et al, 1987
Dr. F. J. Gonzalez, pers. comm.









Characterization of this clone shows that it corresponds to a P-450
responsible for the metabolism of mephenytoin (an anti-convulsant in
humans) and tienilic acid (an anaesthetic). This P-450 also
corresponds to a rat and rabbit P-450s involved in steroid
oxidations, the human P-450mp has the potential to bind steroids but
no specific metabolic transformation has been reported for it.
Southern blot analysis indicates that this cDNA encodes a member of
a small multigene family, P450C2C, which maps to chromosome 10q23-
10q24. This cytochrome P-450 does not correspond to any of the
hepatic cytochrome P-450 gene families previously mapped in humans.
Sequence comparisons indicate that related forms of this P-450 are
rapidly evolving in different species which may imply a consequent
change in substrate specificity. Therefore these may not serve as
useful models for human oxidative metabolism by members of P450C2C
gene family. However it does illustrate the flexibility of this
gene family in relation to environmental chemical stress. On
average cytochrome P-450 gene families are more complex in rodent
and rabbits than in humans. This may reflect a selective pressure
for increased P-450 function in response to an increase in chemical
diversity faced by these species.
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CHAPTER 4
THE PB-1 (P450-2C) GENES IN THE MOUSE
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4.1. INTRODUCTION
A number of mouse models have been developed for chemically
induced metabolism and carcinogenesis (Gurtoo et al, 1978; Stout
and Becker, 1986; Drinkwater and Ginsler, 1986; Reynolds et al,
1987). It is of interest to assess the role of P-450s in these
model systems and to see how applicable they are to human
experience. Therefore I decided to use the powerful mapping tool of
recombinant inbred strains of mice (Taylor, 1978) to determine the
chromosomal organization and assess some candidate function for the
PB-1 (P450-2C) gene family in mice. The approach depends on the
identification of restriction fragment length variants (RFLVs)
between progenitor strains which can be used as linkage markers in
sets of RI lines.
I had two rat PB-1 cDNA clones available, pTF-1 and pTF-2 which
contained inserts of 1227ovnd 410 base pairs respectively and were
shown to have 80% nucleic acid sequence identity (Freidberg et al,
1986). pTF-1 was chosen for the identification of PB-1 related
sequences in the mouse for the following reasons. Firstly, when
identical Southern blots of rodent and human DNA were probed with
pTF-1 and pTF-2 respectively it was found that pTF-2 did not detect
any additional DNA fragments (data not shown). Secondly, on a
screen of a mouse DBA/2 genomic library every positive plaque
detected by pTF-2 was also detected by pTF-1. This indicated that
pTF-2 although distinct from pTF-1 did not detect additional genes.
4.2. Genomic complexity PB-1 P-450 related sequences and
identification of RFLVs.
Firstly to demonstrate that the rat PB-1 cDNA can detect mouse
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sequences Southern blots of BamHI digested rat and mouse DNA were
probed with pTF-1. This revealed a complex pattern of hybridization
with up to 25-30 bands representing 150-200 kb of DNA (Fig. 4.1).
The pattern of hybridization in rat and mouse DNA was very similar
indicating the presence of several related genes in both species.
In the previous Chapter gene counts with 5' and 3' human PB-1 cDNA
clones indentified a minimum of 7-8 genes for the P450-2C gene
family in rodents.
In the inbred strains examined two basic patterns could be
observed, a DBA/2 pattern seen in DBA/2, AKR, CBA/Ca, C3H/He, 129
and BALB/c, and a C57BL/6 pattern seen in C57BL/6 and C57L. When
longer gels were run with BamHI and Hindlll digests of inbred strain
DNA the DBA/2 pattern could be further subdivided between DBA/2 and
AKR (Fig. 4.2). DBA/2 has RFLV at 12kb and 4.8kb in BamHI digests
not seen in AKR which has an additional band at „15kb. Similar
observations can be made on Hindlll digests. The C57BL/6 and C57L
patterns appear quite distinct from the DBA/2 and AKR pattern with a
minimum of 6 polymorphic fragments on Hindlll digestion. To further
extend the RFLV search I used C57BL/6 and DBA/2 as representative
strains and cut these DNAs with a number of different enzymes (Fig.
4.3). On this analysis SstI appear to generate the largest number
of variant fragments. SstI was subsequently used to examine a
number of other mouse strains with pTF-1. Again 3 patterns of
hybridization could be observed (Fig. 4.4). This suggested that the
DNA pattern was segregating as a haplotype i.e. the members of the
PB-1 (P450-2C) gene family are linked. Most of the inbred strains
examined could be classified as possessing one of three DNA haplo-
types designated P450-2Ca, P450-2Cb and P4502Cc (Table 4.1). On
SstI digest the four strains designated P450-2C^ differed from P450-
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FIGURE 4.1.
Southern blot analysis of BamHI digests of genomic DNA (5ug) from
rodents. The mouse DNA samples were M.D., Mus musculus domesticus;
M.M.. Mus musculus musculus; M.sp, Mus spretus; C56BL/6, C57L,
AKR, CBA/Ca, C3H/He, BALB/C and four DNA preparations from mouse
cell lines (strain in parentheses: EB22 (129), C127 (RIII), PC13
(129) and L cell (unknown). The blot was probed with ^P-labelled
pTF-1 PstI insert.
Haplotyping different rodent DNAs with TF~1.
Each DNA sample was digested with Bam HI.
FIGURE 4.2.
Southern blots of Hindlll and BamHI digests of genomic DNA (5pg)
from inbred strains probed with pTF-1: The indicated mouse strains





















AKR/Fu 020 C57/L C3H/He 129
FIGURE 4.3.
RFLV search between C57BL/6 and DBA/2. D, DBA/2; B, C57BL/6; M,
Hindlll. C57BL/6 and DBA/2 genomic DNA were cut with the indicated
restriction enzymes and analysed as in Fig. 4.1.
-0.6
Southern Blot of DBA/2 and C57BL/6
DNAs cut with different restriction
enzymes and probed with pTF— 1 .
FIGURE 4.4.
Haplotype analysis of rodent DNAs digested with SstI and probed with
pTF-1. M,"X Hindlll; A, DA rat; B, wistar rat; C, 129 mouse; D,
C3H/He, mouse; E, AKR, mouse; F, C57L mouse; G, DBA/2 mouse. The
blot was analysed as in Fig. 4.1.
 
Table 4.1.
Distribution of P450-2C Haplotypes Among Inbred Mouse Strains
Haplotype Inbred Strains
a C57BL/6, C57BL/10, C57L
b DBA/2. C3H/He, 020, CBA/Ca
c AKR, AKR/Fu, BAUl/c, 129, STS, GRS
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2C^in two variant fragments (Fig. 4.4 D vs C). P450-2Ca differed
L £
from P450-2C and P450-2C with respect to a minimum of 9 different
fragments (Fig.4.4 F vs G and E). When pTF-2 was used as a probe
the pattern of hybridization was less complex and fewer variant
fragments were seen. For example on SstI digestion DBA/2 (P450-2C^)
and AKR (P450-2Cc) cannot be distinguished from each other (Fig.
4.9). The difference between C57BL/6 (P450-2Ca) and DBA/2 (P450-
20®) is one additional fragment in the C57BL/6 track at _16kb and
loss of a band at „7kb (Fig. 4.5). This suggests that most of the
variants detected by pTF-1 lie at the 3' end of the gene. However
pTF-2 was able to detect differences between C57L and C57BL/6 on
Mspl digestion (Fig. 4.5). Where C57L has an additional band at
9.4kb this is seen in AKR mice as well but not in DBA/2, C57BL/6 or
C3H/He mice (Fig. 4.5). AKR can be distinguished from C57L by two
additional bands at 15-18kb. These do not appear to represent a
partial digest because when these blots are probed with a 31 P-450
probe C57L gives the same pattern as C57BL/6 (see later).
The distribution pattern has been established among inbred
strains for DNA variants detected by a rat PB3a (P450-2B) cDNA probe
(Simmons and Kasper, 1983). These authors detected two DNA
haplotypes, a DBA/2 pattern and C57BL/6 pattern and typed a number
of mouse strains with respect to this pattern. The distribution of
P
these hajlotypes was distinct from that seen for P450-2C haplotypes
which implied these two loci were not closely linked. I repeated
their analysis using a probe for P450-2B with the additional strains
used in the pTF-1 analysis and found an extra variant haplotype.
129 mice had a distinct pattern from DBA/2 and C57BL/6 (Fig. 4.6).
This was also detected in independent 129 samples and extraembryonic
cell line DNA derived from these mice. Thus three haplotypes can
- 142 -
FIGURE 4.5.
Southern blot analysis of human and rodent DNA with pTF-2. Blots
were hybridized with ^P-labelled psti insert from pTF-2. The mouse
strains and restriction enzymes used are indicated. The human DNA








































Haplotyping with pR17/p5'2 (P450-2B). See Legend in Figure 4.1.
for source of DNA samples. Blot was hybridized with ^2p labelled
PstI inserts from pR17 and p5'2.
Halotyping different rodent DNAs with pR17/p52.
Each DNA sample was digested with Bam HI.
FIGURE 4.7.
Further haplotyping with pRl7/p5'2 (P450-2B). The same blot as in





















Distribution of P450-2B haplotypes among inbred mouse strains.
Haplotype Inbred Strains
C57BL/6, AKR, C3H/He, A/He, A,
BUB/Bn, PL, RF, SJL, BAUO/c Hea,
BALB/c By, STS, 020, AKR/Fu
DBA/2, C57L, C57BR/cd, DBA/1
CBA /C®
129/fi'
Data from Simmons and Casper (1983) and this study.
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be seen for the P450-2B locus as well (Table 4.2 ) which I have
designated P450-2Ba, P450-2B^ and P450-2BC these do not show
concordance with the P450-2C haplotypes for the strains examined in
common. One point of note is that both CBA/Ca and 129 mice show
discordance between the Coh phenotype (Wood and Taylor, 1979) and
P450-2B. In the case of CBA/Ca these mice have low coumarin
hydroxylase (Coh^) activity which is seen in C57BL/6 (P450-2B—) but
has a DBA/2 (P450-2B^) DNA haplotype pattern. Similarly 129 mice
have high coumarin hydroxylase (Coh*1) activity but a distinct DNA
haplotype (P450-2BC) that is different to the DBA/2 and C57BL/6
patterns. Interestingly the CBA/Ca and 129 strains have been
classified as medium metabolizers of coumarin and 7-ethoxycoumarin
by Lush and Andrews (1978) which supports the idea that these are
two closely linked loci involved in coumarin metabolisms.
4.3. Genomic organization of P450-2C
Recombinant inbred mouse strains were used to determine the
relative chromosomal location and organization of the members of the
PB-1 gene family. The BXD series of mouse strains was initially
used as it has been extensively characterized with chromosomal
markers and contains the largest number of independent lines.
Figure 4.8 shows the hybridization patterns observed in a number of
BXD RI DNA samples when digested with SstI and probed with pTF-1.
For 26 lines analysed each RI line showed the inheritance of either
the C57BL/6 (P450-2Ca) or the DBA/2 (P450-2C^) progenitor haplotype.
No intermediate patterns were observed (Table 4.3) which
demonstrates the PB-1 genes map to a single chromosome and are
present as a large cluster within a maximum of lcM of DNA. This
locus was designated P450-2C in accordance with the new cytochrome
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FIGURE 4.8.
Southern blot analysis of SstI digests of genomic DNA from BXD mouse
strains and their progenitors. Blot was probed as in Figure 4.1.
 
TABLE 4.3.










*CXB D, J , K, N, 0, P C
E,G,I,L,Q,R B
OXA A, B , F,G,I,N,M,N,H 0
C.D.E,J,K,L A
* Determined with pM8-l only. DNAs from 5 sets of RI strains were
digested with restricton enzymes, Southern blotted and probed
with pTF-1 and pM8-l. The progenitor of the various sets are as
follows. AKXL (AKR X C57L), BXD (C57BL/6 X DBA/2), BXH (C57BL/6
X C3H/He), CXB (BALB/c X C57BL/6) and OXA (020 XAKR/Fu). Bold
letters, A, B. C, D, H, L and 0 denote the inherited progenitor
DNA pattern from AKR, C57BL/6, BALB/c, DBA/2J, C3H/HeJ, C57L and
020 respectively. The restriction enzymes used to type the
various RI strains were as follows: SstI, (AKXL, BXD, BXH, CXB,
OXA), Hindlll (AKXL, BXD, BXH, CXB, OXA), BamHI (BXH), Mspl
(BXH) and TaqI (BXD).
- 148 -
P-450 nomenclature (Nebert et al, 1987). Comparison of the strains
distribution pattern (SDP) obtained with those markers previously
mapped demonstrated that P450-2C was not tightly linked to any known
genomic loci including the PCN (P450-3) (Simmons et al, 1985) and
the P450-2B (Simmons and Kasper, 1983) loci. Loose linkage (20/26)
was observed to the Env-25 locus on chromosome 12 (Blatt et al,
1983).
Possible linkage for the P450-2C locus was further investigated
using the AKXL (Fig. 4.9), BXH (Fig. 4.10), CXB and OXA RI series.
No intermediate haplotype patterns were observed. This provides
further evidence that P450-2C exists as a clustered array. Again no
tight linkage was found with any known genomic markers including the
P450-1 locus on chromosome 9 (Hildebrand et al, 1985a). pTF-2 was
tested in the BXD and AKXL RI lines and gave 100% concordance with
pTF-1 (data not shown).
4.4. Linkage between P450-2C and constitutive AHH activity.
It has been established several years ago that mice of the AKR
progenitor strain have a high uninduced liver AHH activity (Hutton
et al, 1979). Mice of the C57L and C57BL/6 strain have a
significantly lower basal liver AHH activity associated with it
(Hutton et al, 1979; J. J. Hutton, pers. comm.). This difference
in AHH activity was shown to be heritable and a SDP pattern was
obtained for the AKXL RI series (B.A. Taylor and J. J. Hutton, pers.
comm.). This segregation showed tight linkage (17/18) with the
P450-2C locus, the only discordance being in the AKXL If line (Table
4.4). In spite of the use of a number of restriction enzymes as
well as different PB-1 cDNA clones no recombination within the P450-
2C locus in the AKXL \f~ line was observed. The genetic distance
- 146 -
FIGURE 4.9.
Southern blot analysis of SstI digests of genomic DNA from AKXL
mouse strains and their progenitors. Blot was probed as in Figure
4.1.
AK*L RI strain
M S S'38 37 29 28 25 24 21 19 17 IB 14 13 12 9 8 7 61








Southern blot analysis of Mspl digests of BXH mouse strains and








11 12 14 19
xHind111
TABLE 4.4.
Distribution of Constitutive Liver AHH activities (nmole/g
tissue/min) and P450-2C in the AKXL Recombinant Inbred Strains
Strain AHH Activity Genotypes* Progenitor P450-2C
(mean ± SE) (con. AHH) DNA pattern
5 42.5+3.9 A A
6 21.1±1.8 L L
7 24.4±1.6 L L
8 21.8±2.0 L L
9 30.4±1.9 A A
12 32.0+2.9 A A
13 24.4±1.5 L L
14 22.7±0.9 L L
16 19.0±1.1 L L
17 23.0±1.3 U X L
19 21.6+1.0 L L
21 28.0+2.6 A A
24 34.8±4.4 A A
25 22.2+1.7 L L
28 19.9+1.6 L L
29 29.8±2.4 A A





"A" and "L" refers to the pattern observed for the parental
AKR/J and C57L/J strains respectively. The "X" represents an
apparent recombination event that occurred between the two loci.
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between P450-2C and constitutive AHH activity is 1.52cM and the 95%
confidence limits are 0.04 to 11.55cM (Silver, 1985).
4.5. Non-linkage between P450-2C and candidate functions
The oxidative metabolism of estradiol is mediated by cytochrome
P-450 reactions (Waxman, 1984; Cheng and Schemkman, 1983). A
correlation between high circulating 16a-hydroxy estradiol levels in
vivo and the incidence of breast tumours has been reported in humans
(Schneider et al, 1982) and mice (Bradlow et al, 1985; 1986). In
C3H/He mice the extent of estrogen 16a-hydroxylation is increased
relative to C57BL/6 mice. This difference was shown to be heritable
and a SDP established for the BXH series of RI strains (Bradlow et
al, 1985; 1986). No linkage was observed between the P450-2C locus
and the reported SDP for this activity (Table 4.5). Also it was
established that the P450-2C locus is not linked with either the
e poxidation of the hepatocarcinogen aftatoxin B^ (Gurtoo et al,
1978) or the induction of liver tumours by N-ethyl-N-nitrosourea
(Drinkwater and Ginsler, 1986).
4.6. Isolation of mouse PB-1 cDNA clones.
I decided to isolate mouse PB-1 cDNA clones for a number of
reasons. Firstly they might improve the analysis of various mouse
haplotypes and detection of possible recombination events in RI
lines. Secondly, the use of mouse cDNAs would facilitate the
analysis of Chinese hamster/mouse somatic cell hybrids for those
hybrids which retained mouse chromosomes containing the P450-2C
locus.
A male DBA/2 liver cDNA library (Clontech) constructed in
pBR322 was plated out to a density of 20,000 colonies per 20 x 20cm
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TABLE 4.5.
Distribution of P450-2C and estrogen 16a-hydroxylase activity in the
BXH RI strains. The estrogen 16a-hydroxylase activity is from
Bradlow et al, 1985; 1986.














1) "B" and "H" refers to the pattern observed for the parental
C57BL/6 and C3H/He strains respectively.
2) In Bradlow et al, 1985 strain BXH4 was reported to have a H
phenotype but in Bradlow et al, 1986 this was switched to a
B phenotype.
- 149 -
nitrocellulose filter and screened with pTF-1 insert by the method
of Grunstein and Hogness (1975). Approximately 0.5% of the clones
were identified as being homologous to pTF-1 insert. Four clones
came through the secondary and tertiary screening. These were
termed pPB3-15, pM8-l, pPB5-21 and pPB4-l. On Pst-I digestion pPB3-
15 and pM8-l had inserts of 1350 and 650bp respectively. pPB4-l and
pPB5-21 had lost a PstI site because PstI digestion only linearized
these plasmids. These plasmids were then cut with Mspl whose sites
are deficient in eukaryotic genomes (Bird, 1986), this gives a
fragment of approximately 2kb of which 110 base pairs can be
attributed to pBR322 if the plasmid is unrearranged (Fig. 4.11).
4.7. Characterization of mouse PB-1 cDNA clones.
Firstly restriction digestions of purified plasmids were
Southern blotted and shown to hybridize with pTF-1 and not with
pR17/5'2 (P450-2B) (data not shown). Secondly, a mixed oligomer to
the conserved Cysl52 region of rat PB3a was used to probe the mouse
cDNA clones. pPB3-15, pPB4-l and pPB5-21 all lit up with this
oligomer (Fig. 4.11). This suggested that these clones were at
least 3/4 full length. pM8-l could be a short 3' prime which did
not contain this region. Northern blots with these probes showed
they detected a 2kb mRNA with a high level of expression which was
slightly phenobarbital inducible (data not shown). Preliminary
sequence analysis of pPB3-15 and pM8-l sequests that pM8-l is a
truncated version of pPB3-15 and that coding portions of these cDNAs
are 88% homologous to the rat PB-1 cDNA (J. Sweeney, pers. comm.).
4.8. Haplotyping with mouse PB-1 cDNA clones
A number of different restriction digests of mouse inbred
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FIGURE 4.11.
Sizing and identification of mouse PB-1 (P450-2C) cDNA probes. All
plasmids except pPB5-21, pPB4-l and pBR322 were digested with PstI.
The aforementioned three plasmids were digested with Mspl. Plasmids
were fractionated on a 1.2% agarose gel, Southern blotted and
hybridized to mixed oligomers directed towards the conserved Cysl52
fragment of rat PB3a (P450-2B) protein. Size markers were \ Hindi11
and 0X174 Haelll. PB-1 cDNA plasmids were pM8-l, pPB3-15, pPB5-21
and pPB4-l (mouse); pTFl-3 and pHL5,5 (Human); pTF-2 and pTFl
(rat). Also included were rat PB3a cDNAs pR17 and p5'2, a human
P450C2B cDNA pR17-13 and the Woods cDNA library.
*7 c/j S3 csj
Bl "O rvj If) fP5? S S co oc
P450 - 2C and P450 - 2B cDNA plasmids probed
with conserved mixed oligomers to Cys1 52 region
of PB3a protein.
strain DNAs were probed with pM8-l, pPB3-15 and pPB5-21. All showed
the same haplotype distribution detected by pTF-1. A number of
differences were noted. For instance, pM8-l was a highly poly¬
morphic probe and detected many variant fragments on SstI digestion
(Fig. 4.12). pPB3-15 had a low level repeat associated with it but
even against this background it gave a similar hybridization pattern
and the same strain distribution pattern in the progenitor strains
as pTF-1. pPB5-21 did not detect as many variant fragments as the
pM8-l and pPB5-15 probes (Fig. 4.12 and 4.13). However it did give
a similar pattern to pTF-2 which suggests that this is a 51 PB-1
cDNA clone lacking the 3' region which detects the variant fragments
in mouse RI lines.
The pM8-l cDNA clone was investigated further because of its
polymorphic nature. Mouse strain DNAs were probed with pM8-l to see
if the DNA haplotypes detected by pTF-1 and pTF-2 could be further
subdivided. Examples of such analysis are shown in Figures 4.14 and
4.15. As shown in Figure 4.14, BALB/c DNA digested with Hindlll
appeared to give a new variant fragment at 9.4kb when probed with
pM8-l, but this variant band could not be detected in subsequent
experiments. With every digest looked at additional variants not
uncovered by the pTF-1 probe could be detected by pM8-l but no
additional subdivisions could be detected i.e. the only haplotypes
detected by pM8-l corresponded to P450-2Ca, P450-2C^ and P450-2Cc.
Of note is that pM8-l could detect no differences between C57BL/6
and C57L even on probing Mspl digests of their strains (Fig. 4.15).




Southern blots of SstI digests of mouse strain genomic DNA probed
with pM8-l. The indicated mouse strain DNAs were used and the blot
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FIGURE 4.13.
Haplotyping with pPB5-21. Hindlll digests of the indicated mouse
strain DNAs were Southern blotted and probed with 32p_iabenec} Mspl
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FIGURE 4.14.
Haplotyping with pM8-l. The same blot as in Figure 4.2 was stripped












Mouse haplotyping with pM8-l. The same blots as in Figure 4.5. were
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4.9. Mapping with pM8-l in RI lines
pM8-l was used to map in the BXD, AKXL, BXH, CXB and OXA RI
strains. An example is shown for the w*/ft* Wo*/<3*0 rj lines (Fig.
4.16) in all these analysis pM8-l gave a 100% concordance with pTF-
1. When used in the AKXL RI lines pM8-l could not detect any
possible recombination events within P450-2C in the AKXL 38 line
(data not shown).
4.10. Chromosomal location of P450-2C locus
From the genetic and molecular analysis of the mouse PB-1 cDNA
clones it was certain these clones represented the same locus mapped
with the rat pTF-1 cDNA. A panel of Chinese hamster/mouse hybrid
DNA (kindly provided by J. Hilkens) was used to determine the
chromosomal assignment of P450-2C. The parental cell lines were
digested with a number of restriction enzymes, Southern blotted,
hybridized and washed at high stringency to find the conditions
which best suited the detection of mouse PB-1 sequences on a Chinese
hamster background. For pM8-l this turned out to be Hindlll digest
and for pPB5-2 Bglll digestion. Fig. 4.17 shows a series of Hindlll
digested mouse, Chinese hamster and hybrid DNAs Southern blotted and
probed with pM8-l. Of note is that the fragments mapped in this
experiment correspond to those mapped in the C^A ri lines on Hindlll
digestion (Fig. 4.16). Hybrids were also analysed by BamHI and
Bglll digestion and pM8-l probing and a segregation pattern
obtained. As pPB5-21 detected additional fragments not observed
with pM8-l it was also used to probe Bglll digests of Chinese
hamster/mouse somatic cell DNA (Fig. 4.18). This gave 100%
concordance with pM8-l for hybrids analysed in common which
suggested that these sequences were linked on the same chromosome.
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FIGURE 4.16.
Mapping in RI strains with pM8-l. The indicated RI strains and











Southern blot analysis of Hindlll digests of Chinese Hamster/mouse
somatic cell hybrid DNAs and their parental cell lines. The blot
was probed as in Figure 4.12. parental cell lines were E36 (Chinese
hamster) and GRSA (mouse). Also included are mouse strain DNAs
showing the Hindlll polymorphism detected by pM8-l and another
Chinese hamster cell line, CHO. Two Chinese hamster/mouse somatic
cell hybrids were analysed in this analysis, '+• is a hybrid
positive for mouse DNA and is a hybrid negative for mouse DNA.
-p
FIGURE 4.18.
Chinese hamster/mouse somatic cell hybrid DNAs digested with Bglll
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Chinese hamster/mouse hybrid DI\IAs.
i
+ ++ + +- + + - ___
40 93 58 62 73 100 99 74 92 44 75 39 38 37
y
"+"=Positive for mouse PB-1 fragments.
Negative for mouse PB-1 fragments.
These experiments were done blind and the resulting segregation was
analysed by J. Hilkens to see whether P450-2C segregated with any
chromosomal markers in these hybrids. Table 4.6 shows that P450-2C
hasl00% concordance with Got-1 on chromosome 19.
In situ hybridization was used as an additional approach to map
the P450-2C locus. Unlike human chromosomes most mouse chromosomes
are telocentric and do not vary much in size (Miller and Miller,
1981). However specific chromosome rearrangements can be used to
unequivocally identify specific mouse chromosomes. In collaboration
with R. M. Speed and J. R. Gosden this approach was used to localize
the P450-2C locus. A wild strain of mouse (Mus musculus), CD, has
all its chromosomes apart from the 19, X and Y fused as metacentrics
(Capanna et al, 1975). The 19, X and Y are readily distinguishable
as acrocentrics. Firstly a G-banded karyotype from trypsin banded
somatic chromosome preparations from the bone marrow of CD mice was
made. In female CD mice the 19 is readily distinguishable from the
X on account of its much smaller size (Fig. 4.19). The karyotype
showed that the CD mice were of the right chromosome constitution.
The pPB3-15 cDNA probe was labelled with tritium and then
annealed with total mouse DNA to eliminate the hybridization of the
repeat sequence (Sealey et al, 1985; Porteous et al, 1987). The
annealed probe was used against metaphase spreads of CD mouse bone
marrow cells. A representative metaphase spread is shown in Fig.
4.20. In this figure three out of the four chromosome 19s have
grains associated with them. Ten cells were analysed with a total
of 88 grains, of these 21 (23.9%) were located on mouse chromosome
19 and of these, 19 (91.5% of total) were localized to within the 19
D1/D2 region at the tip ( Fig. 4.21).
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FIGURE 4.19.
The trypsin-giemsa-banding patterns of the karyotype of a female CD
mouse. Figures underneath represent the fusions between the
respective acentrics. Note the small uctoaatttc chromosome 19.
(Kindly provided by R. M. Speed.)
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Karyotype of CD mouse (9).
FIGURE 4.20.
Metaphase spread of mouse chromosomes hybridized with tritiated
pPB3-15. Hybridization was done in situ with pPB3-15 to mouse
chromosomes from CD female mice. Note 3/4 chromosome 19s are
labelled (arrows) (provided by D. Rout).
 
FIGURE 4.21.
Autoradiographic grain distribution of pPB3-15 on mouse chromosome
Localisation of P450-2C
on mouse chromosome19





TOTAL NO. OF GRAINS IN 10 CELLS - 88
TOTAL NO. OF GRAINS ON 19 - 21 (24%)
NO. OF GRAINS WITHIN D1/2 REGION - 19
% OF GRAINS WITHIN D1/2 REGION - 91.5%
19
TABLE 4.6.
Segregation of P450-2C in mouse-hamster hy orids*
Chromosome Marker Concordance Discordant Concordancy L
(N=TOT)
1 PEP3 15 9 AZ 5< (N=24)
2 SDH1 11 12 44 8 (N=23)
AK1 12 12 50.0 (N=24)
3 RASN 5 7 41.6 (N=12)
4 PGD 12 12 50. 0 (N=24)
5 PEP 7 13 11 54. 1 (N=24)
6 TP 11 10 14 41. 6 (N=24)
L0C2 5 8 38.4 (N=13)
7 GPI1 12 12 50.0 (N=24)
LDH1 12 12 50.0 (N=24)
PEP4 8 10 44.4 (N=18)
8 GR1 18 6 75.0 (N=24)
APRT 15 5 75. 0 (N=20)
DIA 15 8 65. 2 (N=23)
9 MODI 14 10 58.3(N=24)
M PI l 15 9 62.5 (N=24)
PK3 15 9 62.5 (N=24)
10 PEP2 14 10 58.3 (N=24)
11 GALK 8 6 57. 1 (N=14)
TCN2 6 6 50. 0 (N=12)
SHU 9 7 56. 2 (N=16)
12 ACPI 14 9 60. 9 (N=23)
13 ARSB 21 2 91.3 (N=23)
14 NP1 11 13 45.8 (N=24)
ES10 12 12 50.0 (N=24)
15 ARSA 12 12 50. 0 (N=24)
MYC 9 6 60.0 (N=15)
1NT1 6 2 75.0 (N= 8)
16 SOD1 14 10 58.3 (n=24)
LOC3 8 5 61.5 (N=15)
17 GL01 10 6 62. 5 (N=16)
SOB 2 16 8 66.8 (N=24)
C3 12 6 66. 6 (N=18)
PIM-2 15 7 68. 1 (N=22)
18 PEP1 12 8 60. 0 (N=20)
19 GOT1 24 0 100. 0 (N=24)
n total 24 hybrid DNAs were analysed but markers were availab




The power of mouse genetics for analysis of a multigene family
as complex as cytochrome P-450 is evidenced by its dual ability to
determine chromosomal organization and gene function. Genetics can
provide the best evidence for in vivo function of specific P-450
families (Simmons and Kasper, 1985; Nebert et al, 1981; Taylor,
1984). In this Chapter it has been shown that P450-2C is a
clustered multigene family, it is not linked to any other known P-
450 loci and is associated with constitutive AHH metabolism.
4.11.1. P450-2C forms part of a syntenic linkage group in human
and mouse
P450-2C was mapped to the tip of chromosome 19 by mapping in
somatic cell hybrids and by in situ hybridization to mouse metaphase
chromosomes. This mapping data suggests that P450-2C in mice and
its equivalent P450C2C in human map to regions of homology Got-1,
PGAM, LIPA, and TdT all map to chromosome 19 in mice and chromosome
10 in human (Greschik and Kazazian, 1985; Yeng Fang et al, 1986;
Davidson and Roderick, 1986). P450C2C , Got-1, PGAM and TdT have
been localized to 10q23-10q25 with P450C2C being centered at
10q24.2. In mice the in situ hybridization experiment cannot
distinguish the relative order of markers, but in human Got-1 is
more distal than P450C2C (Figure 4.22). When the human PB-1 cDNA
plasmid pHL5,5 is used as a probe against mouse metaphase spreads it
also preferentially hybridizes to the D1/D2 region of chromosome 19
(J. Gosden, pers. comm.). The extent of the chromosomal homology
could be estimated by utilizing more flanking markers from human
chromosome 10 and mouse chromosome 19. For instance if PSA-A could
be mapped in the mouse this could detect how far up this region of
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FIGURE 4.22.
Homologous loci containing PB-1 genes in mice (P450-2C) and humans
(P450C2C). Shown are mouse human chromosomes 19 and 10 respectively
with the localization of the P450-2C genes and their flanking
markers. Loci at the end of the chromosomes have not been
localized. The human chromosomal and regional mapping was performed
using somatic cell hybrids, in situ hybridization and family studies
(Grzeschik and Kazazian, 1985; Bruns et al, 1987; Yang-Feng et al,
1986). The mouse chromosomal locations were determined by
recombination analysis and in somatic cell hybrids (Yang-Feng et al,













































Homologous loci containing PB-I genes in
mice (P450-2C) and humans (P450C2C).
synteny goes on the respective chromosomes.
4.11.2. Size of P450-2C locus
No recombination between any of the P450-2C haplotypes could be
observed in 81 RI strains. This represents a maximal genetic
distance of 0.96cM (95% confidence limits) Taylor, 1978). A
centimorgan of DNA in the mouse is approximately 2 x lO^bp. 0.96cM
is equivalent to approximately 1920kb of mouse DNA. pTF-1 detects
up to 200kb of genomic DNA on Southern blot analysis. pTF-2 and
pM8-l represent 5' and 3' coding regions for the rodent PB-1 mRNA.
When the same blot is probed and stripped and reprobed with pM8-l
and pTF-2 respectively (Fig. 4.5 and 4.15) it can be estimated that
there are 5-7 bands in common representing a minimum of 5-7 genes in
the mouse. These probes also hybridize very well to human DNA
(Figs. 4.5 and 4.15) and give a minimum estimate of 2-3 genes in
humans. This estimate agrees with the minimum gene count estimated
with the human 5' and 3' cDNA probes (Chapter 3). The number of
PB3a (P450-2B) genes in rat has now been found to be 11 (Adesnik
and Atchison, 1986) and has a similar genomic complexity on Southern
blots to PB-1 (P450-2C) genes (Fig. 4.6 vs Fig. 4.1). The minimum
size of a PB-1 (P450-2C) gene is 20kb in DBA/2 mice (data not shown)
which is equivalent to that found for PB3a of 15-25kb (Atchison and
Adesnik, 1983; Mizukari et al, 1983; Suwa et al, 1985). Thus a
maximum estimate of the size of PB-1 (P450-2C) gene family is 11-14
genes in mice and 4-6 in humans.
4.11.3. P450-2C and function
The apparent recombination between P450-2C and constitutive AHH
might suggest that these are different but closely linked loci.
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However it is likely that constitutive AHH activity is encoded by
P450-2C as purified PB-1 (P450-2C) proteins from rat, rabbit and
human have this activity (Waxman and Walsh, 1983; Runcy and
Johnson, 1985; Shimada et al, 1986). So this appears to be a
highly conserved function. This constitutive AHH activity was
determined several years ago, given the modest difference between
AKR/J and C57L/J progenitors a single discordant RI strain might be
due to statistical variation. Antibodies to PB-1 will inhibit this
function in certain microsomal preparations (Adams et al, 1985). A
third possibility is that P450-2C has a closely linked regulator of
constitutive AHH metabolism. Proteins within the PB-1 (P450-2C)
family therefore have the potential to play a role in the
deactivation or activation of polycyclic hydrocarbons. Their role
in carcinogenesis remains to be established. It has been proposed
that the diminished potency of 3MC with respect to TCDD as an AHH
inducer in whole animals as compared to tissue culture results from
the metabolic inactivation of 3MC in whole animals (Poland and
Glover, 1973; Niwa et al, 1975). In studies of expression pf P-
450s in hepatoma cells (tissue culture) I found that PB-1 (P450-2C)
mRNA levels are not maintained whereas MCla (P450-1) levels are
(data not shown). Thus loss of PB-1 expression may be concommitant
with the inability to inactivate 3MC as an AHH inducer.
PB-1 proteins in rats also have activity towards steroids at
the 2, 1513 and 16a positions and the 25 hydroxylation of vitamin D
(Astrom and De Pierre, 1986). A male specific form of PB-1 has
estrogen 16a-hydroxylation activity in rats and probably in mice
(Harada and Negishi, 1984). This sexual dimorphism is not seen in
vitro (Bradlow et al, 1985; 1986); taken together with our BXH RI
data this would suggest that circulating levels of 16a-
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hydroxyestrogen are not determined by P450-2C.
In rat six distinct forms of PB-1 isozymes have been isolated
(Haniu et al, 1984; Wolf et al, 1986b) termed P-450 - PB^a, PB^,
f, g, h and i. Sequence analysis of PB^a, f and h (M) cDNA clones
show them to have greater than 75% amino acid identity (Freidberg et
al, 1986; Gonzalez et al, 1986a; Yoshioka et al, 1987). The
estimate of divergence time between these forms is 50-80 mya
(Chapter 3) which is prior to the mouse/rat divergence time of 25
mya (Sarich, 1985). The locus defined as P450-2C has the potential
to code for all these PB-1 isoenzyme forms so orthologous forms
might be expected in both species. Indeed preliminary sequence
analysis of pPB3-15 shows it to have 88% identity with PB^a of rat
at the nucleotide level over the sequences compared (J. Sweeney,
per. comm.). This makes pPB3-15 more similar to PB^a of rat than
either f or h(M). Thus pPB3-15 could encode the mouse orthologue of
rat PBia. BB|a in rat is active in the hydroxylation of steroids at
the 16a- and 16|3-positions (Astrom and De Pierre, 1986) and is
induced 2-4 fold on phenobarbital administration in rats (Freidberg
et al, 1986).
4.11.4. Haplotyping of P450-2C and P450-2B in mice
The finding that members of P450-2C map close together supports
the idea that these particular genes arose by a process of
duplication from an ancestral gene after the rodent/human split.
This process seems to have been happening over a longer time scale.
Members of the P450-2C and P450-2B multigene families have 50% amino
acid identity in rats (Gonzalez et al, 1986a) the same will probably
be true in mice. This suggests that they arose by a duplication of
an ancestral gene 200 million to 300 mya (Nebert et al, 1987).
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After these genes began to diversify, two distinct gene families
would have resulted and become separated genetically at (or post)
the initial amplification event. This initial amplification event
seems to have led to an explosion of P-450 gene families. To date
there are 5 P450-2-1ike distinct multigene sub-families showing 50%
amino acid identity in rat and humans (Nebert et al, 1987), four of
which map to distinct locations in humans. P450C2B and P450C2A both
map to chromosome 19 in human (N. J. Spurr, pers. comm.). Linkage
of related gene families has also been noted for multigene families
encoding the protease inhibitors a anti-trypsin and contrapsin in
mice (Hill et al, 1985). Both of these proteins share 50% amino
acid identity and map to within lcM on mouse chromosome 12. This
linkage is also seen for these gene families in humans (R. Hill,
pers. comm.). Therefore it would not be surprising if P450-2B and
P450-2A were found to be in the same proximity in the mouse genome.
The haplotyping of P450-2B in mice tentatively suggests this. It
shows discordance with coumarin hydroxylase activity in two strains
of mice which suggests a closely linked locus is responsible for
this activity. Purification schemes for P450coh in mice suggest it
has testosterone 7a-hydroxylase activity (Huang et al, 1976;
Kaipainen et al, 1984), this activity is normally associated with
proteins encoded by members of the P450-2A gene family (Nagata et
al, 1987). Therefore P450-2B and P450-2A could map to within 1cm in
mice.
The P450-2BC haplotype in 129 mice is very unusual in that it
is seen only in this strain and looks like loss of a gene in
comparison to other inbred mice strains. 129 mice are also unusual
in that females express 10-fold less protein in comparison to mice
«T>h haplotypes (Noshiro et al, 1986). Theof the P450-2Ba and P450-2B0 y 3v '
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PB3a protein in mice has 16a-testosterone activity (Devore et al,
1985). The lack of this activity does not appear to have adverse
effects on these mice as they maintain a high 16a-estrogen
hydroxylase activity in vivo (Bradlow et al, 1985) which would
appear to rule out the contribution of PB3a form to this activity.
Conceivably it could be performed by another member of this gene
family which is extrahepatic in its expression.
Two of the three P450-2C haplotypes detected by pTF-1 and pM8-l
are very similar and are examplified by AKR (P450-2Cc) and DBA/2
(P450-2ck). These two strains are distinct from C57BL/6 (P450-2Ca).
If pTF-2 is used as a probe the haplotypes are very similar which
suggests most of the variation that is being detected is due to
differences in the 3' part of P450-2C gene members. The cDNA
encoded by pTF-2 corresponds to the region of the protein that is
putatively involved in substrate specificity and the first conserved
cysteine containing fragment whose function is unknown. Thus we
might expect members of the P450-2C family to have similar substrate
specificity between different mouse strains but correspondingly
different specific activities due to differences in heme and
reductase binding sites as detected by pM8-l. This could explain
why AKR (P450-2Cc) mice have a substantially greater constitutive
AHH activity as compared to C567BL/6 (P450-2ca) and DBA/2 ((P450-
2ch) mice (Hutton et al, 1979). In this context it would be useful
to develop a set of specific substrates which detect these




PATTERN OF LIVER GENE EXPRESSION IN MOUSE VISCERAL
YOLK SAC AND FOETAL LIVER
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5.1. INTRODUCTION
In the developing embryo many complex programs of activation of
cellular and gene processes are programmed resulting in the
differentiated adult organism. For mammals this will mean that at
critical periods the fetus may have different sensitivities to
toxicological agents which may or may not cross the placental
barrier. For example in mice and rats it has been shown that the
MClb (P450-1) is not inducible by 3MC in liver until a couple of
days prior to birth (Chen et al, 1982; Negishi and Nebert, 1979).
Similarly the PB3a (P450-2B) genes do not become responsive to
phenobarbital in liver until the early neonatal period in rats
(Giachelli and Omiecinsk, 1986).
A pertinent question would be when, or if, does the foetal
liver resemble the adult liver in its pattern of expression? The
visceral yolk sac (VYS) one of the extra-embryonic membranes
surrounding the mouse embryos expresses a number of liver functions
including alpha-fetoprotein (AFP) and transferrin (Dziadek and
Adamson, 1978; Janzen et al, 1982; Adamson, 1982; Dziadek and
Andrews, 1983). However the extent of the overlap in the programme
of gene expression between the VYS and the foetal and adult liver is
not known. The VYS consists of visceral endoderm and mesoderm and
it is the visceral endoderm which is thought to express the liver
functions (Dziadek and Adamson, 1978; Adamson, 1983). The visceral
endoderm has very different embryological origins to the liver, it
is purely an extra-embryonic tissue derived from a population of
primitive endoderm cells which arise on the fifth day of development
and subsequently gives rise only to cells in the visceral and
parietal yolk sacs (summarized in Hogan et al, 1986). Descendants
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of the primitive endoderm do not colonize any tissues in the foetus
proper (Gardner and Rossant, 1979). In contrast, the liver
develops from an outgrowth of the gut endoderm at around 9 days of
development. This diverticulum is derived from the definitive
endoderm which traces back to the embryonic ectoderm (Hogan et al,
1986). When this work was begun I had available a number of liver
cDNA clones for mouse liver serum proteins (Barth et al, 1982) which
have subsequently been identified as coding for albumin,
apolipoprotein Al (ApoAI) (Millar et al, 1983; alpha^antitrypsin
(a^-Pl), contrapsin a member of the antichymotrypsin family (Hill et
al, 1986) and the major urinary proteins (MUPs) (Bennet et al, 1982;
Shaw et al, 1983). These were used to characterise the pattern of
serum protein gene expression in mouse VYS and foetal liver.
Subsequently I used the cytochrome P-450 genes and a set of liver
specific genes of unknown function (Derman et al, 1981) to see
whether the observations for the serum protein genes could be
extended to these other hepatic genes.
5.2. Expression of serum protein genes in VYS
Radioactive probes corresponding to albumin, ApoAI, a^-PI,
contrapsin and MUPs were hybridized to total RNA extracted from
several extra-embryonic tissues of 13.5 day post-coitus (p.c.)
embryos (kindly provided by B.L.M. Hogan) and several adult tissues
(Fig. 5.1). The mRNAs coding for albumin, ApoAI and a^-PI were all
detected at relatively high levels in the VYS RNA population. By
comparison with the signal obtained using dilutions of adult liver
RNA it can be concluded that albumin and a^-PI are present at _10%
of the level found in adult liver. Surprisingly the concentration
of ApoAI RNA in the 13.5 day p.c. VYS is several fold higher than
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FIGURE 5.1.
RNA blot analysis to quantify the expression of serum protein genes
in extra-embryonic tissues relative to adult liver. 2pg of total
RNA from adult mouse liver (and dilutions) and submaxillary gland
(submax), placenta, parietal endoderm and trophoblast (PET), amnion
and VYS were size fractionated on a series of 1.5% agarose formalde¬
hyde gels and transferred to a set of nitrocellulose filters. Each
filter was probed separately but under identical conditions with
(32p) labelled cDNA corresponding to the proteins indicated.
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that in the adult liver. It has been inferred from immuno-
precipitation of radioactively labelled protein synthesis by
isolated tissue that transferrin mRNA level is expressed at high
levels in the VYS (Adamson, 1982; Janzen et al, 1982). This was
confirmed by hybridizing a labelled transferrin cDNA probe (Clissold
and Bishop, 1981) to the same series of mRNAs. The transferrin mRNA
in 13.5 p.c. VYS is also several fold higher than in adult liver.
None of these four mRNAs could be detected within RNA from 13.5 p.c.
amnion, placenta or adult submaxillary gland. In each case a weak
positive signal, corresponding to _10% of the intensity observed
with the VYS preparation, was obtained with parietal yolk sac RNA.
It is not clear whether this represents true expression of these
genes by parietal endoderm cells which are thought to arise from
primitive endoderm during development via differentiating visceral
endoderm (Hogan and Tilly, 1981). The other possibility is that the
parietal yolk sac preparations are contaminated with some VYS
material (Dziadek and Andrews, 1983).
In contrast to these results no expression was seen for MUPs or
contrapsin in 13.5 day VYS or any of the other extra-embryonic
tissues at this time. Based on a comparison with a series of liver
dilutions it can be calculated that there are <30 copies per cell of
MUP mRNA and <10 copies of contrapsin mRNA in these extra-embryonic
tissues.
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5.3. Developmental regulation of serum protein mRNA expression in
the VYS and liver
By analysis of RNA-cDNA hybridization kinetics it has been
estimated that each of these serum proteins has a characteristic
time of appearance in the liver during foetal development (Barth et
al, 1982). It was of interest to know whether this pattern of gene
expression is mimicked in the VYS which would imply that the genes
are under the same controls in the two tissues.
Figure 5.2 shows the result of an experiment in which cq-PI,
ApoAI and contrapsin mRNA levels were determined by Northern blot
analysis of total RNA preparations from VYS and livers dissected
from foetuses at the 13th and 15-18th days of pregnancy. As
reported previously there is a 10- to 20-fold increase in the levels
of cq-PI and ApoAI mRNA in the liver between 13 and 18 days (Barth
et al, 1982). However in the VYS there is little change in these
mRNAs during this period of development. At the earliest times
studied here the levels of these mRNAs are considerably higher in
the VYS than in the foetal liver. The mRNA for contrapsin is first
detectable in the liver on the 18th day of development. However as
shown in Fig. 5.2B, there is no detectable level of contrapsin
related mRNAs in the VYS at this stage of development.
5.4. Serum protein gene expression in visceral endoderm and
mesoderm
The VYS is made up of two layers, an outer epithilium of
endoderm cells, highly specialised for both the secretion and the
uptake of nutrients (Franke et al, 1983) and a mesodermal layer in
which blood islands and vessels first differentiate (Hogan et al,
1986). Synthesis of AFP and transferrin is restricted to the
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FIGURE 5.2.
RNA blot analysis to determine the developmental pattern of
expression of serum protein mRNA in the VYS and foetal liver.
2pg of total RNA from adult mouse liver (and dilutions), foetal
liver and yolk sac were treated as in Figure 5.1. The numbers 13-
refer to the days of pregnancy when the tissues were dissected at
around 12 noon e.g. on the 13th day the embryos were 13.5 days old
Panel A was probed with two (^p) labelled cDNAs corresponding
alpha^-PI and ApoAI. Panel B was probed with a cDNA corresponding
to contrapsin a member of the alpha^-antichymotrypsin (a^-achy)
family.
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endoderm layer (Dziadek and Adamson, 1978; Adamson, 1982). To see
if this is true for other serum proteins total RNA from the
separated layers (kindly provided by B.L.M. Hogan) was used in
northern blots for analysis with a^-PI and ApoAI. As shown in Fig.
5.3, a^-PI and ApoAI mRNA are present at much higher levels in the
endoderm than mesoderm. Longer autoradiographic exposure of the
filters showed some specific RNAs in the mesodermal RNA but this may
be due to incomplete separation.
5.5. Cytochrome P-450s are expressed in extrahepatic sites
A number of cDNAs corresponding to members of the P450-1, P450-
2C, P450-2B and P450-3 were used to probe northern blots of RNA from
various adult mouse tissues, all showed expression in the small
intestine (Table 5.1; Figs. 5.4 and 5.5) and except for pR17 (P450-
2B) also showed expression in the kidney. Both these organs are
associated with absorption and excretion of compounds from and to
the outside environment. What was unusual was that pTF-1 (P450-2C)
detected multiple sized transcripts in the small intestine. These
were also evident in 16 day foetal liver and 9.5 day embryo (Fig.
5.^). pR17 (P450-2B) was unusual in that mRNA transcripts were also
detected in the submaxillary gland when the level of the detection
in this experiment was unable to detect any signal in uninduced
mouse liver (Table 5.1). The two members of the inducible family
could also be shown to have different expression characteristics.
The mRNA corresponding to MClb (P450-1) had a high constitutive
level of expression in the kidney and the gut when absent elsewhere.
The MCla form had high constitutive levels in the liver and appeared
absent elsewhere in uninduced animals. Thus these also correspond
to liver specific genes which may show expression in the VYS.
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FIGURE 5.3.
RNA blot analysis to quantify the levels of expression of serum
protein genes in the VYS endoderm and mesoderm. 2pg of total RNA
from adult mouse liver (and dilutions), 13.5 day p.c. VYS endoderm
(and dilutions) and VYS mesoderm (and dilutions) were treated as in
Figure 5.1. The filter was probed with a mixture of(^^P) labelled
cDNAs for alpha^-PI and ApoAI.
 
FIGURE 5.4.
RNA blot analysis with liver derived cdNA probes to determine the
pattern of expression in mouse adult and foetal tissues. (1) lpg
of polyA+ RNA and lOpg of total RNA from mouse and human tissues
were treated as in Figure 5.1 and hybridized with (^P) labelled
probes as indicated. Abbreviations are Lv, liver; Kd; kidney;
Tes, testes; Br, brain; Sm, submaxillary gland; SI, small
intestine; M67 male human liver RNA; Y/S, yolk sac; Am, amnion;
Meso, visceral mesoderm. The probes were pLivS-8, (mouse cDNA);
pLivS-9 (mouse cDNA); pPB2-29 (human cDNA); pTF-1 (rat P450f





































RNA blot analysis with liver derived cDNA probes to determine the
pattern of expression in mouse adult and foetal tissues (2). Blots
were treated as in Figure 5.4. and abbreviations are the same as in
Figure 5.4. The probes used were (A) pLivS-11 (mouse cDNA), (B)
pLivS-7 (mouse cDNA) and (C) pLivS-5 (mouse cDNA).
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5.6. Pattern of expression of cytrochrome P-450 and unknown mouse
liver derived cDNA clones in foetal liver and yolk sac
In this section the developmental regulation of the cytochrome
P-450»and a number of liver specific genes were investigated by
northern blot analysis in uninduced animals. Figures 5.4 and 5.5.
show a series of northern blots containing RNA from extra-embryonic
tissues, foetal liver, various adult mouse tissues, whole 9.5 day
mouse embryo and human liver preparations. In general genes
expressed at high levels in 16 day foetal liver are also expressed
in 13 day yolk sac e.g. pPB2-29, pLivS-5, pLivS-8 and pLivS-9. Also
included in this category is pLivS-10 (Table 5.1). Other mRNA
species which show late developmental gene expression have low to
efc
undatable levels of expression in foetal liver and yolk sac e.g.
pTF-1, pLivS-7, pLivS-11, pPCN12, pMClb and pR17. Some cDNAs which
show low levels of expression in foetal lever also show low levels
A
of expression in the arnj^.on and visceral mesoderm, but clearly these
genes are not liver specific in their pattern of expression (Table
5.1). For example pLivS-8 is very promiscuous in its expression
pattern. pLivS-11 is not detectable in foetal liver or VYS but can
have low levels of expression in the small intestine, testes,
amnion, visceral mesoderm and 9.5 day whole embryo. Thus these
experiments seem to confirm the pattern of expression observed for
the mouse serum proteins, i.e. those ls/er genes that expressed
early in development are also expressed in the developing yolk sac.
5.7. Discussion
In this Chapter a number of liver specific genes have been
shown to have high levels of expression in the VYS as well as the
liver. It is important to consider whether the corresponding
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proteins are serving useful functions during early embryonic
developments. The presence of high levels of ApoAI mRNA in the VYS
suggests this tissue is actively synthesising and secreting other
components of high density lipoprotein (HDL) and low density
lipoprotein (LDL) particles. When yolk sacs are labelled with (^S)
methionine and proteins immunoprecipitated from the culture medium
with antisera to HDL and LDL many components corresponding to
apolip proteins ApoAI, ApoIV, ApoB and ApoE can been seen on SDS
polyacrylamide gels (Meehan et al, 1984; Shi and Heath, 1984).
Functional studies with embryonal carcinoma cell lines suggest that
HDLS can act as growth factors, presumably supplying lipids
necessary for embryonic growth (Shi and Heath, 1984; Heath and
Deller, 1983). The fate of the other serum proteins is unknown.
Also the relative contribution of the liver and VYS to the total
pool of these proteins at different stages of embryonic development
is not known. However the northern blot analysis suggests that the
VYS of the 13 day foetus has a considerably higher concentration of
some of these sequences than the liver at this stage (Fig. 5.2A).
Thus it seems reasonable to assume that these proteins together with
AFP are involved in nurturing and protecting the growing embryo
before the liver takes over these functions. The identity of many
of the liver derived cDNA clones are unknown we can only speculate
as to their function but they may correspond to other components of
HDL and LDL particles especially those showing expression in the gut
as well. The only P-450 that was detected at significant levels in
the developing embryo corresponded to members of the P450-2C gene
family. This may reflect its endogenous role in the metabolism of
steroids and other effector molecules.
One of the unknowns is whether the genes expressed in the VYS
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and foetal liver are the same. There is only one gene for albumin,
ApoAI and transferrin in the mouse so the same gene is being
expressed in both tissues. Southern blot analysis with pLivsS-5, 8,
9 and pPB2-29 show them to have a simple pattern of hybridization
(data not shown) which suggests they are single genes, therefore the
same gene is being expressed in different tissues. pLivS-7 and 10
have a more complex pattern of hybridization which is suggestive of
more than one gene. There are multiple a^-PI (Hill et al, 1985) and
P450-2C genes so it is open to question whether the same genes are
being expressed. It is obvious that multiple sized transcripts
could result from different genes, alternative splicing sites or
attenuation signals.
Studies on cell lineages in mouse embryos using chimaeras have
shown that the visceral endoderm. and liver have very different
lineages. This suggests that the two tissues are independently
programmed to express the same set of genes. It is interesting that
the haematopoietic system is also located in the VYS in the early
embryo prior to migration to the foetal liver (Moore and Metcalf,
1970). The VYS in the human is a much less prominent organ than in
the mouse but immunological studies suggest that the human yolk sac
is capable of synthesizing AFP, albumin, a^-PI and transferrin
(Gitlin and Perricelli, 1970). The possibility thus exists that
patients with teratomas and yolk sac carcinomas may have raised
levels of serum proteins such as a^-PI and apolipoproteins in
addition to AFP (Newlands and Reynolds, 1983). In future it will be
of interest to determine the cis and trans-acting factors which
control the expression of these commonly expressed genes in the
foetal liver and VYS.
The lack of expression of a number of cytochrome P-450 genes is
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intriguing. It could be assumed that the placenta provides enough
of a barrier to prevent foreign compounds harming the developing
embryo. However this is patently not the case for a number of
foreign compounds which cause a birth defect such as thalidomide.
In the next chapter it will be demonstrated that the regulation of
many cytochrome P-450s is dependent on a number of trophic factors
which are themselves expressed late in development.
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CHAPTER 6
REGULATION OF CYTOCHROME P-450 EXPRESSION
ENDOGENOUS COMPOUNDS IN RODENTS
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6.1. Introduction
An important property of P-450s is that their levels of
expression can be modulated by foreign compounds (see 1.4.3). This
can be achieved by a diverse number of mechanisms including
transcriptional activation, protein and mRNA stabilisation.
Initially inducers of drug metabolism could be divided into the
phenobarbital or 3MC type. The 3MC induction of P-450s is
associated with the MCla and MClb forms in rodents (Guengerich et
al, 1982; Negishi and Nebert, 1979). Numerous studies suggest that
this process is due to transcriptional activation of the respective
genes (Kimura et al, 1986; Gonzalez et al, 1984; Adesnik and
Atchison, 1986) which is mediated by the binding of a receptor/
inducer complex to regulatory elements located in the 5' region of
the MCla and MClb genes (Tukey et al, 1982; Durrin and Whitlock,
1987). The mechanism of action of phenobarbital in the induction
response has not been elucidated, this is primarily due to the many
structurally diverse compounds which induce in a similar manner to
phenobarbital. For example phenobarbital and trans non-achlor
treatment of rats leads to induction of PB3a and PB3b (P450-2C)
proteins as well as PB2C (P450-3) (Schuetz et al, 1986). Macrolide
antibiotics will also induce PB2C (Wrighton et al, 1985). A 23-fold
increase in transcription of PB3a and PB3b (P4-50-2B) genes is seen
one hour after treatment of rats with phenobarbital (Hardwick et al,
1983). In a similar manner PCN and dexamethazone treatment of male
Sprague-Dawley rats leads to 2.7- and 6-fold increase in the
transcription of PB2C (P450-3) genes after 6 hours and 1 hour
respectively (Simmons et al, 1987). Attempts to isolate a PB-
receptor complex in the proteins of rat serum, rat liver cytosol or
rat liver nuclei (Tierney and Bresnick, 1981) have proved
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unsuccessful. This suggests the mode of action is not by a receptor
mediated mechanism in the liver.
In the case of family P450-3 the dose of dexamethazone
required to induce these enzymes is 50 times greater than the dose
required to activate the glucorticoid receptor (Schuetz and
Guzelian, 1984) indicating that if a receptor mechanism applies, it
is different. Unlike dexamethazone, organochlorine pesticides
increase the accumulation of PB2C (P450-3) protein by decreasing its
rate of degradation when added to dexamethazone-induced primary
cultures of hepatocytes (Schuetz et al, 1986).
Within certain P-450 gene families many of the proteins are
constitutively expressed at high levels. Some of these are still
inducible by foreign compounds, others are not. Freidberg and
colleagues (1986) demonstrated that the mRNA levels of PB-1
increased four fold in male and female rats on phenobarbital
administration, whereas another member of their family, form f, was
not affected. Form f has four fold higher levels in female than
male rats. These mRNAs are switched on at puberty in male rats with
this increase appearing to be due to transcriptional activation
(Gonzalez et al, 1986a). Similar observations can be made for the
regulation of members of the P450-2A (Nagata et al, 1987), P450-3
(Gonzalez et al, 1986b), P450-2D (Gonzalez et al, 1987), P450-2E
(Song et al, 1986) and P450-4 (Hardwick et al, 1987) gene families.
Age related alterations in drug metabolizing activities can also be
observed in cytochrome P-450 content in male and female rats
(Kamataki et al, 1985). For example constitutive AHH decreases
progressively in male adult rats between the ages of 3 to 25 months.
From these types of studies it can be appreciated that there are a
number of factors which are involved in the endogenous regulation of
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cytochrome P-450 isozymes. As mentioned earlier (Chapter 5) the
inducible P-450s only become responsive to the inducing compound at
specific times during development. In the case of PB3a, Pb3j, and
MCla this appears to be postnatal in rodents. Therefore these
isozymes are subject to some form of endogenous modulation as well.
The genetic characterization of inbred mouse strains make them
a powerful model for the study of multigene families such as the P-
450 system. Nebert and colleagues have used this property
extensively for a molecular genetic characterization of the
structural loci for MCla and MClb in the mouse (Nebert and Jansen,
1979; Adesnik and Atchison, 1986; Eisen, 1986). Apart from this
and recent work by Negishi and colleagues (Noshiro et al, 1986;
Devore et al, 1986) extremely little work has been done on
cytochrome P-450s in mouse liver. This includes studies on the
regulation of the P-450 isozymes by endogenous and exogenous
inducing agents. In this Chapter factors which affect the
expression of P-450s in mice have been studied to try to ascertain
whether differences in the levels of expression exist between
£
different inbred mouse strains and to make interspecies companions
in the regulation of cytochrome P-450s in mice and rats.
6.2. Effect of phenobarbital and 3MC on mouse hepatic P-450s mRNA
The expression of PB3a (P450-2B) and PB-1 (P450-2C) gene
families by the classical P-450 inducers as well as a number of
endogenous type compounds was investigated. Figure 6.1 shows a
northern blot analysis of hepatic total RNA from CBA/Ca mice treated
with various compounds and probed with pR17 and pTF-1. It can be
seen that as in rats phenobarbital treatment induces mouse PB-1 mRNA
(pTF-1) and PB3a mRNA (pR17) (Fig.6.1C) whereas 3MC has no effect
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FIGURE 6.1.
Induction of PB^a (P450-2B) and PB-1 (P450-2C) mRNAs in mouse liver
by phenobarbital. 10pg of total RNA from the livers of CBA/Ca mice
were fractionated on formaldehyde gels, blotted and hybridized with
the indicated [32p] labelled probes. pTF-2 rat P450 PB-1 cDNA;
pR17 rat P-450 PB3a cDNA. A, control; B, injected with crude
interleukin extract; C, phenobarbital treated; D, phenobarbital
plus interleukin; E, 3MC treated; F, 3MC plus interleukin.









on the mRNA levels of these P-450s (Fig. 6.1.E). Crude extracts of
interleukin I from WEHI-TG cell culture medium did not affect the
levels of these P-450s alone or in conjunction with phenobarbital or
3MC.
6.3. Dexamethazone induces PB^a (P450-2B) mRNA in mice
The mRNA levels of PB-1 and PB3a were examined in mouse hepatic
mRNA after treatment with dexamethazone. In both BALB/c and C57BL/6
mice no effect was seen on PB-1 levels after 4 hour and 24 hour
dexamethazone treatment (Fig. 6.2). In contrast, PB3a mRNA was
induced by dexamethazone and required 24 hours for maximal effect.
The induction rate was much slower than the glucocorticoid receptor
mediated induction of metallothion^a-)^ by dexamethazone which
suggests that the mechanism of induction of PB3a may be different to
that of metallothioneine (Fig. 6.2).
6.4. Hypophysectomy induces PB-1 (P450-2C) and PB^a(P450-2B) mRNAs
in mice
A
The pituitary and hypotha]jmus are responsible for producing
many of the tropjic and stimulating hormones, notably adreno-
H
corticotropin hormone (ACTH) and growth hormone (GH) which regulate
corticosterol synthesis (Jefcoate, 1986) and are themselves
regulated by steroids (Oostrom et al, 1983; Diamond and Goodman,
tUU;c.
1985). The hypo^pituitary axis has been shown to be involved in the
regulation of male and female specific P-450s in rats (Adesnik and
Atchison, 1986). It was therefore of interest to what effect
removal of the organs would have on the levels of P-450s in the
mouse. Figure 6.3 shows that in hypophysectomized C3H/He and CBA/Ca
the hepatic levels of PB-1 and PB3a mRNAs are increased.
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FIGURE 6.2.
Dexamethazone induces PB^a (P450-2B) mRNA in the mouse. 10pg of
hepatic RNA from the indicated mouse strains were treated as in Fig.
6.1. and probed with the indicated [^2p] labelled probes. M1PEH4,
mouse metallothionein cDNA probe; pR17, rat PB3a cDNA; pTF-1, rat
f cDNA; C, control mice vehicle only; DEX 4 hr, treated with
























































Hypophysectomy induces PB-1 (P450-2C) and PB^a (P450-2B) mRNA in
mouse liver. 10pg of hepatic mRNa from the indicated mice strains
(CBA = CBA/Ca) were treated as in Figure 6.1. pTF-1, rat f cDNA
probe; pRl7, rat PB3a cDNA probe; C, control mice; Hypox,
Hypophysectomized mice; A + 0, adrenalectomized and ovarectomized;
PB, phenobarbital treated; DEX, dexamethazone treated for 24 hours
Surgically treated mice RNAs kindly provided by Dr. R. E. Hill.
 
Additionally this increase is similar to that observed on treating
mice with phenobarbital for both PB-1 and PB3a, and dexamethazone
for PB3a (Figure 6.3). This induction response was also seen in
hepatic RNA from hypophysectomized DBA/2, C57BL/6, BALB/c, Swiss and
[BALB/c x C57BL/6]Fj mice (data not shown). Also shown on this blot
(Fig. 6.3) is that female mice who have undergone adrenalectomy and
ovtfre.ctomy also show increased levels of PB3a and PB-1 hepatic mRNA
levels. Again this effect was also seen in C3H/He, DBA/2 and
C57BL/6 female mice (data not shown). As controls for these
experiments the mouse contrapsin cDNA p54 was used in the same
northern blots. The expression of this mRNA has been shown to be
abolished in hypophysectomized mice (Hill et al, 1985) but to be
unaffected by adrenalectomy or oveirectomy (R. Hill, pers. comm.).
The expression of contrapsin was only decreased in the
hypophysectomized animals (data not shown). Dexamethazone plus
hypophysectomy and dexamethazone plus phenobarbital could not
superinduce PB-1 or PB3a mRNA further (data not shown).
6.5. Effect of Dexamethazone treatment of rats on P-450 mRNA
levels
The PB3a gene is part of a multigene family of 8-10 genes in
rats and mice. In adult rats 2 major enzymes have been identified
which share 97% sequence homology (see Introduction) but these can
be distinguished by synthetic oligonucleotide probes (Omiecinski et
al, 1985). An oligomer directed towards the major phenobarbital
inducible form PB3a was synthesized (kindly provided by J. Inglis)
and used to probe northerns of rodent hepatic RNAs. Figure 6.4
summarizes a number of observations. Firstly in rats the basal
level of PB3a mRNA varies, when the basal level is high it can be
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FIGURE 6.4.
Use of a synthetic oligonucleotide probe to detect rat and mouse
hepatic PB^a mRNA. 15pg of total RNA or 2pg of poly A+ from the
livers of rat and mouse strains were treated as in Fig. 6.1. The
blot was hybridized with the mouse MClb 3' cDNA probe, pCL46, which
only detected a 23S mRNA in 3MC treated rats. The blot was
subsequently hybridized with an oligomer that distinguishes between
the PB3a and PB3b mRNAs in rats. This oligomer is directed towards
the PB3a form. The second set of Wistar RNA samples on the right of
the Figure are the polyA+ samples. Rat strains, Wistar and Dark
agout; Mouse strains, C57L (C57/L), CBA/Ca (CBA), BALB/c, C3H/He,
C57BL/6. Treatments, C, control; PB, phenobarbital; DEX,
dexamethazone; Hypo, hypophysectomy; INF, inflammed; 3MC, 3
methylchpl/nthrene; 'C 1 = female; ' ' = male.
WISTAR
OA CB7/L CBA BALB/c C3H/He C57BU6 WISTAR
induced further with phenobarbital but not with dexaraethazone. If
the basal level is low then dexamethazone can lead to the
accumulation of PB3a mRNA. Secondly this oligomer is efficient in
detecting an mRNA in mice that gives the same pattern of expression
as the pR17 rat PB3a cDNA probe when it is used in northern
analyses. The RNA detected by this oligomer increases in mice on
dexamethazone, phenobarbital and hypophysectomy treatment. Thirdly,
mice appear to have a consistently lower basal level of PB3a mRNA
when compared to rats and there is a sex difference in the pattern
of expression of PB3a in mice but not rats. Female mice have higher
basal levels of PB3a mRNA than male mice. The same series of
results can be seen when pR17 is used as a probe (data not shown).
The same northern was previously probed with the 31 end of the mouse
MClb cDNA and shown only to be induced on 3MC treatment (the high
molecular weight band in 3MC treated Wistar rat, Fig. 6.4) and not
affected by hypophysectomy or dexamethazone treatment. If the same
blot is reprobed with a human MClb cDNA clone which detects both
MCla and MClb then these mRNAs are only affected by 3MC treatment
(data not shown). In a similar manner to mice dexamethazone had no
significant effects on the levels of PB-1 mRNA levels in rats (data
not shown).
6.6. Expression of P-450 mRNAs in little mice
Little mice arose from a spontaneous mutation in C57BL/6 mice
(Eicher and Beamer, 1976). The defect due to the lit mutation
causes reduced growth rate in mice. The mutation is recessive,
adult lit/lit mice although normally proportioned are reduced in
body size because of their failure to maintain normal neonatal and
pubertal growth rates. This condition could be reversed by addition
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of growth hormone (GH) (Bearaer and Eicher, 1976). Unlike other
growth-defected mouse strains such as Snell and Ames or
hypophysectomized animals, little mice have a defect only in GH with
v.
normal levels of other pituitary hormones such as lute|nizing hormone
and follicle-stimulating hormone (Phillips et al, 1982).
Hepatic RNAs from male and female 1it/+ and lit/lit mice were
kindly provided by Dr. R. Al-Shawi and used in conjunction with
hypophysectomized, dexamethazone and pheobarbital treated hepatic
RNAs for northern analysis. In Figure 6.5 it can be seen that the
levels of PB-1 mRNA are relatively unaffected in the little mice as
compared to phenobarbital and hypophysectomy treatment. In contrast
male lit/lit mice have induced levels of PB3a mRNA but the effect is
not as great as that seen with phenobarbital, dexamethazone or
hypophysectomy treatment. Female mice have higher levels of PB3a
mRNA and removal of growth hormone from male mice appears to restore
PB3a mRNA levels to that of female levels. The same result could be
achieved with PB3a oligomer (data not shown). Interestingly in a
control experiment with pDEX (a cDNA for rat contrapsin) the levels
of contrapsin mRNA were depressed in 1it/1 it mice as in hypophy-
sectomised animals. This suggests that the levels of this mRNA are
maintained by the presence of growth hormone.
To extend the analysis a human PB2a (P450-3) cDNA, pPCNj^, was
used in similar northern blots. The mRNA level of P-450s within
this family, P450-3, also increased in mice on phenobarbital,
dexamethazone and hypophysectomy treatment (Fig 6.6). In lit/lit
male mice a slight induction was observed relative to 1it/+ males
which brought it up to the levels seen in female mice (data not
shown) but the effect was not as great as that observed in mice
which had been induced with phenobarbital, dexamethazone or by
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FIGURE 6.5.
Expression of hepatic PB^g (P450-2B) and PB-1 (P450-2C) mRNA in
little mice. 15pg of total mRNA from the indicated mice strains
were treated as in Figure 6.1 and probed with [32p] labelled pDEX
(rat contrapsin), pRl7 (rat PB3a cDNA) and pTF-1 (rat f cDNA). C,
PB (from CBA/Ca mice); C, DEX (from BALB/c mice); C, Hx (from C3H/He
mice). The little mice are on a C57BL/6 background. lit/lit
homozygous growth deficient, lit/"1" heterozygous normal growth. 'Q.'
= female; '(5 1 = male.
CBA/Ca
FIGURE 6.6.
Induction of PB?a (P450-3) in mice by phenobarbital, dexamethazone
and hypophysectomy in mice. 15pg of total RNA from the indicated
mouse and rat strains were probed with pPCNi2 (a human PB2C cDNA
probe) and pR17 (rat PB3a cDNA). PB,C from CBA/Ca mice; C, DEX from
BALB/c, C , Hx from C3H/He; <Q>, ' from C57L, ' , ' <$'
from 129, •Q ', ' S' from SD rats.
CBA/Ca BALB/c C3H/He C57L 129 SD
i 1 i i i 1 i i r-
PB C C DEX C Hx $ CT 9 Cf $ Cf
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hypophysectomy.
6.7. Effect of hypophysectomy on P-450 levels in rats
To ensure that efficient hypophysectomy had taken place in the
rats hepatic RNAs from operated and sham operated rats were probed
with pDEX (Fig. 6.7). It can be seen that in all hypophysectomized
animals that contrapsin mRNA levels have decreased due to loss of
pituitary function. In male rats hypophysectomy induces PB3a mRNA
levels slightly but has no effect on female PB3a mRNA levels. This
induction is not as pronounced as with phenobarbital treatment. The
overall levels of PB-1 mRNA were unaffected by hypophysectomy in
male rats, in contrast female hypophysectomized rats show a decrease
in PB-1 mRNA levels (Fig. 6.7). Neither PB2a or MCla and MClb mRNA
levels appeared to be affected by hypophysectomy in male or female
rats (data not shown). An anonymous human liver cDNA probe, pPB2-
29, which had been previously shown not to be induced by foreign
compounds or affected by hypophysectomy was also used to check the
relative mRNA loadings of the different preparations. The variation
in mRNA levels seen with this probe cannot account for the slight
induction or repressive effects seen for P-450 and contrapsin
related mRNAs in the hypophysectomized rat liver.
6.8. Suppression of rat and mouse PB-1 P450 during acute phase
response induced by bacterial endotoxin
Mammalian liver responds to systemic injury such as acute
inflammation by changes in the activity of a number of genes. Adult
mouse hepatocytes respond in vivo to inflammation by an increased
synthesis and secretion of a^-acid glycoprotein, haptoglobin,
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FIGURE 6.7.
Effect of hypophysectomy on hepatic P-450 levels in rats. 15)ag of
total RNA from Wistar rat liver were treated as in Figure 6.1 and
hybridized to [^2p] labelled pDEX (rat contrapsin), pR17 (rat PB3a),
pTF-1 (rat f), pPB2-29 (an anonymous human liver cDNA probe). Hx =
hypophysectomy, C = sham operated, C, control; PB, phenobarbital;
3MC, 3 methylcholanthracene. = male, 1 Q' = female.
cf 9 cf
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hemopexin and serum amyloid A. In addition the synthesis of
albumin, ApoAI and MUPs is reduced (Baumann et al, 1983; 1984). In
rats traumatic injury decreased the metabolism of a number of P-450
mediated activities (Griffith et al, 1984). Many of these responses
are thought to be mediated by lymphokines (Baumann et al, 1986;
Balkwill et al, 1984). For instance tumour necrosis factor leads to
an overall reduction in P-450 content in mice (Ghezzi et al, 1986).
This would therefore represent another form of regulation of
constitutive P-450 levels.
Male CBA/Ca mice were treated with phenobarbital, 3MC alone or
concomitant with bacterial endotoxin to assess the effect the acute
phase response had on hepatic mRNA levels of specific P-450s.
Northern blot analysis showed that the levels of PB-1 mRNA (Fig.
6.8) decreased with increasing doses of endotoxin in control
animals. The same affect was observed with phenobarbital and 3MC
treated mice who also had increasing doses of endotoxin. The reason
why the control mice in this experiment had low basal levels of PB-1
mRNA is unclear. The mRNA levels of PB3a and MCla and b were only
detected in phenobarbital and 3MC induced animals respectively and
did not appear to be affected by endotoxin treatment (data not
shown). Metallothionein was used as a marker for acute phase
response which was significantly induced by endotoxin treatment
(Fig. 6.8). Methallothionein induction by endotoxin was potentiated
when dosed with phenobarbital and 3MC. It was interesting that
metallothionein mRNA level was induced by 3MC alone. This
observation was also observed for other acute phase markers such as
serum amyloid A, fibrinogen and hemopexin (W. Liao, pers. comm.).
PB-1 mRNA was also suppressed on turpentine induced
inflammation of rats (Fig. 6.9), (RNA kindly provided by R.E. Hill)
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FIGURE 6.8.
Acute phase represses PB-1 (P450-2C) mRNA levels in mice. 10pg of
total liver RNA from CBA/Ca mice were treated as in Figure 6.1. and
hybridized to [32pj labelled pTF-1 (rat f cDNA), mipEH-4 (mouse
metallothionein cDNA). C, control mice, vehicle only, L = 2pg dose
of endotoxin; M = 7.5pg dose of endotoxin; H = 25pg dose of
endotoxin. PB = phenobarbital; 3MC, 3 methylcholanthrene.
PB 3MC
C L M H '~C L M H ""c L M H '
pTF— 1
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Inflammation represses PB-1 (P450-2C) expression in rats. 2pg of
polyA+ from rat liver RNA was treated as in Figure 6.1. and
hybridized to [^2P] labelled pTF-1 (rat f cDNA); PB, phenobarbital;
3MC, 3 methylcholanthrene; DEX, dexamethazone; Inflm, acute phase
induced rat mRNA (kindly provided by Dr. R. E. Hill).
 
but had no visible effects on PB3a on MClb levels (data not shown).
6.9. Discussion
One of the most surprising findings in the regulation
experiments was the inductive effect of dexamethazone on PB3a levels
in mice but not rats. This result led to a more comprehensive
on
biochemical analysis of this phenomena with Dr. L. M. Forrester
which demonstrated that the change in mRNA levels was reflected in
changes in protein levels and enzymatic activities. Firstly
o
increases in the metabolism of the moijfoxygenase substrates
benzphetamine, benzyloxyresorufin and pentoxyresorufin (marker
substrates for PB3a in rats [Wolf et al, 1986; Ryan et al, 1982])
were significantly elevated in mice but not rats following
dexamethazone treatment. Secondly polyclonal antibodies to rat PB3a
were used to inhibit the microsomal metabolism of benzyloxyresorufin
in rat and mouse to see if the reactions were mediated by equivalent
P-450s in both species. At the highest concentration this antibody
inhibited 95% of the metabolism of this substrate in mouse and rat
samples. Antibody to rat PB2C had no inhibitory effect on this
activity. Thirdly, Western blot analysis with PB3a, PB-1 and PB2C
antibodies agreed closley with the observations made on RNA and
activity analysis. Together these results suggest that increased
levels of PB3a mRNA observed in the mouse leads to increased levels
of PB3a protein and subsequent activities mediated by these P-450s.
A difference between rats and mice P-450 regulation has been
reported for the compound 1,4,bis[2-3,5-dichlorophyridyloxy]-
benzene[TCPOBOP] (Poland et al, 1981). TCPOBOP is a highly potent
inducer of benzphetamine metabolism in mice, a marker substrate for
'phenobarbital-1ike' induction but has no effect in rats even at
high doses. Whether TCPOBOP has other 'dexamethazone-1ike'
properties has not been established.
6.9.1. Potential mechanism of species difference
The species differences in the regulation of certain members of
the PB-1 (P450-2C), PB3a (P450-2B) and PB2C (P450-3) gene families
allows some speculation about the site and mode of action of the
compounds which regulate these proteins.
First of all growth hormone does play a role in the regulation
of these P-450 families in mice and PB-1 and PB3a in rats. Certain
members of the PB-1 family are regulated in a sex-specific manner in
mice and rats (Morgan et al, 1985; Noshiro and Negishi, 1986).
Testosterone 16a-hydroxylation is higher in male rodents than in
female rodents. Hypophysectomy abolishes this sex difference. The
male predominant expression of this activity can be restored by
pulsatile but not continuous secretion of growth hormone in lit/lit
mice (Noshiro and Negishi, 1986) and hypophysectomized rats (Morgan
et al, 1985). This observation is in agreement with previous
findings by Norstedt and Palmiter (1984) concerning the male
predominant expression of MUPs. A similar conclusion has been drawn
to explain the female specific expression of P-450^5p (P450-2C) in
rats (MacGeoch et al, 1985). This P-450 has 16 fold higher levels
in female than in male rats. Hypophysectomy reduces the sex
difference which can be restored by continuous but not pulsative
infusion of growth hormone. The northern blots using pTF-1 as a
probe will not distinguish between these two members of the P450-2C
gene family in rats or mice, thus the overall changes in the
expression of members of this gene family is being measured on
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northern blots of phenobarbital treated, hypophysectomized, adrena-
lectomized and ovarectomized and in lit/lit mice. However, it is
obvious that phenobarbital administration and surgical treatment of
normal mice has more profound effects than just the absence of
growth hormone in lit/lit mice. This implies that some other factor
besides growth hormone has a suppressing effect on the levels of
members of this gene family in mice.
The level of PB3 related mRNA is sexually dimorphic in mice but
not in rats (this study and Noshiro et al, 1986). Growth hormone
also appears to play a role in this dimorphism in mice (Noshiro and
Negishi, 1986) but again hypophysectomy has greater inducing effects
than the absence of growth hormone. The species difference in
response to dexamethazone may be related to this i.e. dexamethazone
affects the level of pituitary factors in mice but not in rats.
Adrenalectomy coupled with ovarectomy had the same effect as
hypophysectomy in mice on the levels of PB3a mRNA. The expression
of PB2a suggests a similar mode of regulation to that for PB3a in
mice and rats.
Although these experiments are by no means conclusive it does
suggest the exciting prospect that there exists a single mechanism
for the regulation of many P-450s in mice. Hypophysectomized mice
offer an assay with which to examine this process, i.e. different
pituitary factors such as ACTH can be added back to mice to see if
they can suppress the levels of the PB3a related P-450s. Does
phenobarbital act by effecting the secretion of tropic factors from
the pituitary? What effect does adrenalectomy have on P-450 levels
in the rat? Is the increase in expression in P-450s in hypophy¬
sectomized and dexamethazone treated mice due to transcriptional
activation?
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6.9.2. The phenobarbital-inducible gene family in the mouse
No differences in phenobarbital or dexamethazone inducible PB3a
mRNA levels were observed in any of the mouse strains studied. This
is interesting because the metabolism of coumarin, which has been
ascribed to the phenobarbital-inducible P-450s within the PB3
family, has been shown to be strain dependent (Wood and Cooney,
1974; Lush and Andrews, 1978; Wood and Taylor, 1979). In addition
no sex differences have been reported in the metabolism of coumarin
whereas the PB3a mediated metabolism of benzyloxyresorufin and
pentoxyresorufin is higher in female mice than in male mice (L.
Forrester, pers. comm.). This again argues that the Coh locus is
distinct from the major forms of phenobarbital inducible P-450 in
mice. It would be of interest to know whether dexamethazone or
hypophysectomy could affect coumarin hydroxylase activity in mice.
6.9.3. Extrapolation between species
There are many similarities in cytochrome P-450 isozyme
composition between species and orthologous forms between rat,
mouse, rabbit and human have been identified (Nebert et al, 1987).
However, it is clear that this gene superfamily has evolved very
rapidly and to different extents in different species. Thus the
human P-450 superfamily appears less complex than that in small
mammals. As a consequence it is difficult to establish which model
may best reflect the mechanism of isozyme regulation in humans. Do
PB3 related mRNAs in humans respond to dexamethazone and pituitary
regulation?
6.9.4. Inflammation and P-450s
The acute phase response also appear to play a role in the
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regulation of P-450 levels. The northern blot experiments have
again signposted a number of ways in which this may be investigated,
i.e. whether these probable lymphokine factors act directly or





7.1. Comparison of rodent and human P-450s
A number of factors prevent an easy extrapolation of
experimental data on P-450 function obtained in rodent models to
human experience. These are a consequence of differences in gene
number, organization, substrate specificity and regulation.
Rodents appear to have at least twice the number of PB-1 (P450-
2C), PB3a (P450-2B) and PB2b (P450-3) genes (this study, Simmons et
al, 1985; Beaune et al, 1986; J. Miles, pers. comm.). This will
undoubtedly lead to differences in detox ification (and activation
capacity) in the different species. The metabolism by P-450s within
specific gene families is often conserved although there is
increasing evidence that this is not always the case. For example,
h
mephe,ytoin is metabolized principally by PB-1 P-450 (P450C2C) in
humans (Shimada et al, 1986) but is metabolized principally by PB2b
(P450-3) in rats (Shimada and Guengerich, 1985). The steroidal
activities attributed to rat PB-1 (P450-2C) forms have not been
noted in humans (Umbenhauer et al, 1986), although steroids are
inhibitors of S-mephenytoin activity in human microsome preparations
(Inaba, 1986). In contrast constitutive AHH activity seems to
involve members of the mouse (P450-2C) multigene family (this study)
and at a functional level rat, rabbit and human purified forms of
PB-1 P-450 (Waxman and Walsh, 1983; Raucy and Johnson, 1985;
Shimada et al, 1986). This therefore seems to be a highly conserved
activity and suggests that this gene family has the potential to
play a role in the deactivation or activation of polycyclic
hydrocarbons. It is not at present clear whether orthologous forms
within the different species are performing this activity. Analysis
of the sequence relationship of the various rat, rabbit and human
PB-1 forms (Chapter 3) has not been able to satisfactorily identify
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any orthologous forms between the different species examined.
Preliminary sequence analysis suggests that the more closely related
species, rat and mouse, do have orthologous P-450 forms. It is
possible to speculate that the chemical environment experienced by
rodents is different to that of humans. House mice are best known
for their consumption of human foods but they do show a preference
for cereal grains and their derivatives (Sage, 1981). Aboreal
species of rodents also show a preference for cereals but can
indulge in insects, fungi and moss sporangia (Sage, 1981). Thus
diet, a major source of foreign chemicals to a host, is perhaps not
sufficiently different between house mice and humans to explain the
differences in gene multip licity. Whether this is also applicable
to inbred strains of mice is not known but the genomic complexity of
the P450-2C and P450-2B loci of the inbred and wild mouse strains is
very similar (Chapter 4).
Differences in gene number have been noted between human and
rodents for a number of other gene families. For example the
protease inhibitor genes alpha^-anti-trypsin and alpha^-antichymo-
trypsin exist as single copy genes on human chromosome 14 (Rabin et
al, 1986). In mice they are both members of two small multigene
families on chromosome 12 (Hill et al, 1985). The mouse major
urinary proteins are encoded by a cluster of approximately 35 genes
on chromosome 4 (Bennet et al, 1982; Bishop et al, 1982). As yet
no human homologues to the MUPs have been conclusively identified.
The multiple protease inhibitor genes has been speculated to be an
important defence against parasites in mice (Hill and Hastie, 1987)
whereas the major urinary proteins are possibly important as
carriers for behavioural cues (Shaw et al, 1983).
What are the functions of the rodent P-450s? There are three
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major possibilities:
1) They evolved as a need for detoxification.
2) They evolved as a need to metabolise hormones.
3) A mixture of 1 and 2.
In an English population of Mus musculus domesticus the warfarin
resistance gene (War) was found to reside on chromosome 7 (MacSwiney
and Wallace, 1978). In a similar manner to the P-450s, warfarin
resistance exhibits age and sex dependent variability. In the light
of the physiological regulation of P-450s in mice by hormones
(Chapter 6) it is possible to speculate that the Coh loci which maps
to chromosome 7 (P450-2B and P450-2A) could be responsible for
warfarin resistance. Interestingly total hepatic testosterone
hydroxylase activity shows circannual variation in inbred strains of
mice (Ford et al, 1979). The highest level of activity occurred in
December and was nearly four times lower by April. This variation
in testosterone metabolism existed in both sexes and showed a
reciprocal relationship to the number of births per female per
month. Whether this relationship is causal or casual is not known.
This raises the possibility that the increased number of P-450 genes
in rodent has less to do with chemical detoxification and more to do
with behavioural response to hormonal cues. This would explain why
many P-450s are responsive to changes in hormonal status.
Particularly the families which have diverged most. Transcripts
corresponding to members of the PB3 (P450-2B) gene family have been
found in the adrenal and preputial glands in uninduced rats
(AdesniK . and Atchison, 1986) and in mouse submaxillary gland
(Chapter 5). PB-1 (P450-2c) genes are expressed in human (L.
Forrester, pers. comm.) and mouse mammary tissue (data not shown).
Thus it is possible that the role of these P-450 forms is in either
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the synthesis or catabolism of hormonal factors.
Not all P-450 gene families are amplified in rodents with
respect to humans. There are only two members of P450-1 family in
all species (Nebert et al, 1987) and one member in P450-2E for both
humans and rats (Song et al, 1986). Gene number for the steroid-
iogenic P-450s is also very similar between species (Nebert et al,
1987). In spite of this, it is still feas'ble that even these P-
450s have not preserved common functions. The existence of multiple
members in other P-450 families in rodents could lead to transfer of
substrate specificity between P-450 families.
A powerful strategy for the elucidation of human P-450
substrate specificity (particularly for forms which are difficult,
if not impossible to purify) is, the cloning out of individual full-
length cDNAs and putting these cDNA clones in an expression system
such as yeast and testing in vitro for enzyme activity towards
marker substrates. This however should not be at the expense of
rodent research which offers a source of multiple P-450s which can
be utilized to determine those regions of the protein which are
important for their regulation, function and for the evolution of
new substrate specificities.
How substrate specificity relates to in vivo effects is further
complicated by the differences in P-450 regulation between species
as exemplified by the study between rats and mice, two closely
related species (Chapter 6). Dexamethazone and hypophysectomy
induces PB3a (P450-2B) in mice but not rats. Hypophysectomy also
effects the levels of other P-450s in both species. It is not known
which model best reflects the situation in humans. Regulation of
PB3 (P450C2B) is of potential pharmacological and toxicological
importance in view of the wide use of glucocorticoids in combination
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with other drugs in therapy and the high activity of certain
proteins within the PB3 family to a variety of exogenous and endo¬
genous substrates. PB?c(P450C3) has been shown to be inducible by
dexamethazone in human liver and in a human hepatoma cell line
(Molowa et al, 1986) as well as in rats and mice (Chapter 6). There
are however no reports on the effect of this compound on PB3
expression in humans. The coordinate regulation of a number of P-
450 isozymes by hypophysectomy found here indicated that foreign
compounds may exert their inductive effects by perturbing the
hypothalmus and pituitary rather than by direct effects on the
liver. This also raises other intriguing questions. For example
at what level of control is induction by hypophysectomy regulated,
i.e. is it by a transcriptional or post-transcriptional mechanism?
Another experimental approach to study the regulation of human P-
450s is to isolate the genomic clones for these genes and make
transgenic mice which carry these genes (Palmiter and Brinster,
1986). The factors which regulate these genes in mice could provide
clues to their endogenous regulation in humans, i.e. are they sex
specific and do they respond in the same way as their mouse
counterparts?
7.2. P-450s in other species
Sequence comparisons, indicate that the mammalian cytochrome P-
450 gene families arose from a primordial gene and through a series
of gene duplications and gave rise to a series of distinct gene
families. The hybridization of rat pTF-1 (P450-2C) and pR17 (P450-
2B) to Southern blots of DNA from diverse species is shown in Figure
7.1. The signal intensity is intense in mammals which are closely
- 192 -
FIGURE 7.1.
Southern blot analysis of a variety of genomic DNA samples probed
with pTF-1 (P450-2C) and pR17/p5'2 (P450-2B). In the case of pTF-
5pg of the indicated DNAs were digested with BamHI and used on
Southern analysis. M.Sp, Mus spretus; M.M., Mus mus musculus;
M.D. Mus mus domesticus. In the pR17/p5'2 Southern 5yig of the
indicated DNAs were digested and Southern blotted.
I











related to rat such as mouse and Chinese hamster. Significant
hybridization can also be seen for more distantly related species
including chicken, rainbow trout and the African clawed toad
(Xenopus). On other blots signal could also be detected with
Drosophila melanogaster and Saccharomyces cerevisae DNA samples. In
the latter case the same signal was detected in S.cerevisae with
both pTF-1 and pR17 cDNA probes (data not shown) which may indicate
a common ancestral region. Oligomers to conserved regions of
cytochrome P-450 also detect specific bands in Southern blots of DNA
from diverse species (Fig. 7.2). Both C128 and C129 which are
derived from the rat PB3a cDNA (see Materials and Methods) detect
DNA fragments in rat, mouse Chinese hamster, human and Drosophila
melanogaster (Figure 7.2). These data suggest that there is a high
degree of conservation of these genes and it is clear that in many
species several genes must exist in each family. In Chapter 3 we
saw that the C128 oligomer detected cDNAs from distinct P-450
families. If this is used in northerns to rodent RNA samples
(Figure 7.3) several distinct transcripts can be observed in rat
liver, one of which is highly phenobarbital inducible and probably
corresponds to PB3a (P450-2B) mRNA. A lower molecular weight mRNA
probably corresponds to a PB-1 (P450-2C) transcript whilst the
identity of an even lower molecular weight transcript is unknown.
Multiple transcripts can also be observed in mouse liver and other
tissues notably 15 day foetal liver and possibly the yolk sac. This
suggests there may be foetal forms of expressed P-450s. If
oligomers to the PB3a (P450-2C) hypervariable region of rat and
mouse are used in Southern blots they also detect a large number of
fragments in rat, mouse and human genomic DNA (Figure 7.4). The rat
PB3a oligomer detected the highly phenobarbital inducible mRNA in
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FIGURE 7.2.
Southern blot analysis of a variety of DNAs probed with oligo¬
nucleotides derived from rat PB^a (P450-2B). 10pg of the indicated
DNA samples were digested with PstI and Southern blotted. Mouse
DNAs, DBA/2, L cell, PC13; Chinese hamster, CHO; Rat; human;
chimp, chimpanzee; HepG2 human liver hepatoma cell line;
Drosophilia, Drosophila melanogaster.
Detection of sequences homologous to an
oligonucleotide directed against a conserved region
of the rat PB-3 gene. CL- 2-%
Southern analysis of DNA's from different
species using an oligonucleotide directed
against the heme binding region of a rat / 2 c\
P.450 gene-PB-1, PB-3.
FIGURE 7.3.
Northern blot analysis of rodent tissue RNA samples with C128
oligomer. 10pg of total RNA or 2pg of polyA+ RNA were fractionated
on formaldehyde gels and northern blotted. Lv, liver; Tes, testes
kd, kidney; S.I., small intestine; Sm, submaxillary gland; Br,
brain; Y/s visceral yolk sac; Am, amnion; Ms, visceral mesoderm;
En, visceral endoderm; 15d f.l., 15 day foetal liver. C = control
PB = phenobarbital treated; 3MC = 3 methylcholanthrene treated; 4
hr DEX, 4 hour dexamethazone treated; 24 hr DEX; 24 dexamethazone





Mouse Poly A+ Mouse total RNA
Hybridization of CL28 oligo (Rat PB3a,cys152) to rodent RNA samples.
FIGURE 7.4.
Southern blot analyses of rodent and primate DNAs with rat and mouse
PB^a (P450-2B "hypervariable" oligomers. 5pg of the indicated DNA
samples were digested with BamHI and probed with the indicated
oligomers.
 
rats and mice (Chapter 6) whilst the mouse oligomer detected
multiple transcripts on Northern blots none of which is
phenobarbital inducible (data not shown). It now appears that the
original sequence analysis of mouse PB3a was wrong (D.W. Nebert,
pers. comm.) which would explain the unusual results obtained with
this oligonucleotide. From this brief analysis it can be
appreciated that many organisms contain cytochrome P-450s which have
become adapted to specific functional requirements of the organism.
As such by our present analysis they represent a highly maleable
system for the metabolism polycyclic aromatic hydrocarbons.
7.3. Conclusion
The study of the rodent liver cytochrome P-450s offers an
opportunity for a fuller understanding of the cellular, hormonal and
genetic factors which determine tissue and species specific patterns
of P-450 gene expression. An investigation of closely related
species such as the genus Mus may provide comparisons with which to
devise mechanisms for the evolution of substrate specificity and
function for the P-450 gene families. A comparison of rodent and
human PB-1 (P450-2C) gene families has identified similarities in
forms of linkage groups and selected metabolic activities but
significant differences in relation to gene number and by inference
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1) The typing errors have been corrected.
2) The strain of bacteriophage lambda used was c1857 Sam7 from Boehringer
Mannheim.
3)It is apparent from biochemical analysis that there is a multiplicity
of P450 forms corresponding to P450IIC in rodent and human liver microsomal
preparations(Shimada et al,1986 Gut;at al,1986;Wolf et al,1986).
These obsevations have been reinforced by the isolation of distinct
cDNAs coding for these forms in rat(Friedberg etal,!987) and human(Meehan
et al,1988;Umbenhauer et al,1987;0kino et al,1987,3.B.C.,262,16072
-16079). Southern blots with human and rodent P450IIC cDNAs
to both human and rodent genomic DNA detects numerous hybridizing fragments.
Sequence analysis shows that a high degree of identity exists between
different forms of P450IIC in and between rodent and human(Meehan
et al,1988;0kino et al,1987). Therefore gene fragments identified
on Southern blots with a distinct P450IIC probe,e.g. pHL5,5 in figure
3.9, also correspond to related P450IIC genes. To get a minimum
estimate of gene number,identical Southern blots of human and
rodent genomic DNA were probed with 5' and 3' human(figures3.12;3.13)
and rodent(figures4.3;4.15) cDNA probes. Firstly it is apparent
that the complexity of hybridization observed in rodent is
greater, three times, than human irrespective of wheather
a human or rodent probe is used. Secondly the distinct halves
of the cDNA probes pick up a number of fragments in common.
These fragments must represent pieces of DNA where the two
probes are contigious and minimally could represent a distinct
gene. When a number of fragments are seen in common this must
M
represent a minium gene count for the restriction enzyme used.
ii
The estimate for the minimum number of P450IIC genes in humans
was two to three,and three times that number in rodents,and agrees with
estimates made on molecular cloning and biochemical analysis.There is
no conflict between the estimates as stated in the abstract about gene
number for P450IIc gene family in human and rodent,and the experimental
evidence presented in chapters 3 and 4.
4) The freguency of recessive poor metabolizera of mephenytoin in the
British Caucasian population has been recalculated using the Hardy-
Weinberg equilibrium eguation.
3) All the additional CXB RI strains were developed by Dr.J.HILGERS
(J.Hilgers,pers. comm.)
6)The hybrids used un this study were not charaacterized cytologicaly
but only by the use of biochemical and molecular markers. Therefore the
table of hybrids on page 154 cannot be presented in a more conventional
manner(see Hikens et al,1986, for details of somatic cell hybrid
construction and marker analysis). The assignment of P4502C to
chromosome 19 in mouse was supported by iun situ hybridization analysis
of mouse metaphase chromosomes and by apparent synteny with the human
locus. Linkage analysis of a set of interspecific mouse backcross
is being investigated using mouse chromosome 19 markers gnd P4502C.
7) The text description onpage 152 referring to figure4.16 has been
ammended.
8) Size markers have been included for figure 4.17.
9) A number of criteria were used to ascertain the integrity of RNA
samples; by O.D. absorbance at 320,280,260 and 240nm, by visualization
of RNA on ethidium bromide stained denaturing gels and comparing to a
set of standards, and by blotting with a battery of liver derived cDNA
probes. Treatments know to effect particular RNA species were checked
with the corresponding cDNA.
iii
Only effects of greater than five fold were taken to be significant in
the experiments assesing the regulation of P450 mRNA levels.
